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Abstract 
Clinical isolates of Plasmodium falciparum frequently consist of multiple genotypes, 
particularly within areas of high infection endemicity. Understanding these infections is 
important, as they have been linked to traits including drug resistance and virulence. I 
compared interpretations on within-host diversity from the allele-frequency based FWS 
index on whole-genome sequence data within a set of clinical isolates with 
microsatellite genotyping. Whilst there is significant correlation between the two 
methodologies, over half of isolates consist predominantly of a single genotype by FWS, 
yet possess multiple genotypes through the microsatellite typing, thus providing 
correlative and complementary information. Furthermore, genomic diversity within an 
infection can be produced by meiotic recombination between heterozygous haploid 
gametes, classical superinfection, or arise through de novo mutation. I applied FWS as a 
genome-wide scan of diversity within four West African populations. Through two 
approaches, utilising gene and bootstrapped SNP scores of FWS, I attempted to identify 
loci with consistently high levels of within-host homozygosity relative to their within-
population heterozygosity, that were posited to be under within-host directional 
selection. These approaches did not consistently identify outlier loci across the four 
populations, but I discuss alternative approaches to identify targets of within-host 
selection. 
 
Experimental work performed within rodent malaria species has reported that growth 
and gametocytogenesis are two plastic phenotypes affected by the presence of a 
competitor genotype. Utilising qPCR assays, comparison of the expression levels of 
the gametocyte commitment markers AP2-G and GDV-1, in addition to the sex-specific 
markers Pfs25 and Pfs230p, between two West African populations of differing 
transmission intensity, were all not significantly different. In addition, I designed a multi-
cycle low starting density growth assay, initially using four laboratory clones, finding 
mean parasite multiplication rate (PMR) of these clones to range from 7.59 to 10.53 
over the assay. When applied to fourteen recently adapted ex vivo clinical isolates, 
mean PMR was much lower at 2.90, with a range of 1.97 to 4.10. In combination with 
allele-specific qPCR, the growth assay was applied to assess competitive growth of the 
four laboratory clones, with no evidence of a significant induced plastic growth 
response of any clone. Together, these approaches will enable competitive growth 
studies of clinical isolates. The baseline quantitative data provided in this thesis 
supports the investigation of plastic phenotypes of P. falciparum. 
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Chapter 1. Introduction 
1.1 Clinical burden of Plasmodium falciparum 
P. falciparum is a protozoan parasite within the phylum Apicomplexa and is the 
major causative agent of human malaria cases globally. Within the rest of the 
genus Plasmodium, five other species are also known to cause human 
infections; P. vivax, P.malariae, P. ovale wallikeri, P. ovale curtisi and P. 
knowlesi.  Greater than 2 billion people are estimated to be at risk of infection 
from P. falciparum (Gething et al. 2011), with endemic regions stretching across 
Africa, the Middle East, Central and South-East Asia and Latin America (Figure 
1.1). Recent estimates by the World Health Organization have put the annual 
total number of cases of the disease caused by P. falciparum at approximately 
200 million globally, with P. vivax being the second species of Plasmodium 
most greatly responsible for cases with just under 14 million annually (World 
Health Organization 2015). Despite public health interventions within sub-
Saharan Africa having decreased the incidence of P. falciparum by 40% within 
the last 15 years (Bhatt et al. 2015), this region continues to be the major focus 
of cases, with greater than 85% of malaria cases occurring here, of which 70% 
of fatalities are seen within children under the age of five (World Health 
Organization 2015). In addition, the presence of widespread malaria cases 
within a country has been estimated to limit economic growth by 1.3% annually 
when other socioeconomic factors including human capital are taken into 
account (Gallup & Sachs 2001). Across sub-Saharan West Africa, there is a 
range of endemicity due to the presence of a north-south transmission gradient 
that is driven by the season and volume of rainfall across the region (Hay et al. 
2009), but is also associated with the intensity of local control programmes.  
17 
 
  
 
 
 
 
 
 
 
Figure 1.1 Distributions of global transmission intensity and infection endemicity within the African continent. Panel 
A) highlights differences in the entomological inoculation rate (PfEIR) across different global regions, while panel B) is a 1km2 
spatial resolution map where P. falciparum parasite rate (PfPR) was calculated from the prevalence of infection within children 
between the ages of 2 and 10 in 2010 (adapted from Gething et al. 2011 and Noor et al. 2014 respectively). 
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1.2The life cycle of P. falciparum 
1.2.1 Pre-erythrocytic stages 
P. falciparum possesses an indirect life cycle consisting of a human host and 
female Anopheles species mosquito vector (Figure 1.2). Human infection is 
initiated when the mosquito vector takes a blood meal from the host, thus biting 
and injecting sporozoites into the human dermis (Ponnudurai et al. 1991), prior 
to reaching the bloodstream. Although approximately 10000 sporozoites have 
been estimated to be present within the salivary glands of the infected 
mosquito, a median of <50 sporozoites have been found to be injected into the 
human host (Rosenberg et al. 1990). The sporozoites make their way through 
the vascular system towards the liver where they invade hepatocytes, form a 
parasitophorous vacuole and develop into hepatocytic schizonts, with 
thousands of daughter merozoite cells produced for each of the initial 
sporozoites that successfully invaded (Prudencio et al. 2006). This represents 
the end of pre- erythrocytic development, with the daughter merozoite cells 
being fully developed after approximately 7 days (Vaughan et al. 2012; Soulard 
et al. 2015),  which rupture and invade into erythrocytes. 
1.2.2 Erythrocytic asexual stages  
The intraerythrocytic asexual cycle of P. falciparum is approximately 48 hours in 
duration, although this can vary considerably between 43 and 51 hours for 
different cultured lines in vitro (Reilly Ayala et al. 2010). A recently invaded 
merozoite will develop into a ring stage, which feeds on the host erythrocyte 
through a cytostome, which is an infolding of the parasitophorous vacuolar 
membrane and the parasite plasma membrane. Erythrocyte cytoplasm is taken 
up through the cytostome and haemoglobin is trafficked to the parasite digestive 
19 
 
 Figure 1.2 The life cycle of Plasmodium falciparum. Included within the 
figure are the hepatocytic, intraerythrocytic and mosquito stages (Bannister & 
Mitchell 2003). 
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vacuole inside double-membrane vesicles (Milani et al. 2015). The ring stage is 
commonly seen by microscopy within clinical infections and subsequently 
develops into the trophozoite stage, during which period the majority of the 
surrounding host cell cytoplasm is ingested (Francis et al. 1997). Following this, 
at approximately the 32 hour timepoint for a P. falciparum parasite with a 48 
hour intraerythrocytic cycle, the trophozoite begins to undergo nuclear division, 
developing into erythrocytic schizonts consisting of between approximately 16 
and 32 daughter merozoite cells. Trophozoite and schizont stages are not seen 
microscopically within the peripheral blood system in clinical infections due to 
parasite sequestration within organs (Miller 1969). Synchronous egress of large 
numbers of merozoites from schizonts is responsible for the periodic fevers 
consistent with the length of the replication cycle (Kwiatkowski & Nowak 1991), 
due to the release of pyrogenic parasite toxins that are recognised by innate 
host immune cells, which induce a thermoregulatory response through the 
production of inflammatory cytokines (Oakley et al. 2011). 
The asexual erythrocyte stages are responsible for the clinical manifestations of 
the disease (Figure 1.2), and may reach a level of 1 x 1012 parasites or more 
within an individual who has a case of severe malaria (Dondorp et al. 2005). A 
considerable proportion of adults within highly endemic areas can harbour 
asymptomatic infections (Okell et al. 2009), whilst approximately 1% of 
symptomatic infections result in severe malaria (Miller et al. 2013). The clinical 
syndromes seen within severe cases of malaria can include anaemia, 
respiratory difficulties, metabolic acidosis and cerebral malaria (Mackintosh et 
al. 2004). The trophozoite and schizont stages of the intraerythrocytic cycle play 
a significant role within the clinical pathogenesis of the disease, as it is during 
this period that the protein P. falciparum erythrocyte membrane protein-1 
21 
 
(PfEMP1) is exported to the surface of the erythrocyte and subsequently 
induces sequestration of these stages to endothelial cells, preventing immune 
clearance and potentially causing organ damage (Miller et al. 2013). 
 
1.2.3 Sexual stages 
Within the intraerythrocytic stages, a small proportion of parasites become 
committed to development into the sexual life cycle stages, known as 
gametocytes, which facilitate transmission from the human host into the 
mosquito vector. The process of gametocyte development takes between 8 to 
12 days (Sinden 2009) and has been reported through histological examination 
to be principally undertaken within the bone marrow of the host (Joice et al. 
2014). All merozoites present within an erythrocytic schizont are either 
committed to undergo gametocytogenesis (Bruce et al. 1990) or to remain 
asexually replicating. Those that are committed to sexual development, 
following invasion of a new erythrocyte, slowly develop through the five stages 
of gametocytes that have been morphologically characterised, resulting in 
distinct female and male stage V gametocytes (Talman et al. 2004), which are 
released from the bone marrow into the peripheral bloodstream. 
For P. falciparum to complete its life cycle, the male and female gametocytes 
are ingested in a mosquito blood meal, differentiating into their sex-specific 
gamete forms, before the exflagellated male microgamete penetrates the 
female macrogamete to produce a diploid zygotic stage. It is during this stage 
that meiotic recombination can occur (Sinden & Hartley 1985) and if the 
macrogamete and microgamete are of different genotypes, then this will result 
in the generation of novel allelic combinations across the genome (Walliker et 
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al. 1987) (section 1.4). The diploid zygote develops within 24 hours into a motile 
ookinete form, which navigates itself into a position on the midgut wall and 
differentiates into an oocyst. Subsequently, the oocyst undergoes around ten 
rounds of nuclear division (Gerald et al. 2011), forming thousands of haploid 
sporozoites over approximately two weeks (Angrisano et al. 2012; Baton & 
Ranford-Cartwright 2005). 
 
1.3 P. falciparum genomics 
1.3.1 The genome of P. falciparum 
The haploid nuclear genome of P. falciparum is just over 23 million nucleotides 
in length and is organised into 14 linear chromosomes. Chromosome sizes 
range from ~0.65Mb up to ~3.29Mb (Gardner et al. 2002) and approximately 
5400 genes have been described. In addition to the nuclear genome, P. 
falciparum also possesses two organellar genomes, a ~35kb apicoplast 
genome (Wilson et al. 1996) and a ~6kb mitochondrial genome (Feagin 1994). 
For the majority of its life cycle, the genome of P. falciparum is haploid, 
becoming diploid briefly only within the mosquito stages following the fusion of 
male and female gametes uptaken during a blood meal (Figure 1.2). The rate of 
meiotic crossover within P. falciparum has been shown to range from 
approximately 10 to 15kb per centimorgan (Su et al. 1999; Jiang et al. 2011). 
Genomic variation can also be generated in the human intraerythrocytic stages 
of the disease through mitotic recombination and is particularly concentrated in 
immune evasion gene families located within sub-telomeric chromosomal 
regions (Bopp et al. 2013). Pairwise single nucleotide polymorphism (SNP) 
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diversity has been estimated at 1.16 x 10-3 from sequencing of laboratory 
clones and clinical isolates (Volkman et al. 2007).  
 
A highly AT-rich nuclear genome, at greater than 80% of A and T, gives 
difficulty in sequencing some parts, particularly intergenic regions. Whilst the 
original reference genome sequence for P. falciparum clone 3D7 was produced 
through a whole chromosome shotgun sequencing strategy (Gardner et al. 
2002), the development of next-generation sequencing technologies provided a 
comparatively cheap method to sequence entire genomes in a single run, of 
which Illumina quickly became a market leader using fluorescent reversible 
nucleotides (Metzker 2010; Bentley et al. 2008). Due to the AT-bias, standard 
library preparation methods for Illumina sequencing, which utilise polymerase 
chain reaction (PCR) amplification, were shown to introduce artefacts through 
preferential amplification of genome regions with balanced nucleotide content 
(Kozarewa et al. 2009). However, with sequencing of clinical P. falciparum 
isolates often required to be performed with low quantities of initial parasite 
genomic material, novel methods have begun to reduce the challenges of 
sequencing these biased genomes (Oyola et al. 2012).  One advantage of 
applying a next-generation sequencing technology such as Illumina to clinical 
infections of P. falciparum is to be able to go ‘deep’ beyond the consensus 
sequence to assay genomic variation of P. falciparum within an individual 
(Manske et al. 2012). In addition, this technological advance has begun to allow 
for large scale population level sequencing analyses aimed at identifying 
genome regions under selective processes (section 1.3.2 and Figure 1.3) due to 
pressures such as drug resistance and host immune evasion (Park et al. 2012; 
Amambua-Ngwa et al. 2012), with global consortia efforts having sequenced  
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Figure 1.3 Schematic diagram of the type of allele frequency distributions 
at loci under A) balancing selection, B) neutrality and C) directional 
selection within a haploid population. Each black line represents an 
individual haploid P. falciparum genome within the intraerythrocytic stages of 
infection, with ten individual genomes in each case, whilst blue dots represent 
the location of alleles differing from the majority type (adapted from Weedall & 
Conway 2010).  Whilst under neutrality, the accumulation and maintenance of 
polymorphism is effectively random, being only influenced by genetic drift or 
mutation and is not under selection. Balancing selection will keep population 
alleles at relatively intermediary frequencies, whilst directional selection will 
skew the frequency of one allele over another. 
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over 2500 genomes of P. falciparum (MalariaGEN 2016). Gene expression 
throughout the intraerythrocytic cycle has been profiled using both microarray 
based and RNA-sequencing approaches (Le Roch et al. 2003; Bozdech et al. 
2003; Otto et al. 2010). Moreover, population level transcriptomic studies have 
elucidated the upregulation of transcripts involved in artemisinin resistance from 
natural populations (Mok et al. 2015) and probed correlations between host and 
parasite transcriptional responses (Yamagishi et al. 2014). 
 
1.3.2 Population genomic scans of selection in P. falciparum 
Allele frequency based tests have historically been applied to assess evidence 
of selection operating on the nucleotide sequence of P. falciparum on a per 
locus-of-interest basis. These studies utilised metrics such as Tajima’s D 
(Tajima 1989), which assesses the number of segregating sites and the 
average number of pairwise nucleotide differences within a given sequence,  to 
investigate evidence for potential balancing selection signatures in proposed 
vaccine candidate genes (Polley & Conway 2001; Conway et al. 2000; Baum et 
al. 2003), calculated measures of inter-population divergence at particular loci 
through the use of FST (Drakeley et al. 1996; Conway et al. 2001) or for 
evidence of heterozygous deficiency within the diploid oocyst stage of infection 
from dissected mosquitoes (Anthony et al. 2007; Mzilahowa et al. 2007; Hill et 
al. 1995). With the increased availability of P. falciparum DNA sequence data, 
application of such tests has progressed from analyses of individual loci, to 
comparisons of multiple candidate loci (Tetteh et al. 2009; Ochola et al. 2010). 
Subsequently, the advent of next-generation sequencing technologies (section 
1.3.1) has paved the way for the use of whole genome approaches to identify 
evidence of natural selection on a variety of model and natural organisms 
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across a range of taxa (Haasl & Payseur 2015). High density maps of 
polymorphic genomic markers have allowed for genome-wide analyses of 
variation and selection upon the P. falciparum within geographically distinct 
parasites, in addition to comparative genomic studies across the Plasmodium 
genus that have uncovered signatures of adaptive evolution within the P. 
falciparum genome (Otto et al. 2014; Sundararaman et al. 2016).  
Supported by sequencing projects (Manske et al. 2012; Miotto et al. 2013; 
MalariaGEN 2016), genome scan based methods have been adopted for the 
detection of signatures of selection operating on whole  P. falciparum genomes 
sequenced from clinical isolates. These analyses have applied haplotype-based 
methods to identify genome regions that show evidence of directional selection 
(Cheeseman et al. 2012; Park et al. 2012; Takala-Harrison et al. 2013; Miotto et 
al. 2013; Nwakanma et al. 2014; Ocholla et al. 2014), which is often associated 
with drug resistance evolution. In addition, a whole genome scan approach has 
been utilised to identify candidate loci under balancing selection (Amambua-
Ngwa et al. 2012, Mobegi et al. 2014). Some of the latter signatures are 
predicted to be under host immune selective forces (Weedall & Conway 2010). 
Furthermore, FST based genome scans have also been applied to look for loci 
that are extremely geographically divergent between P. falciparum populations 
and thus may be under local selective pressures.  This approach has previously 
been used to identify loci that have been implicated within a sub-population 
specific artemisinin slow clearance phenotype and gametocytogenesis 
(Cheeseman et al. 2012; Miotto et al. 2013; Mobegi et al. 2014; Duffy et al. 
2015). 
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1.4. Sexual recombination within P. falciparum 
P. falciparum is known to have a high recombination rate, consistent with cross-
fertilisation within experimental genetic crosses between laboratory clones 
(Walliker et al. 1987; Ranford-Cartwright et al. 1993) and measurement of 
reduced levels of linkage disequilibrium over increasing physical genetic 
distance along a chromosome (Conway et al. 1999; Manske et al. 2012). Within 
areas of higher transmission intensity there is very little linkage disequilibrium 
(Anderson et al. 2000) and a high level of outbreeding as shown by oocyst 
stages containing products of meiosis at polymorphic loci (Ranford-Cartwright et 
al. 1991; Paul et al. 1995; Mzilahowa et al. 2007; Anthony et al. 2007). 
Recent comparative analyses of the frequency of novel SNP and indel variants 
found in progeny from three distinct genetic crosses (Walliker et al. 1987; 
Wellems et al. 1990; Hayton et al. 2008) have shown that whilst the generation 
of indels appears to occur approximately at twice the level of SNPs across the 
whole genome, within coding regions, SNPs account for around two-thirds of 
the novel variants produced (Miles et al. 2016). Whilst experimental estimations 
of the meiotic recombination rate derived from crosses appears to be much 
higher than that of other Apicomplexans (Katzer et al. 2011; Tanriverdi et al. 
2007; Ranford-Cartwright & Mwangi 2012), the effective rate of recombination 
that is actually seen within natural populations is significantly lower than this. 
This is due to the possibility of selfing occurring at meiosis between two 
genetically identical haploid gametes (Figure 1.4). The probability of selfing 
happening is lower within natural populations that exist within areas of higher 
transmission intensity, where a high proportion of infections consist of more 
than one individual genotype. Thus within many African parasite populations, 
rates of effective recombination are higher than within populations where  
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Figure 1.4 Outcomes of sexual recombination within the mosquito vector 
for P. falciparum. Within this example, 5 haploid gametocytes of a different 
genotypic background (A-E) have been uptaken within a blood meal by the 
mosquito and have produced random diploid zygotic stages. Following meiotic 
recombination, the pairwise levels of identity-by-descent (IBD) that exist 
between the haploid, sporozoite progeny are displayed, with one example of 
selfing and thus pairwise IBD of 100% having occurred, whilst all other progeny 
are produced by meiosis of different genotypes (adapted from Nkhoma et al. 
2012). 
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infection endemicity is lower (Conway et al. 1999; Anderson et al. 2000; 
Anderson 2004). 
 
1.5 Investigating the within-host diversity of P. falciparum infections 
1.5.1 PCR-based approaches 
Whilst pioneering studies utilised isoenzyme electrophoresis (Carter & 
McGregor 1973) and differential monoclonal antibody staining using indirect 
immunofluorescence (Conway et al. 1991), since the early 1990s and the 
advent of widespread use of the polymerase chain reaction (PCR), studies into 
P. falciparum within-host diversity have focused on the use of PCR-based 
genotyping to distinguish between distinct parasite clones. Such assays offer 
low cost, sensitive methods able to discriminate P. falciparum genotypes 
present at certain loci. Commonly analysed targets including the single-copy 
genes encoding merozoite surface protein-1 (MSP1), merozoite surface protein-
2 (MSP2) and glutamate rich protein (GLURP) (Snounou et al. 1993; Farnert et 
al. 2001). Focusing on the measurement of multiplicity of infection (MOI) at such 
loci has continued to be used widely to provide information on overall infection 
complexity (e.g. Paul et al. 1995; Owusu-Agyei et al.2009; Stresman et al. 
2014). These approaches however are limited by the number of loci that are 
used to discriminate between genotypes and varying conclusions on the 
multiplicity of infection have been seen even in assays undertaken by different 
laboratories (Farnert et al. 2001).  
To further detail the within-host diversity and population structure of P. 
falciparum infections, selectively neutral polymorphic microsatellite markers 
have been utilised to provide a measure of the number of alleles detectable at 
30 
 
multiple loci across the genome (Anderson et al. 1999). Profiling of the genetic 
diversity present within multiple populations globally, revealed population 
structures that ranged from being highly clonal and in strong linkage 
disequilibrium within areas of low transmission towards more interbreeding and 
almost panmictic populations within areas with higher rates of transmission 
(Anderson et al. 2000). Subsequently, application of these methods has 
characterised the genetic structure of P. falciparum within many different 
locations (e.g. Machado et al. 2004; Schultz et al. 2010; Pumpaibool et al. 2009; 
Iwagami et al. 2009), which have advanced local understanding of 
epidemiology. A recent systematic characterisation of population structure 
within the West African region using ten locus microsatellite typing within the 
region has found more genotypically mixed infections within more southern 
populations, where rainfall is generally higher and infection endemicity is 
greater  (Hay et al. 2009; Mobegi et al. 2012).  
 In addition, SNP-based barcode methods have also been designed using 
SNPs with high population minor allele frequency across global populations at 
>=24 positions across the genome, with the possibility to be performed on a 
real-time PCR machine that allows for simpler application of multi-locus 
genotyping (Daniels et al. 2008; Sisya et al. 2015). A combination of PCR-
based approaches, ex vivo manipulation and propagation of clinical isolates 
offers a powerful system for the dissection of the within-host diversity of P. 
falciparum infections. Barcode based genotyping methods have been used 
alongside such low-throughput physical separation of genetically distinct P. 
falciparum clones by limiting dilution (Nkhoma et al. 2012) to highlight that P. 
falciparum parasites can show a spectrum of relatedness, confirming the 
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findings of an earlier study which had analysed clones from only two isolates 
(Druihle et al. 1998). 
The genetic spectrum of relatedness seen within P. falciparum infections is 
driven by their recent history of sexual recombination, which can occur between 
distinct or clonal genotypes (section 1.4). Within an infection, pairwise 
comparisons of nucleotide variation between isolated clones can reveal 
chromosomal haplotypes which show evidence of having been inherited from a 
shared ancestor, known as identity-by-descent (Browning & Browning 2012). A 
pair of parasites whose recent ancestors have undergone sequential rounds of 
meiosis with another distinct genotype, will possess relatively short and 
infrequent identical chromosomal regions, whilst two parasites that have 
experienced recent rounds of recombination with a closely related genotype at 
meiosis, will have longer shared regions. Genome-wide profiling of clones 
isolated from infections has revealed that average levels of relatedness, as 
determined through calculation of pairwise allele-sharing, is higher between 
parasites found within than between infections and attributable to the 
inoculation of genetically related sporozoites within the mosquito vector (section 
1.2.1). In addition, genotypically distinct haplotypes within an infection can show 
evidence of extreme levels of relatedness (Figure 1.5), with a low proportion of 
pairwise allelic differences or contain unrelated parasites that are alternatively 
the result of classical superinfection (Nkhoma et al. 2012; Nair et al. 2014).  
1.5.2 Sequencing based approaches 
The first deep-sequencing study to investigate within-host diversity at a small 
selection of loci applied massively parallel pyrosequencing to quantify the 
number of unique allelic variants found within certain commonly used  
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Figure 1.5 High levels of relatedness between six genotypically distinct 
parasites isolated by limiting dilution cloning from a clinical isolate. The x-
axis marks the chromosomal position of each SNP, which are found at the ticks 
at the top of each of the 14 chromosomes of P. falciparum. The six different 
haplotypes are represented by the six different blocks, which are clear at 
chromosomal regions that are shared with the haplotype seen within the first 
block and black at loci which possess the alternate SNP. Within this Malawian 
isolate, the top two haplotypes are distinct at only 9 SNP positions out of 316, 
which can be seen on chromosomes 3, 10 and 13 (adapted from Nkhoma et al. 
2012). 
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genotyping loci, MSP1-block 2 and MSP2, uncovering consistently greater 
numbers of variants using the deep sequence approach over PCR-based 
genotyping for a small number of Cambodian and Malawian isolates (Juliano et 
al. 2010). This approach has been extended further to characterise the 
haplotype diversity of the circumsporozoite protein, which is the target of the 
RTS/S vaccine candidate (Bailey et al. 2012) and to probe longitudinal within-
infection subpopulation specific responses during artemisinin treatment (Mideo 
et al. 2016).  
Due to the complex levels of relatedness of different clones within infections 
uncovered by PCR-based methods, an alternative deep-sequencing based 
approach was developed to provide quantitative information on this. The FWS 
metric (Manske et al. 2012; Auburn et al. 2012) was proposed to provide a 
measure of heterozygosity using deep sequencing data from the haploid 
erythrocytic stages of the parasite life cycle within an individual infection relative 
to the rest of the population. Calculation of this metric across multiple 
populations globally has shown that a combination of local transmission 
intensity and genetic isolation have an effect on the metric (Manske et al. 2012). 
Development of single-cell genome sequencing methods have also been 
applied to characterise the genomic diversity of individual P. falciparum infected 
erythrocytes from in vivo infections and identify genomic regions that show 
evidence of being identical-by-descent between different parasites (Nair et al. 
2014).  
 
1.6 Importance of understanding multiple genotype infections of 
Plasmodium 
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1.6.1 Drug resistance and virulence evolution  
The presence of co-infecting genotypes has been theoretically linked to 
important parasite traits including drug resistance and virulence evolution. The 
historical and genetic origins of P. falciparum resistance to artemisinin, 
chloroquine and sulfadoxine-pyrimethamine have consistently been found within 
Western Cambodia (White 2010). Distinct subpopulations within this region 
have been characterised as having high levels of haplotype homozygosity and if 
a genotype arises through meiotic recombination that possesses both drug 
resistance alleles and an appropriate level of biological fitness, the inbreeding 
seen within these subpopulations will aid the emergence of drug resistance 
within the area (Dye & Williams 1997; Miotto et al. 2013). Theoretical modelling 
across different transmission intensities has predicted a reduction in the 
capacity of drug resistant parasites to successfully increase in frequency within 
a population with high levels of multiple genotype infections (Klein et al. 2012). 
The repeated appearance of drug resistance within the same region raises the 
question of whether drug treatment policy should differ depending on local 
population structure. 
 Recent experimental work on P. chabaudi has highlighted some of the difficulty 
in deciding whether aggressive drug treatment would be the most appropriate 
course of action to limit the evolution of drug resistance (Kouyous et al. 2014). 
Once resistance has appeared within a population, a more concentrated drug 
dose within a multiple genotype infection will give a higher degree of 
competitive release to the resistant parasite due to increased suppression of its 
drug sensitive competitors and lead to its greater propagation within the 
population (Huijben et al. 2013; Pollitt et al. 2014). The interaction between local 
population structure, inbreeding and competition between clones within an 
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infection clearly plays an important role in drug resistance emergence (Hastings 
2006), but requires further investigation within natural populations of P. 
falciparum. 
Several studies have also attempted to associate clinical disease severity with 
the genotypic mixedness of an infection, although conclusions have been 
predominantly negative and are likely to suffer from the difficulties of single time 
point sampling of infections as a survey of genotypic diversity (Conway 2007; 
Farnert et al. 1997). In addition, studies of within-host genotype competition 
using different rodent malaria species have yielded different conclusions on the 
intrinsic competitive ability of particular genotypes and the subsequent 
transmission ability. Studies on P. chabaudi have reported that competitive 
ability strongly correlates with clone virulence and transmission success to the 
mosquito vector, thus the process of within-host competition is posited to select 
for virulence within Plasmodium parasites (de Roode et al. 2005; Bell et al. 
2006). Conversely, studies with P. yoelli report the opposite of this, with less 
virulent clones within single infections outcompeting more virulent clones within 
mixed infections and subsequently the less virulent clone also going on to have 
greater transmission ability (Abkallo et al. 2015), with a resulting hypothesis that 
the more virulent clone was subject to immune-mediated clone-specific 
selection. Thus, it is unclear as to which, if any, of these findings might also hold 
true for P. falciparum and underlines the need to translate for studies on human 
infectious Plasmodium species where possible. If within-host competitive 
processes did play a role in driving virulence evolution of P. falciparum, it may 
be possible that parasite virulence is higher in areas of higher infection 
endemicity or that the fitness costs associated with drug resistance may cause 
parasites with such alleles to be competitively suppressed (Conway 2007). 
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1.6.2 Gametocyte investment plasticity  
A few studies have investigated differences in gametocyte commitment 
amongst co-infecting genotypes when compared to single clone infections, 
particularly within rodent malaria species. Restrained investment in 
gametocytes has been reported in multiple genotype infections of P. chabaudi, 
as parasites seek to maximise their competitive ability within the host (Pollitt et 
al. 2011). Whilst this model system allows for initiation of known starting 
genotypes within a host system, a limitation of this work is the limited number of 
clones that are used, which is not truly reflective of the diversity or relatedness 
spectrum seen within natural populations of P. falciparum. In addition, plasticity 
of clone gametocyte sex ratio has been studied as a phenotype which is 
predicted to be affected by the clonal composition of a Plasmodium infection. 
Hamilton’s local mate competition theory (Hamilton 1967) has underpinned 
such work by proposing that in the presence of multiple genotypes, a higher 
proportion of sexual stage investment is to be allocated to male gametocytes. If 
a single Plasmodium clone does infect a mosquito, then gametocyte sex ratio 
would be predicted to be heavily female biased as one male gametocyte can 
fertilise more than one female gametocyte, due to up to 8 male gametes being 
produced per male gametocyte (Read et al. 1992). Production of male 
gametocytes above the minimum required to fertilise all female gametocytes 
would be a wasteful investment of resources (Leggett et al. 2014). Hence, the 
optimum Plasmodium sex ratio within an infection is predicted to be dependent 
on the male fecundity, in terms of the number of viable gametes produced per 
male gametocyte and the likelihood of selfing at meiosis (Schall 2009). 
In agreement with this, controlled infections of again a limited number of 
genotypes within P. chabaudi and P. mexicanum have reported alterations to 
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the sex ratio of clones in response to the presence of other genotypes within the 
infection (Reece et al. 2008; Neal & Schall 2014; Figure 1.6). Changes in sex 
ratio within P. falciparum can have a significant impact upon parasite 
transmission success at certain gametocyte densities (Mitri et al. 2009), 
demonstrating their importance. However, analyses on the sex ratio of P. 
mexicanum in natural populations, with robust sample sizes and using 
microsatellite determination of within-host diversity, has seen no significant 
variations in sex ratio to correlate to within-host diversity of the infection (Neal & 
Schall 2014). 
Furthermore, sex ratio changes have not solely been linked to within-host 
diversity, with host anaemia also shown to have a significant effect on the sex 
ratio of P. gallinaceum and P. vinckei (Paul et al. 2000). In addition, 
experiments using P. relictum have recorded significantly increased levels of 
transmission to their mosquito vector when subjected to biting (Cornet et al. 
2014), whilst changes in the genotypic composition of asymptomatic infections 
of P. falciparum longitudinally have also been recorded (Farnert et al. 1997), 
reinforcing the difficulty in truly being able to relate the sex ratio of gametocytes 
to the within-host diversity present. In order to transmit successfully, P. 
falciparum parasites are required to be able to adapt and respond to a changing 
environment consisting of heterogeneous host, parasite and environmental 
factors. Understanding parasite plasticity and potential transcriptional variation 
within gametocyte stage commitment could therefore have important 
consequences. 
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Figure 1.6. Predictions of male gametocyte proportions within 
Plasmodium infections with differing clonal compositions. Within this 
figure, r*=proportion of male gametocytes, s=predicted selfing rate and f=mean 
number of viable gametes produced by one male gametocyte (adapted from 
Schall 2009).  In addition, the open circle represents the gametocyte sex ratio of 
approximately 0.45 that was calculated from an experiment with P. chabaudi 
when six clones were in competition. Closed black circles represent the 
calculated gametocyte sex ratio of two different clones of P. chabaud, both with 
an estimated f=8, which had their relative proportions and gametocyte sex 
ratios calculated using reverse transcription PCR assays (Reece et al. 2008). 
Assuming f=5 as suggested for P. falciparum, the lower limit of r* for P. 
falciparum would thus equal 0.17, which is in line with its estimation of 0.18 
within a highly inbred population of Papua New Guinea (Read et al. 1992). 
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1.7 Phenotypic and transcriptional variation of P. falciparum   
A small number of laboratory clones of P. falciparum are regularly used for in 
vitro investigations, with different parasites available from a range of original 
populations, with 3D7A, a clone of an airport malaria isolate from the 
Netherlands (Ponnudurai et al. 1981), being the most commonly cultured P. 
falciparum genotype. Laboratory cloned parasites which have been adapted to 
ex vivo culture for potentially long periods of time, offer a genetically tractable 
system with relatively robust growth rates (Reilly et al. 2007) for in vitro 
propagation and manipulation, including targetedtransfection strategies. 
Profiling of laboratory clones has revealed remarkable levels of transcriptional 
variation that are found within even laboratory clones of P. falciparum, with 
heterogeneity existing in the expression of genes involved in a variety of 
functions including metabolic processes, host cell remodelling and host-parasite 
interactions such as antigenic variation and erythrocyte invasion (Rovira-Graells 
et al. 2012).  
Several ex vivo phenotyping studies of P. falciparum have been performed 
within the first asexual replication cycle, when parasites are in the red blood cell 
they were parasitizing within the host. Studies of erythrocyte invasion have 
characterised substantial phenotypic and transcriptional diversity within local 
endemic populations (Baum et al. 2003; Gomez-Escobar et al. 2010; Bowyer et 
al. 2015). In addition, ex vivo first-cycle parasite multiplication rate (PMR) has 
also been characterised (Chotivanich et al. 2000; Deans et al. 2006), reporting 
a range of initial replication rates. Thus, whilst ex vivo adaptation and 
phenotyping of clinical isolates of P. falciparum is clearly achievable, there 
remain several challenges including the low ex vivo PMR reported, particularly 
40 
 
within certain populations (Deans et al. 2006) and the logistics of sampling, 
cryopreservation and storage. 
In addition, to the asexual erythrocytic stages, it has been well established ex 
vivo that different clones of P. falciparum vary in their baseline rates of 
commitment and their sex ratios.  A study of clones derived from clinical isolates 
by limiting dilution cloning determined that rates of gametocytogenesis varied 
significantly between different parasite clones that had come from the same 
parent isolate (Graves et al. 1984). Across a collection of 22 isolates from cases 
of malaria imported within the Netherlands, the ratio of male to female 
gametocytes ranged from 1:3 to 1:8 (Ponnudurai et al. 1982), whilst the sex 
ratio of one clone was shown to be relatively stable over 15 weeks of 
subculturing (Burkot et al. 1984). Continuous asexual culture of P. falciparum 
parasites does however appear to lead to a reduction in the viability of 
gametocytes for transmission (Delves et al. 2016). Long-term laboratory 
adapted clones have been found to no longer be able to undergo 
gametocytogenesis, due to the deletion of a particular genome region (Alano et 
al. 1995), complicating the investigation of gametocyte commitment. 
Asexual parasite replication, gametocyte sex ratio and overall gametocyte 
commitment are thus clinically and epidemiologically important parasite 
phenotypes that show evidence of variation from ex vivo analyses of isolates 
and have also been suggested to be inducible plastic phenotypes that can 
respond to the presence of a competitor genotype (Reece et al. 2008; Pollitt et 
al. 2011), although inferences on replication rate have come from the 
assessment of the end point density of genotypes in competition (Bell et al. 
2006; Wacker et al. 2012). 
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1.8 Linking phenotypic variation to genetic determinants   
Identification of genes that are accountable for phenotypic variation can be 
determined using either reverse or forward genetics, with both approaches 
having been utilised within the study of Plasmodium parasites. Reverse 
genetics attempts to uncover gene function by knocking out, knocking down or 
performing allelic replacement of a specific target locus, although this can be 
laborious within Plasmodium due to the relatively slow rates of growth and low 
in vitro parasite densities of any potential transfectants. In addition, reverse 
genetic approaches have been applied to confirm the essential role of genes 
involved within the early stages of commitment to gametocytogenesis. The 
complementation of gametocyte development 1 gene (GDV-1) to a laboratory 
clone that had lost the ability to produce gametocytes, restored this phenotype, 
whilst overexpression of this gene in a laboratory clone that could produce 
gametocytes enhanced sexual commitment (Eksi et al. 2012). Furthermore, the 
essential role of the transcription factor AP2-G, a member of the Apicomplexan 
AP2 protein family, was confirmed through production of a knockout mutant 
without AP2-G function through double homologous recombination and 
inducible knockdown of gametocytogenesis from targeting PfAP2-G (Kafsack et 
al. 2014). 
Classically, reverse genetics has also relied on a posterior knowledge of a 
particular molecular pathway to investigate gene function, although recent 
approaches have begun to systematically probe this at least for genes 
expressed within the asexual erythrocytic stages. A genome-wide set of >2000 
gene-specific plasmid vectors have been developed for interrogation of gene 
function in P. berghei (Schwach et al. 2014; Rita Gomes et al. 2015) and high-
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throughput approaches using transposon mutants have begun to be applied to 
P. falciparum (Bronner et al. 2016). Whilst approximately 5400 genes are 
present within the P. falciparum genome, less than half have a known function 
and thus systematic investigation of gene function is much desired. Molecular 
tools for reverse genetic investigation of P. falciparum are also improving with 
the use of systems such as efficient CRISPR-Cas9 genome editing (Ghorbal et 
al. 2014). 
Forward genetics-based approaches to gene function discovery have been 
applied using genetic crosses of genetically distinct clones of P. falciparum 
(Walliker et al. 1987), requiring the synchronised production of gametocytes and 
transmission to mosquito colonies. Quantitative trait loci (QTL) analyses of 
these have classically played a major role in uncovering the chloroquine 
resistance transport locus, providing resistance to chloroquine, which was 
further confirmed by reverse genetic manipulation (Wellems et al. 1991; Fidock 
et al. 2000; Culleton & Abkallo 2015). In addition to drug resistance, a genetic 
cross based approach utilising QTL has uncovered loci associated with traits 
including cell cycle duration (Reilly Ayala et al. 2010), erythrocyte invasion 
(Hayton et al. 2008) and transcriptional regulation (Gonzales et al. 2008). In 
addition, linkage group selection, which relies on phenotype-specific selection of 
uncloned cross progeny and subsequent comparison of genome-wide marker 
frequencies to the unselected progeny has also been used to identify loci 
associated with drug resistance, strain-specific targets of immunity and growth 
rates (Culleton et al. 2005; Pattaradilokrat et al. 2009; Cheesman et al. 2010). 
An alternative, more recent forward genetics approach for P. falciparum has 
used a combination of clinical phenotyping of artemisinin clearance rates within 
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a South-East Asian population and whole-genome scans of selection to identify 
loci associated with the artemisinin slow clearance phenotype. These studies 
first used identical parasite genotypes found within different individuals in an 
analogous manner to human 'twin' studies to estimate genetic heritability of the 
artemisinin slow clearance trait (Anderson et al. 2010) and subsequently 
performed FST and haplotype-based genome scans of selection to identify 
associated loci (Cheeseman et al. 2012). This approach however makes the 
assumption that environmental and genetic factors of ‘twin’ genotypes could be 
considered as independent, but due to the increased probability of spatial or 
temporal clustering of these identical genotypes, such an assumption is unlikely 
to be true (Hastings et al. 2016). Nevertheless, these studies highlight the 
possibility of using underlying phenotypic variation of clinical isolates, 
phenotype-specific screens and whole-genome sequencing for forward 
genetics. 
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1.9 Aims of this thesis summary 
This thesis investigates the within-host diversity of P. falciparum infections 
through a combination of whole-genome sequence analyses, in vitro 
competition studies and characterisation of the phenotypic variation seen within 
two reportedly induced plastic phenotypes through examining the following 
questions: 
x How do conclusions from allele-frequency based genome-wide estimates 
of within-host diversity concord with interpretations from traditional 
microsatellite genotyping? 
x Utilising deep-sequence data on within-host and within-population allele 
frequencies from four distinct West African populations, is it possible to 
identify genomic loci that are consistently under directional within-host 
selection? 
x Within two West African populations of contrasting infection endemicity, 
are there differences in the expression levels of two key early 
gametocytogenesis markers and the gametocyte sex ratio? 
x What baseline variation in parasite multiplication rate is present within 
four commonly cultured laboratory clones and a selection of West African 
isolates undergoing ex vivo culture adaptation? 
x Does the parasite multiplication rate of P. falciparum laboratory clones in 
monoculture change when placed into competition with an additional 
genotype?  
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Chapter 2. Materials and Methods 
2.1 Bioinformatic whole genome sequence analyses of within-host 
diversity 
2.1.1 Sample collection and whole genome sequencing: 
For the whole genome sequence analyses of Guinean isolates collected within 
the N’Zérékoré region described within section 3, Illumina paired-end short-read 
genome sequencing has previously been described and made available at the 
European Nucleotide Archive (Mobegi et al. 2014). Briefly, sequencing was 
performed on an Illumina HiSeq machine at the Wellcome Trust Sanger Institute 
and mapping of reads was done using SMALT 
(http://www.sanger.ac.uk.resources/software/smalt/), against the P. falciparum 
3D7 reference sequence (version 3). Subsequent SNP calling was executed 
using the SAMtools software (http://www.samtools.sourceforge.next), with 
SNPs being removed if they were positioned within var, rifin or stevor gene 
families or in any sub-telomeric chromosomal regions. Finally, SNPs were also 
removed if they were found within loci identified as possessing highly repetitive 
sequences as defined by Tandem Repeat Finder (Benson 1999). 
Whole genome sequence data of P. falciparum clinical isolates used for the  
independent population comparison of an FWS based selection scan within 
section 4 were taken from four previously published sequence read data sets 
available at the European Nucleotide Archive collected within the N’Zérékoré 
region of the Republic of Guinea (Mobegi et al. 2014), the Greater Banjul area 
of The Gambia (Amambua-Ngwa et al. 2012) and two distinct locations within 
Ghana, Kintampo and Navrongo, (Duffy et al. 2015), which are located within a 
holoendemic and a hyperendemic area respectively. Briefly, sequencing was 
46 
 
performed on an Illumina HiSeq machine at the Wellcome Trust Sanger Institute 
as part of the MalariaGEN P. falciparum community project (Manske et al. 2012; 
MalariaGEN 2016), read alignments were done using the Burrow- Wheels 
Aligner program (http:\\bio-bwa.sourceforge.net) and subsequent SNP calling 
was executed using SAMtools software (http:\\www.samtools.sourceforge.net). 
To further minimise potential alignment errors, they underwent a further 
alignment step using SNP-o-matic (Manske & Kwiatkowski 2009). A variant call 
format (VCF) file for each of these four populations was downloaded from the 
MalariaGEN website (http://www.malariagent.net/welcome), containing 
metadata on all potential SNPs for each isolate and was used for all 
downstream analyses.   
2.1.2 SNP and coverage filtering procedures 
For calculation of the FWS metric, allele frequencies of biallelic SNPs are needed 
at the within-host level, which requires deep sequencing data beyond the 
consensus sequence of an isolate (Manske et al. 2012). For this reason, 
additional filtering of SNPs and isolates was performed on the consensus-level 
sequences used for previous analysis of this population (Mobegi et al. 2014), to 
ensure the validity of the SNPs included. Rare alleles, defined as not being 
found at greater than 10 reads within at least one isolate and not being at a 
greater than 1% minor allele frequency within the population were removed 
along with SNPs which were located within non-protein coding regions. 
Population total coverage for each SNP was calculated through the summation 
of coverage levels across all isolates, with SNPs discarded if their population 
total coverage was not found within an approximate Gaussian distribution of 15-
85% around the median population total coverage. Furthermore, SNPs within 
isolates which were not above a coverage threshold of 5 reads for an individual 
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allele or reach a total coverage threshold of 20 reads across both potential 
nucleotides for each biallelic SNP were classed as missing data and ignored 
within the analysis. These coverage filter designations also led to the removal of 
all samples that did not have read count information remaining for at least 80% 
of all SNPs present within the catalogue. Similarly, SNPs were also removed 
which were missing data for greater than 10% of the population.  
2.1.3 Genome-wide calculation of the within isolate fixation index FWS 
Using the filtered SNP and isolate coverage datasets, allele frequencies were 
calculated at each SNP position for each isolate individually, through the 
formula p= 1-q, whereby p and q represent the proportions of read counts for 
the major and minor alleles. All SNPs were then assigned to ten minor allele 
frequency (MAF) intervals, representing the proportional frequency of the minor 
allele at each SNP across each population, with the ten equally sized intervals 
ranging from 0-5% up to 45-50%. From this, levels of within-host (HW) and 
within-population (HS) heterozygosity at each SNP were calculated as 
Hw=2*pw*qw and Hs=2*ps*qs. The mean HW and HS of each MAF interval were 
then computed from the corresponding heterozygosity scores of all SNPs within 
that particular MAF interval.  The resulting isolate specific plot of HW against HS 
was produced and a linear regression model was used to determine a value for 
the gradient Hw/Hs, with FWS = 1- (HW/HS). Isolates with an FWS score of >=0.95 
were regarded as predominantly single genotype infections in agreement with 
published definitions (Auburn et al. 2012), with all other isolates being 
characterised as being genotypically diverse infections. All FWS analyses were 
performed using custom scripts in R, with an example script found within 
Appendix 1. 
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2.1.4 Population comparison of isolate FWS scores: 
For each of the four West African populations used for the genome-wide scan of 
FWS, the VCF file format was manipulated using custom Bash scripts, to 
produce a dataframe for each population containing all necessary information 
for downstream processing and filtering in R, including candidate SNP 
annotation information and the biallelic sequencing read counts of all candidate 
SNPs. Population minor allele-frequency distribution analyses were performed 
using R-based scripts. SNP and coverage filtering was performed as described 
previously in section 2.1.2, leaving four separate SNP sets for each of the West 
African populations. Subsequently, isolate wide FWS scores were calculated 
using linear regression based estimation within population minor allele 
frequency intervals of the relationship HW/HS (section 2.1.3). 
2.2 Clinical isolate collection for ex vivo studies 
For all ex vivo clinical isolate gametocyte transcript expression profiling and ex 
vivo growth (section 5 and 6 respectively) studies, blood samples of up to 5 mL 
were collected and cryopreserved using glycerolyte (section 2.3.2) from patients 
who had gone to local area health centres and provided written informed 
consent to have their blood collected. These isolates were collected by teams 
within each region led by Dr Alfred Amambua-Ngwa in Guinea, Dr Gordon 
Awandare in Ghana, Dr Ambroise Ahouidi in Senegal and Dr Mahmadou 
Diakite in Mali. 
For ex vivo gametocyte transcript expression profiling (section 5), all 
Senegalese isolates were collected from Pikine within late 2013 and Ghanaian 
isolates were collected from Navrongo and Kintampo between August and 
October 2013 and May and August 2013 respectively. For ex vivo clinical 
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isolate growth studies (section 6.3.3), Guinean isolates were collected from 
near Faranah in November 2012, Malian isolates were collected Nioro de Sahel 
in 2013 and Senegalese isolates were collected from Pikine within late 2014. 
Once in glycerolyte, these isolates were frozen (section 2.3.2) and transported 
on dry ice to LSHTM, where they were stored in LN2. 
2.3 P. falciparum cell culture techniques 
2.3.1 Parasites studied 
For all monoculture and competitive growth studies (sections 6.3.2 and 7.3.2 
respectively), four different laboratory parasites of were cultured; 3D7A-GFP, 
Dd2, D10 and HB3. These four clones offered a range of geographical origins 
and were also being used for other purposes in Chapter 4. Clone 3D7A was 
derived from isolate NF54 which originated from a case of airport malaria within 
the Netherlands (Ponnudurai et al. 1981; Walliker et al. 1987) with 3D7A-GFP 
subsequently being a clone of 3D7A that had been transfected to constitutively 
express green fluorescent protein without any reported effect on parasite growth 
or gametocytogenesis phenotype (Talman et al. 2010). Dd2 is a clone of the 
isolate W2 (Guinet et al. 1996), which originated from South East Asia 
(Campbell et al. 1982), whilst HB3 was cloned from the Honduran I/CDC isolate 
(Bhasin & Trager 1984) and D10 was cloned from the FCQ27 isolate that 
originated from Papua New Guinea (Chen et al. 1980). These four clones were 
also used for transfection experiments (section 7.3.3), with the exception that a 
wild-type 3D7A clone was used instead of 3D7A-GFP.  
2.3.2 Thawing and cryopreservation of P. falciparum parasites 
Parasites were thawed from long-term storage in liquid nitrogen by initially 
placing in a 37°C waterbath for 2 minutes. Subsequently, the volume of blood 
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(V) within the cryovial was determined and 0.1x the volume of NaCl was added 
to this and mixed gently by shaking, before being left for 2 minutes. Following 
this, a 10x volume of V of 1.6% NaCl was also added and mixed gently again by 
shaking. This solution was then centrifuged for 5 minutes at 500 g and the 
supernatant was removed, washed with completed medium and the remaining 
blood pellet was added to 10 mL of complete medium in a T25 flask, at a 
haematocrit of approximately 3%.  
When cryopreservation was required, parasites were grown to have a ring-
stage parasitemia of at least 2% and the culture was spun down at 500 g for 3 
minutes, before the supernatant culture medium was aspirated. The volume of 
the blood pellet was estimated and 0.33 x the volume of glycerolyte solution 
was added dropwise, shaken gently and left at room temperature for 5 minutes. 
Subsequently, an additional 1.33 x the blood pellet volume of glycerolyte 
solution was added, the tube was gently shaken and the cell suspension was 
then transferred to a cryovial tube and put into a liquid nitrogen freezer. 
2.3.3 Erythrocyte preparation: 
For general parasite culture, A+ erythrocytes (National Blood Transfusion 
Service) were washed thrice with incomplete medium (RPMI-1640, Sigma 
Aldrich) through centrifugation at 2500 g for 5 minutes, prior to being diluted to a 
haematocrit of 50% using complete medium and kept at 4°C. These cells were 
kept for up to 10 days, or for a shorter period if they appeared to show any 
evidence of haemolysis or inability to support parasite growth. 
2.3.4 General parasite culture conditions 
Laboratory clone parasites were generally cultured asynchronously in complete 
medium consisting of RPMI 1640 medium (Sigma-Aldrich) supplemented with 
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25 mM HEPES, 2 µg/mL sodium bicarbonate, 25 µg/mL gentamycin, 0.2% 
glucose and 0.5% albumax, at a haematocrit of between 3 and 5% in a 10mL 
total culture volume, with a gaseous environment of 95% Nitrogen and 5% 
carbon dioxide and a temperature of 37°C (Trager and Jensen 1976). Media 
was changed in accordance with flask parasitemia, which was monitored by 
creating a blood smear on a microscopy slide that was subsequently giemsa 
stained and parasitemia determined through light microscopy. Clinical isolates 
undergoing ex vivo adaptation were maintained under the same conditions, with 
the exception of a gaseous environment of 1% O2, 3% CO2, 96% N2 within an 
orbital shaking incubator operating at 50 rpm and a haematocrit of no more than 
3%. 
2.3.5 Synchronisation of parasite stages 
Ring-stage laboratory clone parasites were synchronised using a 5% sorbitol 
solution (Lamrbos & Vanderberg 1979) to remove trophozoite and schizont 
stages. P. falciparum cell cultures were centrifuged at 500 g for 3 minutes, 
before being resuspended within 10 x the blood pellet volume of  5% sorbitol for 
5 minutes and incubated at room temperature. These solutions were 
subsequently washed three times with complete culture medium and 
resuspended once again at between 3% and 5% haematocrit. 
2.4 Genomic DNA extraction and preparation of genomic standards 
Genomic DNA was prepared to produce DNA standards from each of the four 
cultured laboratory clones. For this, parasites were grown asynchronously 
under general culture conditions (section 2.3.4) to a parasitemia of 
approximately 10%, frozen at -20°C and were subsequently extracted using a 
QIAamp DNA Blood Midi Kit (Qiagen). Once extracted these standards were 
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quantified against a calibrator PCR product generated from two primers that 
were designed outside the target region of a pan-genotype Pfs25 assay 
(Schneider et al. 2015, Table 7.1): Pfs25 outer forward 5’-
GGAACTTTGCCTATATTACATGAGCA-3’ and Pfs25 outer reverse 5’-
CGAAAGTTACCGTGGATACTGTATG-3’ using a 2x 5 µL SYBR Select Master 
Mix (Life Technologies), with 300 nM primers, 2.9 µL of nuclease-free water and 
1.5 µL of 3D7A-GFP DNA. The generated PCR product was quantified using a 
Qubit 2.0 Fluorometric Quantitation device and the dsDNA HS assay kit (Qubit). 
Subsequently, this PCR product was diluted tenfold in 5 ng/µL salmon sperm 
DNA and used as an additional calibrator standard to quantify the genomic DNA 
standards of the four clones against. The concentration of the Pfs25 product 
dilution series ranged from 0.01 ng/µL down to 1 x 10-7 ng/µL. For this, a Kapa 
Probe Fast kit (Kapa Biosystems) was used, with a 10 µL total reaction volume 
consisting of 2x Kapa Probe Fast Mastermix, 250 nM primers of the highly 
conserved pan-genotype Pfs25 assay (Table 7.1), 250 nM of the probe 6FAM-
5’-CCGTTTCATACGCTTGTAA-3’-MGB (Schneider et al. 2015), 5.5 µL of H2O 
and 3 µL of DNA per reaction. All quantitative PCR (qPCR) reactions were 
carried out using a Rotor-Gene 3000 qPCR machine (Corbett). Tenfold genomic 
DNA standards were subsequently created for each laboratory clone, with 5 
ng/µL salmon sperm DNA used as diluent and all genomic DNA standards were 
kept at -20°C. 
2.5 Parasite genotyping 
2.5.1 Sequencing and genotyping of MSP-1 block 2 for laboratory clones 
For the four sets of laboratory clone DNA, their identity was initially confirmed 
by capillary sequencing of the highly polymorphic MSP-1 block 2 region. PCR 
products were generated by nested PCR (Snounou et al. 1999) using the pan-
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genotype M1-OF/M1-OR primer set for the first nest, with thermocycler 
conditions of 95°C for 10 minutes, followed by 25 cycles of 94°C for 1 minute, 
58°C for 2 minutes and 72°C for 2 minutes, with a final extension of 72°C for 5 
minutes, using a Kapa blood PCR kit (Kapa Biosystems). Products from the first 
nest were diluted 1 in 100 and 1 µL was added to the second nest, where the 
three allelic type specific PCR sets were used (K1, MAD20 and RO33), with 
thermocycler conditions of 95°C for 10 minutes, followed by 30 cycles of 94°C 
for 1 minute, 61°C for 2 minutes and 72°C for 2 minutes, with a final extension 
of 72°C for 5 minutes. PCR products were visualised on a 3% agarose gel, 
providing initial confirmation of the clone identity.  
For additional confirmation, the MSP-1 block 2 region underwent capillary 
sequencing using all of the allelic-type specific primers using a BigDye 
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems), on PCR product 
from nest 1, which had been purified using a QIAquick PCR Purification kit 
(Qiagen). Thermocycling conditions for the cycle sequencing were 25 cycles of 
96°C for 30 seconds, 50°C for 15 seconds and 60°C for 4 minutes. The 
sequencing product then underwent ethanol precipitation prior to being 
resuspended in highly de-ionised formamide. Sequencing products were 
assessed using an ABI 3730 DNA Analyzer (Applied Biosystems) and the 
results were visualised using SeqMan alignment software (DNAStar). 
Laboratory clone parasites being cultured were intermittently re-checked for 
their identity by MSP-1 block 2 nested PCR typing as described or through 
allele-specific qPCR (Table 7.1).  
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2.5.2 Microsatellite genotyping of ex vivo clinical isolates 
For ex vivo phenotyping of clinical isolates parasite multiplication rate (section 
6.3.3), DNA from the one of the extracted DNA samples taken at Day 2 
XQGHUZHQWPLFURVDWHOOLWHJHQRW\SLQJDWIRXUSRO\PRUSKLFORFL7$3RO\Į3I3.
and TAA109), which were selected due to their previously published high levels 
of expected heterozygosity within the Republic of Guinea (Mobegi et al. 2012). 
Genotyping of each marker was undertaken using the hemi-nested protocol 
reported previously (Anderson et al. 1999; Mobegi et al. 2012). Both nests were 
performed in separate tubes for each loci, in a total volume of 11 µL, consisting 
of 1x ThermoPol II reaction buffer (New England Biolabs), 0.2 U Taq DNA 
Polymerase, 0.25 µL of 10 µM forward primer, 0.25 µL of 10 µM reverse primer, 
0.1 µL of 100mM MgSO4, and 1 µL of template, 6.55 µL of H2O and 0.8 µL of a 
10 mM dNTP mix. PCR products were run separately using Genescan and 
subsequently analysed on a Genetic Analyzer 3730 capillary electrophoresis 
machine (Applied Biosystems). Allelic electrophoresis sizes were determined 
using GENEMAPPER version 4.0 software, with the predominant allele 
identified as the peak with the greatest height, whilst minor alleles were also 
noted if their peak height was at least 25% the size of the predominant allele 
recorded. 
2.5.3 Primer selection and design for allele-specific qPCR assays: 
In silico visualisation of the DNA sequences of the four aforementioned 
laboratory clones was performed in Jalview 2.8.1 (Waterhouse et al. 2009) for 
merozoite surface protein 1 (MSP1, PF3D7_0930300), merozoite surface 
protein 6 (MSP6, PF3D7_1035500), merozoite surface protein 7 (MSP7, 
PF3D7_1335100), duffy binding-like merozoite surface protein (DBLMSP, 
PF3D7_1035700) and erythrocyte binding antigen-175 (EBA-175, 
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PF3D7_0731500). A literature review found two suitable P. falciparum allele-
specific quantitative PCR assays for these clones which both are targeted to the 
MSP1 gene (Wacker et al. 2012; Chen et al. 2014). This indicated that the two 
published assays should be able to distinguish between 5 of the 6 different 
pairwise scenarios desired, with an additional allele-specific assay needed to 
distinguish the Dd2 and D10 clones. Primer design was aided by use of the 
Primer 3 (version 4.0, Untergasser et al. 2012) software. In addition, the qPCR 
assay targeting the highly conserved Pfs25 gene locus was used to provide 
pan-genotype quantification of parasite DNA (Schneider et al. 2015). 
2.6 Standardised conditions for quantitation of growth rates of P. 
falciparum 
2.6.1 Standardised culture conditions 
For all monoculture, ex vivo and competitive growth assays performed (sections 
6.3 and 7.3.2), biological replication was implemented, with each replicate 
defined as having a different erythrocyte donor, whose blood group was 
unknown. These donors were collected from the blood service at LSHTM one 
day prior to being put into a growth assay and coagulation was prevented 
through the addition of 50 units of heparin to each 50 mL falcon tube of blood. 
Subsequently, erythrocytes were prepared as previously described (see section 
2.3.3).  
2.6.2 Monoculture laboratory clone growth assays 
For all monoculture laboratory clone growth assays (section 6.3.2), the four 
clones were cultured simultaneously, with 6 biological replicates being 
performed. Culture conditions for all laboratory clone growth assays were as 
follows: 10mL cultures consisting of complete medium with 0.5% albumax, 5% 
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starting haematocrit of erythrocytes and a gas composition of 95% N2 and 5% 
CO2 with atmospheric O2 at a temperature of 37°C.  For setup on Day 0 of each 
assay, the asynchronous parasitemia of the parent flask was calculated from 
counting 1000 red blood cells of a giemsa smear using a light microscope. 
Replicates were asynchronously initiated at a parasitemia of 0.02% in fresh 
complete medium. Complete medium changes were performed on Day 2, 4, 5, 
6 and 7. Every 48 hours (Day 0, 2, 4, 6 and 8) a 300 µL sample of resuspended 
culture medium was taken, from which 100 µL was pelleted and used to make a 
giemsa-stained slide, with the remaining 200 µL frozen at -20°C.  
2.6.3 Ex vivo clinical isolate growth assays 
For quantitation of ex vivo clinical isolate growth rates a total of 61 isolates from 
three different locations across West Africa (section 2.2) underwent adaptation 
to ex vivo culture. To minimise any effect upon the parasites of the freezing, 
transport and thawing of red blood cells from multiple locations, isolates 
underwent several replication cycles of culture adaptation. This involved the 
thaw and maintenance of clinical isolates under the conditions stated in section 
2.3.4. Assay conditions were set as described (section 2.6.1), with the 
exception of a 3% haematocrit and a gaseous composition of 1% O2, 3% CO2 
and 96% N2, within an orbital shaking incubator operating at 50 rpm. These 
growth assays were performed for 6 days, with media being changed on Day 2, 
4 and 5 and a 200 µL sample of total culture was taken every 48 hours and 
frozen at -20°C.  In addition, to provide a control that would allow for 
normalisation across the triplicates of erythrocyte donors used, all performed 
clinical isolate growth assays were run alongside a 3D7A-GFP control.  
2.6.4 Competitive growth assays of P. falciparum 
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Pairwise competitive growth assays were set up between the four 
aforementioned laboratory clones. Use of these parasites provided a total of 6 
co-culture scenarios; 3D7A vs Dd2, 3D7A vs HB3, 3D7A vs D10, Dd2 vs HB3, 
Dd2 vs D10 and HB3 vs D10. These were set up identically to the monoculture 
laboratory clone growth assays, except that for each competitive scenario, such 
as Dd2 vs D10, there were three monoculture flasks of Dd2 and D10 each 
begun at a parasitemia of 0.02% and three competitive flasks where 0.01% of 
each parasite was added to the starting culture in order to try to ensure that the 
starting density of the control and experimental groups remained equivalent. 
Allele-specific qPCR assays were used to monitor growth rates of individual 
clones experiencing competition (section 7.2). 
2.7 qPCR for PMR quantitation of laboratory clones, ex vivo isolates and 
competing clones 
2.7.1 qPCR for analysis of laboratory clone and ex vivo isolate PMR 
To ensure further standardisation of the assay, all biological replicates where 
the same blood batch donor was used were grown simultaneously in the same 
batch of complete medium and all subsequent DNA extractions for each 
biological replicate across the clone combinations were also performed in 
unison for all monoculture, ex vivo and competitive growth experiments. 
All collected blood samples were extracted using the centrifuge-based protocol 
of a Qiagen DNA Blood Mini kit (Qiagen), with all extracted DNA eluted in 40 µL 
of elution buffer and stored at -20°C. For absolute quantitation of the growth 
rate of each laboratory clone, the corresponding genomic DNA standard was 
used, for example Dd2 was quantified against the Dd2 series. For absolute 
quantitation of the growth rate of all clinical isolates profiled, this was compared 
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against the 3D7A-GFP dilution series. All genomic standard controls were run in 
technical triplicate for each run, with a concentration range of 1 million copies 
per µL down to 10 copies per µL. qPCR reactions for all DNA extractions for 
each timepoint of each biological replicate were also performed in triplicate and 
run alongside a no template control sample. Primers targeting the conserved 
Pfs25 locus were used, with the forward primer of 5’-
CCATGTGGAGATTTTTCCAAATGTA-3’ and the reverse primer of 5’- 
CATTTACCGTTACCACAAGTTACATTC-3’ (Schneider et al. 2015). These 
were used in a total reaction volume of 10 µL, consisting of 5 µL SYBR select 
master mix (Applied Biosystems), 0.3 µL of 10 µM forward primer, 0.3 µL of 10 
µM reverse primer and 2.9 µL of H2O. All qPCR reactions were run on a Rotor-
Gene 3000 qPCR machine, with thermo cycler conditions of 50°C for 2 minutes, 
95°C for 2 minutes, 40 cycles of 95°C for 15 seconds and 60°C for 1 minute 
with acquisition being performed in the FAM channel with a gain setting of 7. 
Following each machine run, a melt curve was performed, which comprised 
ramping from 60°C to 99°C in 1°C increments, with a 30 second pause on the 
first temperature step and 5 seconds pauses on each step afterwards. 
2.7.2 PMR analysis of qPCR data for laboratory clones and ex vivo 
isolates 
For each growth assay timepoint, the geometric mean of the estimated parasite 
genome copy number per µL of each technical triplicate was calculated by 
comparison against the corresponding genomic DNA series using the Rotor-
Gene 6 software, with a consistent fluorescence threshold of 0.05 implemented. 
This cut off consistently gave quantification within the log-linear phase of the 
amplification process. These values were collated for all isolates run and using 
the R statistical environment, parasite genome copy densities were log 
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transformed and expressed as the number of genome copies per µL of total 
culture for each isolate. Subsequently, to quantify parasite growth rate, a 
general linear model was fitted within R across all biological replicates and 95% 
confidence intervals of the determined parasite multiplication rate, defined as 
the fold change in growth per 48 hours across the entirety of the assay, were 
calculated using the confint function available within R.  
For normalisation of the clinical isolate growth rates across the sets of different 
biological replications, all independent rates of 3D7A-GFP growth were 
averaged. The difference between the calculated growth rate of the clinical 
isolate and its particular 3D7A-GFP control estimation was calculated and used 
to normalise against the averaged rate of 3D7A-GFP growth across all 
replications. These normalised values were subsequently used to compare the 
repeated growth rate analysis of clinical isolates through the culture adaptation 
process. 
2.7.3 qPCR for analysis of pairwise competition growth rates of laboratory 
clones 
For all monoculture growth assays, growth rate analysis was performed using 
the pan-genotype Pfs25 assay, whilst for all pairwise competition assays, the 
appropriate allele-specific assay (Table 7.1) was used to provide allele-specific 
quantitation. All qPCR reactions were performed in technical triplicate and 
absolutely quantified against the aforementioned genomic DNA standards. The 
absolute copy number of each clone within a competition assay, was quantified 
by the appropriate allele-specific assay to monitor growth rate through general 
linear modelling and determination of 95% confidence intervals within R. All 
extracted timepoints were performed in technical triplicate and run alongside no 
template control samples for qPCR. 
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2.8 Generation of fluorescent P. falciparum parasites for in vitro 
competition studies 
2.8.1 Fluorescent protein selection 
Whilst GFP has been used previously to provide a constiutively expressed 
fluorescent parasite tool for P.falciparum (Wilson et al. 2010; Talman et al. 
2010), for potential competition studies in vitro, a two-colour system would be 
needed. Due to excitation wavelength and emission detection filters available 
using the in-house BD FACSAria Fusion cell sorter two red fluorescent proteins 
were selected; mCherry (Shaner et al. 2004) and mKate2 (Shcherbo et al. 
2009), following visualisation of their emission and excitation spectra at 
nic.ucsf.edu/FPvisualization/. Whilst mCherry has previously regularly 
transfected into P. falciparum (Mancio-Silva et al. 2013), mKate2 has not 
previously been used within P. falciparum, but was chosen due to its reported 
increased brightness and improved spectral suitability for the in-house 
FACSAria Fusion flow cytometer. The plasmid containing the mKate2 sequence 
was synthesised as a gBlocks gene fragment from Integrated DNA 
Technologies using nucleotide sequence derived from a publically available 
amino acid sequence (Shcherbo et al. 2009) and the mCherry protein was PCR 
amplified from a plasmid kindly donated by Dr Hans Dessens. 
2.8.2  E.coli competent cell production 
For use in non-ligation transformations, chemically competent stellar E.coli cells 
were made by growing a colony of cells overnight within a 400 mL conical flask 
of LB-broth supplemented with 100 µg/mL ampicillin, until an OD600 
measurement from a spectrophotometer reached a reading of 0.4. These 
cultures were then centrifuged in 50 mL tubes at 4000 rpm for 15 minutes at 
4°C, These were then resuspended in 200 mL of 100 mM MgCl2 and placed on 
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ice for 10 minutes, prior to repeated centrifugation, aspiration and resuspension 
in 200 mL of CaCl2, prior to being left on ice for 1 hour. Following this, the cells 
were once again centrifuged and aspirated, before cell pellets were 
resuspended in 4mL of 100 mM CaCl2, 15% glycerol solution, aliquoted in 200 
µL and stored at -80°C. 
2.8.3 Restriction digests and ligation reactions: 
Restriction enzymes for digestion were obtained from either New England 
Biolabs or ThermoFisher. All digestions were performed overnight at 37°C. For 
all digestion products and PCR amplified inserts, the product underwent 
agarose gel electrophoresis, before target bands were visualised under 
ultraviolet light and cut out with a scalpel, prior to being purified using a 
Nucleospin Gel and PCR clean-up kit using manufacturer’s instructions and 
stored subsequently at -20°C.  Ligation reactions between the digested plasmid 
vector and PCR amplified insert were performed using an In-Fusion HD Cloning 
Kit (Clontech) in reaction volumes of in 5 µL total reaction volumes, consisting 
of vector to insert ratio of 2:1 and were carried out in accordance with 
manufacturer’s instructions. 
Ligation transformations were performed using the competent cells provided 
within the In-Fusion HD Cloning kit (Clontech). To screen potential 
transformants, colony PCR was performed, whereby between 5 and 10 colonies 
were picked from an agar plate, placed in 30 µL of H2O and lysed at 95°C for 5 
minutes. These then underwent PCR using a Clontech 2x PCR mix, 0.3 µL of 
each 10 µM primer and 4.4 µL of H2O, prior to being visualised using agarose 
gel electrophoresis. Correctly sized colonies were then picked for overnight 
culture in LB-broth and 100 µg/mL ampicillin, prior to a QIAprep Spin Miniprep 
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extraction (Qiagen) and DNA sequencing to confirm successful cloning of the 
insert into the vector. 
2.8.4 DNA sequencing  
Capillary sequencing of ligation colonies was performed using a BigDye 
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems), on plasmid DNA 
which had been isolated using a QIAprep Spin Miniprep kit (Qiagen). 
Thermocycling conditions for the cycle sequencing were 25 cycles of 96°C for 
30 seconds, 50°C for 15 seconds and 60°C for 4 minutes. The sequencing 
product then underwent ethanol precipitation prior to being resuspended in 
highly de-ionised formamide (ThermoFisher). Sequencing products were 
assessed using an ABI 3730 DNA Analyzer (Applied Biosystems) using either 
an in-house faculty service or outsourced to Source Bioscience and the results 
were visualised using FinchTV software (Geospiza). 
2.8.5 Integration into the Pf47 locus 
The parental plasmid, pEFGFP, used for subsequent modification was obtained 
from Professor Bob Sinden (Talman et al. 2010, Figure 2.1) and targets 
integration through single homologous recombination at the Pf47 locus 
(PF3D7_1346800). Visualisation of the homology region locus within publically 
available sequence data from PlasmoDB revealed a high degree of nucleotide 
sequence conservation at this locus.  For this approach, the pEFGFP plasmid 
was initially modified to contain an additional restriction site to facilitate 
replacement of the GFP coding sequencing with that of the mCherry sequence. 
pEFGFP underwent restriction digestion using BamHI and KpnI (New England 
BioLabs), with a total reaction volume of 35 µL. In addition, primers LM20FA, 
LM20FB and LM20R were used to generate a 1.3 kb PCR product from plasmid 
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pEFGFP, which was done to In-Fusion clone the restriction site AVRII in place 
of the GFP sequence producing plasmid pEFGFPINT, which was confirmed by 
colony PCR using primer A0153 and ST516. Subsequently pEFGFPINT 
underwent restriction digestion using KpnI and AvrII in a total reaction volume of 
30 µL. The mCherry coding sequence was PCR amplified using primers 
LM23mCherryF and LM23mCherryR , whilst the GFP sequence was PCR 
amplified using primers LM24GFPF and LM24GFPR. These products 
underwent agarose gel electrophoresis, gel extraction under UV light, before 
being In-Fusion cloned in the digested pEFGFPINT vector. Colony PCR was 
used to screen colonies for insertion using primers ST516 and A0153 and 
candidate plasmids underwent DNA sequencing, leading to the production of 
pEFmCherryLM.  For replacement of the GFP sequence with the mKate2 
sequence, the pEFGFP plasmid was digested using KpnI and CfrI in a 35 µL 
reaction volume, and the mKate2 insert was In-Fusion cloned into the vector 
following PCR amplification using primers LM22mKateF and LM22mKateR, 
prior to colony PCR screening using primers ST516 and A0153 and sequencing 
by A0153 to produce pEFmKate2LM. All primers used within the fluorescent 
parasite generation work can be found in Appendix 2. 
2.8.6 Integration PCR 
Integration at the Pf47 locus was monitored using primers AT1 and AT2 
(Talman et al. 2010) to detect the presence of a wild type Pf47 locus, whilst 
primers AT1 and ST509 were used to detect the presence of plasmid 
integration at the Pf47 locus. Cycling conditions for the wild type PCR were 
95°C for 2minutes, followed by 25 cycles of 95°C for 15 seconds, 56°C for 30 
seconds and 68°C for 70 seconds, with a final elongation step of 68°C for 5 
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Figure 2.1 Schematic of the pEFGFP plasmid. This plasmid was modified to 
express mCherry or mKate2 instead of GFP (adapted from Talman et al. 2010). 
The human dihydrofolate reductase region provides resistance to the antifolate 
compound WR99210 (de Koning-Ward et al. 2000). 
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minutes. Cycling conditions for the integration PCR were 95°C for 2minutes, 
followed by 28 cycles of 95°C for 15 seconds, 57°C for 30 seconds and 68°C 
for 70 seconds, with a final elongation step of 68°C for 5 minutes. All PCR 
products were subsequently run on a 1% agarose gel, alongside genomic wild-
type and 3D7A-GFP integration controls. 
2.8.7 Transfection of P. falciparum parasites 
For plasmid preparation, at least 50 µg of each plasmid were grown up in 
competent E. coli cells and then precipitated overnight at -20°C using 0.1 x V of 
NaOAc and 2.5 x V of absolute EtOH. The following morning plasmids were 
microcentrifuged at 14000 rpm, the subsequent pellets were washed in 70% 
EtOH, prior to being microcentrifuged again at 14000 rpm for 5 minutes. 
Following aspiration and air drying, these pellets were resuspended under 
sterile conditions using 30 µL of 0.2 µM filtered H2O and subsequently 30 µL of 
cytomix, consisting of 120 mM KCL, 0.15mM CaCl2, 2 mM EGTA, 5 mM MgCl2, 
10 mM K2HPO4 pH 7.6 and 25 mM HEPES. 
For all transfections, a spontaneous uptake transfer (Deitsch et al. 2001) was 
performed on parasite cultures with ~5% levels of ring stage parasites. For each 
transfection, a 1 mL aliquot of fresh 50% haematocrit erythrocytes was washed 
in 10 mL of cytomix, aspirated and 400 µL of the pelleted erythrocytes were 
transferred to a 2 mm electroporation cuvette and the 60 µL aliquot of plasmid 
resuspended in cytomix was added to the cuvette and mixed gently. The 
cuvette was placed on ice for 30 minutes, prior to being electroporated using a 
Bio-Rad device (Bio-Rad) with settings of 0.31 kV and 960 uFd capacitance. 
Electroporated erythrocytes were then transferred to pre-prepared falcon tubes 
containing incomplete RPMI and subsequently underwent two rounds of 
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resuspension and aspiration. The final pellet was resuspended in 10mL of 
complete media and parasitemia was diluted down to ~0.5%. Culture media 
was changed daily for the next 7 days, with either 2.5 nM or 5 nM of WR99210 
being added to the culture on Day 2. The health of the red blood cells was 
monitored by microscopy once a week alongside a change of WR-
supplemented media and when deemed necessary, a 1 in 10 dilution of 
erythrocytes was performed.  
2.8.8 Limiting dilution cloning of integrated parasite transfections 
In order to clone out individual parasites possessing an integrated fluorescent 
plasmid copy, the parasitemia of the parent culture was calculated from a 1000 
red blood cell count of a Giemsa stained microscope slide. Following this, the 
haematocrit of the parent culture and the fresh erythrocyte donor was calculated 
using a C-chip haemocytometer (Neubauer Improved), using the manufacturer’s 
instructions. Parasite cultures were subsequently diluted down to a 
concentration of 1 parasite per mL and 250 µL was loaded into each well of a 
96-well plate at a haematocrit of 1%. This low haematocrit allowed for the 
identification of parasite positive wells using a plaque-based approach (Thomas 
et al. 2016) under the 4x lens of a light microscope. For each transfection plate, 
6 parasite positive wells were taken into a 6 well plate and bulked up to a 
parasitemia of ~1%, prior to 200 µL of 50% haematocrit culture being frozen at -
20°C and subsequently extracted using a QIAamp DNA Blood Midi Kit (Qiagen). 
2.8.9 Live parasite imaging 
All parasite images were taken using live parasites, prepared by placing a 
droplet of approximately 30% haematocrit culture under a coverslip on a glass 
microscope slide. These were subsequently imaged under the 40x lens of an 
67 
 
EVOS FL Cell Imaging System (EVOS). When required for counting of the 
proportion of parasites that were fluorescent, DNA was stained prior to imaging 
using Hoeschst stain 33342 (ThermoFisher) at a concentration of 1 µg/mL to 
50% haematocrit cell culture for 45 minutes at 37°C. 
2.8.10 Comparison of quantitation of in vitro competition using a 
combination of allele-specific qPCR and fluorescent imaging 
Following PCR screening of Pf47 integration and limiting dilution cloning, 
measurements of in vitro mixedness were determined using both the allele-
specific qPCR assays and microscopic fluorescence, ring-stage parasites were 
sorbitol synchronised and allowed to develop into early stage trophozoite 
stages. Parasitemia of the parent flask was calculated from a 1000 red blood 
cell count to confirm the absence of multi-nucleate schizont stages and five 
pairwise artificial competitive scenarios were produced consisting of 20:1, 10:1, 
1:1, 1:10  and 1:20 mixtures of the two genotypes. 200 µL aliquots of these 
mixtures were taken for qPCR and processed as described (section 2.7.1), 
whilst microscopic counts were performed on the two parasites with different 
fluorophores using the alternate EVOS Texas Red and GFP Light cubes, for 
distinction between red and green fluorescent parasites respectively. Images of 
these mixtures were taken (section 2.7.9) and proportions of each genotype 
were calculated by counting 200 parasites.  
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3. Genome-wide assessment of P. falciparum within-host diversity within 
a highly endemic West African population  
 
3.1 Introduction 
Clinical infections of P. falciparum regularly contain a mixture of different 
haploid P. falciparum genotypes, particularly in areas of high endemicity where 
superinfection can frequently occur (Anderson et al., 2000).  As previously 
described (section 1.5), analyses of the within-host diversity of P. falciparum 
have commonly used assays to discriminate alleles at a small number of highly 
polymorphic antigen genes loci (Farnert et al., 2001). However, as these loci 
are subject to immune selection from the host, genotyping of multiple putatively 
neutral polymorphic microsatellite marker loci is preferable for most general 
analyses (Anderson et al., 2000). These studies have clearly demonstrated a 
wide variation in prevalence of multiple genotype infections and an inverse 
correlation with multilocus linkage disequilbrium in different geographical 
populations of P. falciparum (Anderson et al., 2000; Machado et al., 2004; 
Anthony et al., 2005; Schultz et al., 2010).  
Further dissection of the within-host diversity of P. falciparum infections has 
recently been performed using genome-wide SNP data. Studies on different 
clones from individual infections have revealed that a high degree of haplotype 
relatedness is exhibited by some distinct clones within infections, in comparison 
to those sampled from separate infections (Nkhoma et al., 2012; Nair et al., 
2014, section 1.5.1). This illustrates a challenge in characterising or quantifying 
the within-host diversity of P. falciparum, as natural infections may consist of a 
single clone, multiple genetically unrelated clones (Figure 3.1), or a mixture of 
closely related non-identical genotypes.  
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Figure 3.1. Schematic diagram representing the presence of multiple 
genotypes within natural infections of P. falciparum. Three infections are 
shown consisting of a single genotype, two genotypes and three genotypes 
respectively, in different relative proportions. This scenario is further 
complicated by different degrees of relatedness exhibited by clones within 
infections (Nkhoma et al. 2012, section 1.5.1). 
 
 
 
 
 
 
70 
 
Moreover, these combinations within a host may be present at different relative 
proportions within an infection, further complicating their analysis and can 
change in proportion over time (Farnert et al. 1997). 
While genome-wide SNP data of clones from an infection can provide resolution 
on closely related but distinct clones following intensive ex vivo culturing, whole-
genome deep sequence data of uncloned samples can also be used to study 
parasite diversity. Due to P. falciparum being haploid during the intraerythrocytic 
cycle, the relative proportions of SNP alleles in whole-genome sequence data 
from an uncloned infection can be estimated from the proportions of reads 
mapping to a reference sequence, and this has been used for computation of a 
within-isolate fixation index (Auburn et al., 2012; Manske et al., 2012). Taking 
this approach, the FWS index has been developed as a quantitative measure 
which compares the extent of average genome-wide within-host diversity (HW) 
to the overall parasite population (or local subpopulation, HS) diversity. This FWS 
index has an upper limit of 1.0, indicative of an extremely clonal isolate where 
sequence diversity is absent or at least very limited, whilst an isolate score of 
zero is indicative of the level of within-host heterozygosity being equal to the 
level of within-population heterozygosity. Thus, the index is influenced by the 
relative proportions as well as the degree of relatedness of genotypes that are 
present within an infection. 
This chapter focuses on the bioinformatic analysis of clinical P. falciparum 
isolate sequence data from the N’Zérékoré region of the Republic of Guinea, 
which has previously been characterised as a highly endemic region through 
ten locus microsatellite marker typing (Mobegi et al. 2012), where the vast 
majority of infections are found to consist of more than a single genotype.  The 
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within-host diversity of P. falciparum infections has been assessed using the 
computation of the allele-frequency based FWS index from whole genome 
sequence data. Further analyses have explored the feasibility of estimating 
genome-wide FWS from small numbers of SNP loci when whole-genome 
sequence data are not obtainable. In addition, measurement of within-host 
diversity through the FWS index has been compared against three other 
proposed methods; the well established method of multilocus microsatellite 
typing (Anderson et al. 1999) and the more recently proposed methodologies of 
estMOI (Assefa et al. 2014) and a complexity of infection likelihood (COIL) 
calculator (Galinsky et al. 2015). These two latter methodologies, rather than 
characterising within-host diversity per se, provide a clone-counting measure of 
an infection through analysis of whole genome sequence alignment files and 
biallelic SNP barcodes respectively. 
3.2 Materials and Methods 
From an initial population of 120 Guinean whole genome sequences that were 
produced from isolates collected within the N’Zérékoré region of the Republic of 
Guinea (section 2.1.1), a total of 95 Guinean isolates and 50082 SNPs passed 
through several quality control filtering procedures (section 2.1.2, Figure 3.1) 
and isolate FWS indices were calculated (section 2.1.3). Subsequently, for 
estimation of isolate FWS from limited numbers of SNPs, FWS indices were 
subsequently derived from sampling a small number (between 1 and 20) of 
randomly selected SNPs and comparing the calculated isolate scores with the 
genome-wide indices previously determined. A Pearson’s correlation coefficient 
with the genome-wide SNP estimate of FWS was determined across all isolates. 
For each limited SNP selection of n SNPs, 100 iterations were performed to 
randomly allocated subset groups of n SNPs and  the mean Pearson’s   
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Figure 3.2 Quality control filtering pipeline of SNPs and isolates for 
calculation of the FWS metric. Example plots represent A) the population 
coverage filter implemented, which removed 13891 SNPs lying outside of the 
dashed lines which indicate an approximate Gaussian distribution and B) the 
isolate missingness filter, whereby 25 isolates were removed which were 
missing coverage data for greater than 20% of the filtered population SNP set. 
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coefficient across these iterations was calculated. This analysis was repeated 
and comparisons performed between sets of SNPs with different ranges of 
population minor allele frequencies. 
Isolate FWS scores were compared with three other proposed measures of 
within-host diversity; PCR based genotyping of ten polymorphic microsatellite 
loci (Anderson et al. 1999) performed by Dr Victor Mobegi (Victor Mobegi, 
LSHTM PhD thesis 2014), a deep sequence based estimator of infection 
multiplicity (estMOI, Assefa et al. 2014) and a bi-allelic SNP barcode estimator 
of infection multiplicity (COIL, Galinsky et al. 2015). For the running of the 
software estMOI, a custom perl based script was written which iterated over all 
of the Guinean isolates sequence alignment files in BAM format. For the 
implementation of COIL, a set of bi-allelic SNP genotype barcodes were 
generated from the Guinean whole genome sequence data for 96 randomly 
selected SNPs (Appendix 3) that had passed all filtering procedures which were 
calculated to have a population minor allele frequency of greater than 20%. 
These barcodes were subsequently uploaded to the COIL programme available 
at http://www.broadinstitute.org/infect/malaria/coil/. 
3.3 Results 
3.3.1 Isolate FWS indices within the Republic of Guinea 
Genome-wide SNP data for each of the isolates were used to generate within-
host FWS fixation indices, for comparison to the microsatellite profiling of the 
same isolates. Using the Illumina short-read sequence reads to estimate 
relative frequencies of SNP alleles within each isolate, the within-isolate 
diversity (HW) was derived, and the gradient of HW/HS (where HS is the diversity 
in the entire local population sample) was calculated within each minor allele 
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frequency bin to derive the FWS index for each isolate (Figure 3.3A). Over all 95 
clinical isolates, the mean genome-wide FWS index was 0.79, with a range of 
0.16 to 1.00 (Appendix 4). Of these, 50 Isolates (52.6%) had an FWS index 
approaching 1 (values of >0.95) indicating that they each predominantly consist 
of a single haploid genome sequence (Figure 3.3B), with any additional 
genotypes being rare, or closely related to the predominant genotype. 
Conversely, 45 of the clinical isolates (47.4%) had an FWS index of <0.95 and 
were thus clearly genotypically mixed infections. No significant correlation was 
seen between average genome sequence read mapping depth and FWS score 
(Pearson's r = 0.02), indicating that there was no bias in estimating within-host 
diversity due to sequence coverage (Figure 3.3C). 
When viewing within-host heterozygosity of all SNPs for each isolate 
individually (Figure 3.4), all 95 isolates had individual SNPs that were biallelic, 
with the number of heterozygous SNPs within each host ranging from a 
minimum of 49 SNPs (0.1% of all 50,082 within-population SNPs) within isolate 
PA0149 to a maximum of 6762 SNPs (13.5% of all within-population SNPs), 
with a mean number of 1995 polymorphic SNPs found within the Guinea 
population, which is to be expected due to the vast majority of population SNPs 
being rare within the population and thus unlikely to be found to be 
heterozygous within an individual isolate. 
 
3.3.2 Identifying SNPs for assay of within-host diversity with a small 
number of loci 
Calculation of FWS indices from genome-wide data may not always be possible 
for clinical samples, due to the absence of genome-wide SNP data. In order to  
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Figure 3.3 Genome-wide computation of Guinean isolate FWS indices . A) 
The linear relationship between within-host  and within-population 
heterozygosity for all 95 isolates used to calculate FWS, where dots representing 
the mean values for each corresponding population minor allele frequency bin. 
The steeper the gradient of the slope Hw/Hs, represents an isolate with a higher 
level of within-host diversity.  B) Cumulative density plot of isolate FWS scores, 
with the horizontal line on the y-axis at 0.95, above which isolates were defined 
as predominantly single-genotype infections. C) No correlation is seen between 
mean coverage depth and isolate FWS, providing support for the quality filtering 
procedures implemented (Pearson’s r = 0.02). 
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Figure 3.4 Frequency of within-host polymorphisms of the Guinean 
population. Whilst 43.1% of isolates (n=41) had an FWS score of >=0.99, 100% 
(n=95) of the Guinean population possessed individual biallelic SNPs. As 
expected there was a significantly negative correlation between the number of 
within-host heterozygous SNPs and the isolate FWS score (Pearson’s r = -0.91, 
p-value <0.001) 
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investigate the potential use of small numbers of SNPs, data from up to 20 
randomly chosen SNPs were used to estimate FWS indices and correlations with 
values derived from genome-wide SNP data (Figure 3.5) were determined. By 
selecting from all SNPs, regardless of allele frequency, correlations with 
genome-wide estimations were modest (for 20 SNPs Pearson’s r<0.71). 
However, by selecting SNPS with minor allele frequencies greater than a 
specified threshold (either <5%, 10%, 20%, 30% or 40%), much higher 
correlations were seen. Correlation for each selection began to plateau above 
~10 SNPs (Figure 3.5). Randomly choosing ten or more SNPs with minor allele 
frequencies of greater than 10% gave correlations of r > 0.9 with the genome-
wide Fws indices. 
3.3.3 Concordance of FWS with other proposed measures of within-host 
diversity  
Microsatellite typing allows an assessment of the proportion of loci that have 
multiple alleles within an infection, as well as a minimum estimate of the number 
of different parasite genotypes, as defined by the highest number of alleles 
detected at any locus. As expected, there was a highly significant negative 
correlation between the FWS fixation index derived from the SNP analysis and 
the number of microsatellite loci with multiple alleles detected within each 
infection (Pearson’s r = -0.88, P < 0.001) (Figure 3.6A). There was also a highly 
significant negative correlation between the isolate FWS index and the number of 
different genotypes within each infection detected by microsatellite typing 
(Pearson’s r= -0.80, P< 0.001). However, many of the infections that appeared 
to contain a single dominant genotype (on the basis of an FWS index of >0.95) 
were seen to contain multiple microsatellite genotypes, and some of these had 
multiple alleles at several of the loci genotyped (Appendix 4).  
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Figure 3.5 Correlation coefficients of isolate FWS indices derived from 
randomly sampled small numbers of SNPs compared with indices using 
all genome-wide SNPs analysed in the local population. The effect of using 
SNPs with allele frequencies above different levels is shown. Within the overall 
SNP set sampled from, 7684 SNPs have a MAF of >5%, 5004 SNPs have a 
MAF of >10%, 2854 SNPs have MAF of >20%; 1719 SNPs have MAF of >30% 
and 833 SNPs have MAF >40%. Replications of 100 random samples of 
different numbers of SNPs (between 1 and 20) were performed and the mean 
correlation coefficient for each is plotted. 
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Moreover, there was strong concordance between the isolate Fws indices and 
the corresponding outputs derived from COIL (Pearson’s r= -0.93, p-
value<0.001). COIL can determine the presence of up to a maximum of five 
genotypes from a 96 SNP barcode as implemented here and defines its 
estimation of infection complexity as the number of individual genotypes 
present. The mean number of clones per infection estimated by COIL was 2.01, 
with 51.6% (n=49) of the isolates estimated to contain a single genotype and 
10.5% (n=10) of the isolates were estimated to contain five different genotypes.  
Alternatively, the estMOI software is designed to use deep sequence data to 
infer minimum numbers of distinct genotypes found within an infection by 
calculating the number of haplotypes derived across SNPs from sequencing 
read pairs (Assefa et al. 2014). However, despite iterations using different input 
conditions for the minimum haplotype frequency to be considered, the output 
estimated number of clones derived from the estMOI software was not 
concordant with the other measures implemented. Across both iterations used, 
not a single isolate was estimated to have greater than or equal to four clones 
present within an infection. In addition, the range of estimated clone numbers 
produced by the software was extremely limited, with greater than 80% of all 
isolates apparently estimated to have two clones present. Furthermore, when a 
minimum haplotype frequency of two was used, only one isolate was estimated 
to consist of a single clone, whilst when a minimum haplotype frequency of 
three was used, no isolates were found to have >=3 estimated clones. When 
these results are considered alongside the estimates of within-host diversity 
provided by the microsatellite typing, the FWS index and COIL, the outputs of 
estMOI did not concur. 
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Figure 3.6 Concordance of Guinea isolate FWS scores with alternative 
measures of within-host diversity. A) Concordance between microsatellite 
genotyping and FWS indices derived from genome-wide SNP data for P. 
falciparum clinical isolates from Guinea (N = 93 with complete 10-locus 
genotype profiles). A highly negative relationship (Pearson’s coefficient = -0.88, 
P < 0.001) was seen between isolate FWS index and the number of 
microsatellite loci with >1 allele detected within the isolate. B) Concordance 
between COIL-based estimation of multiplicity and FWS indices. 
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Table 3.1 Estimations of multiplicity of infection as calculated by estMOI 
software. Two separate minimum haplotype frequencies were implemented, 
but neither iteration showed concordance with the microsatellite profiling or FWS 
scores derived. 
 
 
 
 
 
 
 
 
 Minimum haplotype frequency implemented 
Estimated number of clones 1 2 
1 1 19 
2 77 76 
3 17 0 
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3.4 Discussion 
Within this chapter, genome-wide surveying of SNP-based allele frequencies 
has been used to characterise P. falciparum diversity within clinical infections 
from the Republic of Guinea. The results are indicative of a high degree of 
transmission intensity in the Guinean population studied, and are consistent 
with previous microsatellite data from other samples taken locally (Mobegi et al. 
2012). The genome-wide SNP data here indicate more than half of all infections 
to each be composed predominantly of single genotypes (Figure 3.3), which is 
in agreement with previously published calculations of isolate FWS indices from 
West African populations (Auburn et al. 2012).   
Random sampling of the genome-wide SNP data shows that the within-isolate 
Fws fixation indices may be estimated from modest numbers of SNPs, and 
correlated with the indices derived from genome-wide data. Therefore, to 
estimate genotypic mixedness of isolates without whole genome sequencing, it 
may be feasible to quantitate alleles of between 10 and 20 SNPs with other 
genotyping tools (Daniels et al. 2008), particularly focusing on SNPs with high 
overall minor allele frequencies. Due to the MalariaGEN catalogue of SNPs 
(MalariaGEN 2016), it is now possible to select such genotyping targets. 
Additionally, it is preferable that any such SNPs should be neutral across 
multiple populations, so that estimates are not biased by selection acting on the 
parasite. 
Furthermore, the FWS index has been compared against three other proposed 
alternative measures of within-host diversity within this study. Microsatellite 
typing has been well established to allow for the sensitive detection of distinct 
parasite genotypes present at low proportions within an infection, although 
83 
 
cloning or single-cell analysis of isolates would be needed to estimate the 
degree of relatedness among the different parasite. As expected within the 
Guinean population (Mobegi et al. 2012), the microsatellite genotyping was able 
to detect multiple clones in all but one of the 50 isolates which were found to 
consist predominantly of a single genotype by FWS, in agreement with previously 
reported PCR-based methods (Auburn et al. 2012). These comparisons 
highlight that estimates of genotypic complexity of malaria parasite infections 
using very different methods give correlated and complementary information, 
apart from those obtained by the estMOI software. With a wide range of 
methods now available, studies can choose genotyping and analytical 
approaches to suit personalised goals, recognising relative advantages of each 
in relation to the costs and available resources. 
The terminology used to describe the within-host diversity of P. falciparum 
infections is quite varied and can include multiplicity of infection (MOI), infection 
diversity or infection complexity.  The term ‘single-clone’ infection is regularly 
used to describe infections which have, in most instances, been determined as 
monoclonal from a small number of polymorphic loci using PCR based typing 
methods.  Understanding processes affecting different parasite genotypes 
within an infection could offer insight into mechanisms that are clinically 
relevant. It is possible that some clones within an infection have low proportions 
due to intrinsic growth rate differences, competitive suppression by other P. 
falciparum genotypes, or host selective pressures. Analyses of parasites in 
culture could examine whether particular P. falciparum clones outcompete 
others in terms of asexual replication, or whether relative growth rates are 
dependent on particular co-cultured combinations. Further dissection of the 
patterns of parasite genotypic diversity in clinical isolates, and possible 
84 
 
interactions between genotypes, is a priority for further dissection of the within-
host diversity of P. falciparum parasites. 
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Chapter 4. Assessing evidence of non-neutral allele-frequency based 
polymorphism at the within-host level across the P. falciparum genome 
within West Africa 
4.1 Introduction 
FST based genome scans between P. falciparum populations have been applied 
to investigate loci associated with a sub-population specific artemisinin slow 
clearance phenotype (Cheeseman et al. 2012) and to more generally scan for 
local selection within particular endemic areas (Mobegi et al. 2014; Duffy et al. 
2015). In an analogous manner to FST based genome scans, within this chapter 
the FWS index (Manske et al. 2012) is applied using a genome-wide scan to 
identify loci which exhibit deviant patterns of within-host heterozygosity (HW) 
relative to their local level of within-population heterozygosity (HS). 
For some other pathogenic organisms, studies to identify loci under within-host 
selection pressures are classically performed using time course experiments 
within a host (Wright et al. 2011; Golubchik et al. 2013; Illingworth et al. 2014, 
Didelot et al. 2016), but longitudinal sampling of human P. falciparum infections 
is only possible in asymptomatic individuals (Farnert et al. 1997). The genomic 
variation within a P. falciparum infection is determined by two main processes. 
The initial genomic diversity is representative of the haploid sporozoite progeny 
that are produced following the process of meiosis within the diploid zygotic 
stages of the parasites life cycle (Sinden & Hartley 1985). If this occurs between 
heterozygous haploid gametes, then meiotic recombination will take place, 
resulting in the production of numerous recombinant haploid progeny that have 
inherited different genomic regions from the heterozygous parents (section 1.4). 
Four studies producing experimental crosses in P. falciparum have been 
reported to date, three having involved inoculation of progeny into a 
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chimpanzee host (Walliker et al. 1987; Wellems et al. 1990; Hayton et al. 2008; 
Ranford-Cartwright & Mwangi 2012) and one with the use of human-liver 
chimeric immunocompromised mice (Vaughan et al. 2015). These crosses have 
each reported the generation of tens of distinct recombinant progeny, 
highlighting that in natural parasite populations where endemicity is high and 
the population is outbreeding (Conway et al. 1999; Manske et al. 2012), there is 
potential for high levels of genomic diversity within the initial inoculation of an 
infection. 
In addition to this genomic heterogeneity that can already be present within 
infections, de novo mutations will also occur. Estimation of the mutation rate of 
P. falciparum during the intraerythrocytic cycle on the 3D7 laboratory clone has 
been put at 1.7 x 10-9 per base pair per generation. When adjusted for the 
estimated proportion of deleterious mutations produced, this means that after 
only 25 asexual rounds of replication, the daughter parasite would be expected 
to have accumulated a non-synonymous mutation from the original asexual 
parent (Bopp et al. 2013). When this is extended further to account for the mean 
parasite load found in an acutely infected person of 7.0 x 1011 (Dondorp et al. 
2005) and the possibility of infections persisting for several years (Sama et al. 
2004; Ashley & White 2014), there is significant potential for the generation of 
novel allelic variants during the intraerythrocytic cycle within the human host. 
Finally, particularly within regions of high endemicity, superinfection of unrelated 
parasite genotypes occurs and can also contribute substantially to the genomic 
diversity found within a host (Nkhoma et al. 2012). 
Within this chapter, I test the hypothesis that some of the genomic diversity 
present within an infection may be subject to directional selective forces at the 
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within-host level and assess whether particular loci under these processes can 
be detected using an FWS based scan approach. Directional selection acting on 
genes will result in either purifying or positive selection that will lead to the 
fixation of alleles that improve the parasites ability to grow within the host. Thus, 
using an FWS genome based scan I set out to identify loci with consistently high 
levels of within-host homozygosity relative to their within-population 
heterozygosity (Figure 4.1) analysing data collected from four different 
populations within West Africa. Underlying potential causes of directional within-
host selective forces that would result in increased within-host homozygosity at 
particular loci (Hastings 1996) could include drug selection of parasites 
possessing resistance mutations (Robinson et al. 2011), specific host receptor 
polymorphisms that prevent establishment or growth of certain recombinant 
progeny or alleles, or allele-specific immune selection (Conway et al. 2000; 
Osier et al. 2010).  
4.2 Materials and Methods 
Publicly available whole-genome sequence data from population samples of P. 
falciparum clinical isolates of four West African locations (section 2.1.1) was 
utilised, which consisted of an initial set of 131 isolates from the Republic of 
Guinea, 79 isolates from The Gambia, 68 isolates from Central Ghana and 48 
isolates from Northern Ghana. All isolates underwent quality control filtering 
(section 2.1.2) and isolate FWS indices were calculated accordingly (section 
2.1.4). The within-population heterozygosity calculations and data filtering 
procedures were performed within each of the four populations independently. 
Two separate strategies were then used to apply a scan of FWS across the 
genome, with all analyses being performed using custom scripts within R. 
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Figure 4.1 Schematic diagram of the within-host heterozygosity of three 
infections and the corresponding within-population heterozygosity for 
calculation of the FWS metric at four example nucleotide positions. At locus 
A, no polymorphism is seen within the population. At locus B, all three isolates 
are homozygous, but across the whole population there is heterozygosity. At 
loci C and D, different levels of within-host and within-population heterozygosity 
are derived. Thus, potential FWS values across the population at a particular 
locus has a potential range from 0 to 1, where 0 indicates that the average 
within-host heterozygosity is equal to the within-population heterozygosity, 
whilst a score of 1 indicates that the locus is homozygous at the within-host 
level. Within this figure, each isolate only has four sequences sampled per locus 
per isolate, whereas the deep sequence data filter used in this study had a 
minimum coverage of 20 reads. 
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Firstly, a gene-based genome-wide scan of FWS was employed, where mean HW 
and HS were calculated across all SNPs within each gene. Thus, genic FWS 
values were effectively calculated as a ‘ratio of averages’ (Bhatia et al. 2013; 
Weir & Cockerham 1984), in which the numerator HW and HS are averaged 
independently. Following this, a minimum cut off of 10 SNPs was required to 
produce a gene FWS score. Genes exhibiting putative FWS values with increased 
levels of within-host homozygosity were defined as those where the value was 
found to be >2 standard deviations away from the mean score across all genes 
within that population. The calculation of gene scores also facilitated the use of 
GO-term enrichment analysis to examine the potential presence of significantly 
enriched gene functions across the different populations using Fisher’s exact 
test and the weighted algorithm within the TopGO package in R (Alexa et al. 
2006).  
The second methodology which was implemented was a SNP-based approach 
designed to attempt to identify individual non-synonymous mutations that could 
offer a within-host selective advantage. For this purpose, 95% confidence 
intervals were generated through 100 bootstrapped replications of mean non-
synonymous FWS SNP scores, where HW and HS were calculated individually for 
each SNP. Initially, the Guinean population dataset was used for a pilot analysis 
to determine the relationship between population minor allele frequency and 
estimations of an FWS SNP score, prior to setting a population minor allele 
frequency cut off of 5% across all populations.  Following this, only SNPs 
encoding non-synonymous mutations present within all four West African 
populations were retained, leaving a total of 3906 SNPs. 95% confidence 
intervals of bootstrapped mean SNP-based FWS scores were then calculated 
across each population individually and SNPs were considered significantly 
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more homozygous at the within-host level than expected from the overall within-
population data when calculated to have an FWS value with a 95% confidence 
lower limit boundary higher than the calculated mean across the population. 
This cut off for individual loci followed that previously used for analyses of 
potential non-neutral oocyst inbreeding coefficients (Anthony et al. 2007). 
 
4.3 Results 
4.3.1 Population comparison of isolate FWS indices across West Africa 
From an original sample set of 326 isolates across the four locally sampled 
populations, 90.2% of isolates (n=294) remained following filtering procedures, 
with respective SNP set sizes of 49740, 60148, 69291 and 86403 within The 
Gambia, Northern Ghana, Central Ghana and the Republic of Guinea 
respectively (Table 4.1). Within each of the four populations, the minor allele 
frequency distribution recorded was highly skewed towards low frequency 
variants, with 79.2% of Gambian SNPs and 90.8% of Guinean SNPs found to 
possess a population minor allele frequency of 5% or less (Figure 4.2), whilst 
proportions of the two sites in Ghana were intermediate between these. This 
high frequency of relatively rare minor allele frequency variants, including a 
higher proportion of Gambian SNPs with a minor allele frequency of greater 
than 5% compared to the other sites is in agreement with previous population 
genome analyses of these datasets (Amambua-Ngwa et al. 2012; Mobegi et al. 
2014; Duffy et al. 2015). 
When isolate FWS scores were compared pairwise between the populations 
(Table 4.1), only the Gambian population was found to have a significantly 
different population mean isolate score from all of the other three populations   
91 
 
  
 
 
 
Table 4.1 Summary statistics of quality filtered SNP sets and isolate FWS 
indices from four West African populations.  FWS scores were calculated 
across all quality filtered SNPs within each population individually, thus for the 
Guinean population this was performed across 86403 SNPs.  
 
 
 
 
 Republic of 
Guinea 
(N’Zérékoré) 
The 
Gambia 
(Greater 
Banjul) 
Northern 
Ghana 
(Navrongo) 
Central 
Ghana 
(Kintampo) 
Number of isolates 111 73 47 63 
Number of SNPs 86403 49740 60148 69291 
Mean FWS score 0.81 0.93 0.77 0.81 
Isolate FWS range 0.19-1.00 0.33-1.00 0.16-1.00 0.35-1.00 
Proportion of scores 
>0.95 
54.1% 
(n=60) 
76.7% 
(n=56) 
43.8% 
(n=21) 
50.8% 
(n=32) 
Number of SNPs with 
>5% MAF 
8035 10366 8302 8961 
Number of genes 
with >10 SNPs 
2492 1655 1912 2172 
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Figure 4.2. Population minor allele frequency distributions for all four 
West African population SNP sets. All SNPs within each panel (A= Republic 
of Guinea, B= The Gambia, C= Central Ghana and D= Northern Ghana) have 
been placed into equally sized minor allele frequency intervals, with steps and 
bin sizes of 0.05. 
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(Wilcoxon rank sum test with Bonferroni correction, Gambia vs Guinea:  p-
value=0.008, Gambia vs Northern Ghana: p-value=0.009, Gambia vs Central 
Ghana: p-value= 0.006, Guinea vs Northern Ghana: p-value=1, Guinea vs 
Central Ghana: p-value= 1, Northern Ghana vs Central Ghana: p-value= 1). 
Isolate FWS scores averaged across all SNPs in an isolate ranged from 0.16 to 
1.00. In addition, as previously noted for the Guinean population (Murray et al. 
2016, Figure 3.3) , a considerable proportion of isolates in all four populations 
were found to have sequence data that reflected predominantly single-genotype 
infections, with between 43.8% of isolates from Navrongo and 76.7% of 
Gambian isolates having a FWS value of >0.95 (Figure 4.3, Appendix 5).  
Visualisation of within-host heterozygosity (HW) across the genome for three 
isolates of varying FWS scores illustrates the markedly different levels of 
heterozygosity at the within-host level (Figure 4.4).  The isolate within panel A 
(Figure 4.4), with an FWS value of 0.97 may be defined as consisting 
predominantly of a single-genotype infection, but the modality of the distribution 
of its HW values were found to be at least bimodal (Hartigan’s dip test, p-
value=0.003). Unsurprisingly, this was also the case for isolate B with a FWS 
value of 0.33 (Hartigan’s dip test, p-value< 2.2e-16), but the HW distribution of 
isolate C with an FWS value of 1.00, was found to have a unimodal distribution 
(Hartigan’s dip test, p-value=1). This suggests that even within apparently 
highly clonal isolates across the genome, a small number of loci have apparent 
within-host heterozygosity, although it is possible that this may reflect artefacts 
due to sequencing or mapping errors at a minority of SNPs. 
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Figure 4.3 Cumulative density plot of isolate FWS indices from four West 
African populations. The horizontal dashed line on the y-axis represents an 
FWS score of 0.95, above which isolates were defined as consisting 
predominantly of a single genotype. Scores were calculated through linear 
regression of the relationship HW/HS across minor allele frequency intervals 
(section 2.1.3, Figure 3.3A). 
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Figure 4.4 Genome-wide within-host heterozygosity of three example 
Guinean isolates. Three isolates are shown with varying isolate FWS scores of 
A) 0.97, B) 0.33 and C) 1.00 from top to bottom respectively, where all dots 
represent individual SNPs and alternating colours represent the boundaries of 
the fourteen chromosomes of P. falciparum.  
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4.3.2 A gene-based scan of FWS across the genome 
For identification of genes with outlying FWS scores relative to the rest of the 
population, genes with scores that were found to be greater than two standard 
deviations above the mean population gene score of each population were 
identified (Figure 4.5 and Figure 4.6; Guinea mean FWS gene score= 0.828, 
SD= 0.0345, outliers > 0.897; Gambia mean FWS gene score= 0.919, SD= For 
identification of genes with outlying FWS scores relative to the rest of the 
population, genes with scores that were found to be greater than two standard 
0.0274, outliers > 0.974, Central Ghana mean FWS gene score= 0.804, SD= 
0.0468, outliers > 0.898; Northern Ghana mean FWS gene score= 0.766, SD= 
0.0521, outliers >0.870). This procedure left a total of 78, 10, 35 and 37 outlier 
genes across the Guinean, Gambian, Central and Northern Ghanaian 
populations respectively.  
Across the four populations this identified a total of 154 genes that were found 
within at least one of these outlier subsets, but only three genes were present 
within two of the different population outlier subsets (PF3D7_0906600 in Central 
Ghana and Guinea; PF3D7_1013900 in Central Ghana and Guinea; 
PF3D7_1369000 in Central Ghana and Northern Ghana). These three genes 
putatively encode a zinc finger protein, an initiation factor subunit protein and a 
glycosylphosphatidynlionositol anchor attachment 1 protein respectively. This 
was inconsistent with an initial hypothesis that certain genes would be 
consistently under within-host selection. Some genes did not have sufficient 
numbers of SNPs in all populations to be included in all analyses, but 
PF3D7_1369000 had enough SNPs within all four populations to be present 
within the final analyses without always being present within the outlier subsets. 
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Figure 4.5 Distribution of FWS gene scores within the four West African 
populations. Within each panel, the dashed vertical line represents the cut off 
score implemented for the identification of outlier genes of mean plus 2 SD (  A) 
Guinea outliers = >0.897; B) Gambia outliers = >0.974, C) Central Ghana 
outliers = >0.898; D) Northern Ghana outliers = >0.870). 
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 Figure 4.6 Genome-wide plots of gene FWS scores within four West African 
populations. Within each panel, the dashed horizontal line represents the cut 
off score implemented for the identification of outlier genes of mean plus 2 SD ( 
A) Guinea outliers = >0.897; B) Gambia outliers = >0.974, C) Central Ghana 
outliers = >0.898; D) Northern Ghana outliers = >0.870). Each dot represents a 
gene with >=10 SNPs in that population. 
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In addition, whilst PF3D7_0906600 and PF3D7_1013900 did not possess 
enough SNPs to be present within the final gene score analysis for all 
populations, they did both have 5 or more SNPs within all four populations. 
Subsequent gene-based calculation of FWS for these two genes within the 
corresponding populations in which they had not been performed did not 
produce genic FWS scores that would have been found within the outlying group 
of scores in any other population (Gambia gene FWS of PF3D7_1013900 = 
0.924, Northern Ghana gene FWS of PF3D7_1013900 = 0.770; Gambia gene 
FWS of PF3D7_0906600 = 0.828, Northern Ghana gene FWS of PF3D7_0906600 
= 0.734, Appendices 6 to 9).  
Furthermore, pairwise correlation plots between the four West African 
populations for the remaining set of 1492 genes which had greater than 10 
SNPs within all populations showed no evidence of correlation (Figure 4.7, 
Pearson’s r ranged between -0.05 and 0.1 for all six pairwise comparisons), 
which had been previously been shown to be strongly concordant for other 
allele-frequency spectra based scans of selection within these populations 
(Mobegi et al.2014; Duffy et al. 2015).  
To determine whether there were any putative functional properties that were 
consistently found within the outlier FWS gene scores across the four West 
African populations, gene ontology (GO) term analysis was applied. This found 
no GO terms to be consistently enriched across the four West African 
populations, with only rRNA processing (GO:0006364) found to be significantly 
enriched (p-value <0.005) within only the Navrongo population (Appendices 10 
to 13). 
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Figure 4.7 Concordance between gene-based calculations of FWS across 
four West African populations. Pairwise correlations of the gene-based Fws 
scores for four West African populations, using all 1492 genes for which >=10 
SNPs were present within each population. 
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4.3.3 Bootstrapping of FWS SNP scores across the genome 
For the calculation of SNP-based FWS scores, initially the Guinean population 
set was used to determine the effect of population minor allele frequency on the 
size of the confidence intervals produced through 100 bootstrap replications. 
Examination of the bootstrapping of SNPs within the interval consisting of SNPs 
with a population minor allele frequency of 5% or less indicated the intrinsic 
variation when estimating a SNP-based FWS within this group (Figure 4.8). For 
instance, bootstrapping had no effect for SNPs that were either only found to be 
homozygous at the within-host, but heterozygous within the population (FWS = 
1), nor for SNPs that were only found to be present as a within-host minor allele 
within one isolate and not found within the rest of the population (FWS = <1), as 
there was no within-host variation in heterozygosity to be able to resample for 
bootstrapping to produce an alternative FWS score. 
 Thus, SNPs from this interval were removed prior to bootstrapping across all 
populations, which produced genome-wide mean SNP FWS scores of 0.802 
within Guinea, 0.925 within The Gambia, 0.802 within Kintampo and 0.748 
within Navrongo. As with the identification of outliers using the gene-based FWS 
scan, the lower 95% confidence limits of no bootstrapped SNP FWS scores was 
found to be greater than the respective genome-wide mean population FWS 
score consistently across all four populations. Furthermore, pairwise correlation 
plots between all of the four West African populations for the bootstrapped 
mean FWS score calculated for each of the remaining set of 3906 SNPs showed 
no evidence of correlation (Figure 4.9, Pearson’s ranged between -0.05 and 
0.05 for all six pairwise comparisons). 
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Figure 4.8 Relationship between SNP population minor allele frequency 
and estimation of a mean SNP FWS score through bootstrapping. 
Bootstrapped mean FWS scores and 95% confidence intervals of 100 randomly 
selected SNPs from 6 population minor allele frequency (MAF) intervals from 
the Guinean population. 
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Figure 4.9 Concordance between SNP-based calculations of FWS across 
four West African populations. Pairwise correlations of the lower 95% 
confidence interval of 3906 non-synonymous SNPs present within all four West 
African populations. Dashed lines represent the cut offs within each population 
of the mean genome-wide FWS score for each population. The top right quadrant 
within each panel is the region in which outlier SNPs were identified within the 
two populations compared. 
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4.4 Discussion 
Within this chapter, I present the first attempt to identify loci from deep 
sequence data that are putatively under within-host selective forces in natural 
populations of P. falciparum.  Distributions of isolate scores of FWS are in 
general agreement with previous microsatellite based reports of within-host host 
genotypic diversity within the region and generally consistent with higher levels 
of genomic mixedness being found within areas of higher infection endemicity 
within West Africa (Mobegi et al. 2012). Despite the reported differences in 
transmission intensity within the Ghanaian regions of Kintampo and Navrongo, 
which are holoendemic and seasonally endemic respectively (Asante et al. 
2011; Kasasa et al. 2013; Duffy et al. 2015), isolate scores of FWS did not differ 
significantly within these two populations nor the Guinean population, with only 
the Gambian population having a significantly different mean.  Furthermore, the 
considerable proportion of isolates found to consist predominantly of a single-
genotype is also consistent with previous calculations of FWS within areas of 
high infection endemicity (Manske et al. 2012; Auburn et al. 2012).  
Population replication of a gene-based and bootstrapped SNP-based approach  
to implement an FWS based scan across the genome did not identify any loci 
that were consistently found within the outlier strata across all four West African 
populations as originally hypothesised and only weak correlation in gene and 
SNP FWS scores was seen between the different populations. Genome-wide 
approaches using fixation indices and other allele-frequency based metrics 
have previously identified targets of selection within multiple populations 
(Manske et al. 2012; Mobegi et al. 2014). Whilst this approach was thus 
ultimately unsuccessful, within this section I discuss alternative potential 
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avenues to identify potential molecular targets of within-host selection in 
Plasmodium parasites. 
The approach presented within this chapter shares some conceptual similarity 
with linkage group selection analyses of genetic cross progeny, which can test 
for loci associated with a particular phenotype through drug, growth or strain-
specific immune selection of uncloned progeny (Culleton & Abkallo 2015) using 
genome-wide polymorphic markers. These analyses attempt to identify loci 
amongst the progeny pool following phenotype-specific selection pressure that 
effectively show higher levels of homozygosity when compared to the original 
unselected progeny pool. There are however notable differences, as the FWS 
scan approach within a natural population does not have information on the 
progeny that have been produced within the previous round of meiotic 
recombination within the mosquito (section 1.4).  
Moreover, there are other alternatives to further examine potential evidence of 
within-host selection of P. falciparum from clinical isolates using sequencing 
based analyses. Whilst within this study, an allele-frequency based approach 
has not consistently identified any outlier loci across multiple populations, but a 
similar approach could be used to look for differences in transcriptome-wide 
expression levels of genes when particular allelic types are present. 
Transcriptional variation within laboratory clones of P. falciparum has been 
previously reported (Rovira-Graells et al. 2012) and this ‘bet-hedging’ 
heterogeneity is likely to play an important role in ensuring successful parasite 
replication, antigenic variation and  transmission within the variable host 
environment (Waters 2016). Thus, any within-host selection operating may be 
noticeably more detectable in terms of differential gene expression. Deep 
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sequence SNP calling on transcriptome data has previously been applied to 
clinical isolates of P. falciparum (Yamagishi et al. 2014), although this was 
performed directly on peripheral blood material and investigation of the variable 
expression of merozoite invasion ligands would be of interest, due to the well 
documented variation in expression at this life cycle stage (Mitchell et al. 1986; 
Hadley et al.1987; Bei & Duraisingh 2012; Amambua-Ngwa et al. 2012; Gomez-
Escobar et al. 2010). At present however, no population level RNA-Seq 
datasets are available at the ex vivo late schizont stage for P. falciparum  and 
difficulties do exist in the differences that exist in the length of the cell cycle 
between different clones (Reilly et al. 2007; Lemieux et al. 2009). 
 Furthermore, the development and application of long-read sequencing, at >10 
kb in length, to population studies of P. falciparum, will allow for complete 
chromosome sequencing and de novo assembly of the highly polymorphic sub-
telomeric regions of P. falciparum, which are thus difficult to map against the 
3D7 reference genome. Sub-telomeric regions have previously been shown to 
have increased rates of mitotic recombination in comparison to the core 
genome (Bopp et al. 2013; Claessens et al. 2014) and thus effects of within-
host selection on genes within this region could be more pronounced.  
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Chapter 5. Quantifying variation in gametocyte commitment in clinical 
samples of P. falciparum from two populations in different transmission 
environments 
5.1 Introduction 
Controlled experimental infections of multiple-genotypes within model 
Plasmodium species have assessed the effect of competition upon gametocyte 
sex ratio and commitment phenotypes (Pollitt et al. 2011; Reece et al. 2008; 
Neal & Schall 2014). However, analyses of natural populations have not seen 
such significant effects (Neal & Schall 2014, section 1.6.2). A handful of 
individual population studies have microscopically quantified gametocyte sex 
ratios for P. falciparum (Table 5.1). These have reported small differences in 
sex ratio commitment, although only the Papua New Guinea population 
contains mostly single clone infections (Paul et al. 1995), while all three other 
populations within West Africa possessing higher proportions of multiple-
genotype infections (Konaté et al. 1999; Sowunmi et al. 2009; Ntoumi et al. 
2000). Even with a direct measure of selfing probability, it should be noted that 
an existing issue would be the changes in the clonal composition over the 
course of an infection, as any sexual specific gametocyte commitment decision 
could only be reflective of a brief window during the infection. 
Theoretically, the lower limit of male gametocytes present within an individual, 
known as r*, is dependent on the number of viable gametes produced per 
gametocyte (fecundity, f) and is equal to 1/(1+f). Within P. falciparum infections, 
male gametocytes usually produced 4-6 gametes out of a theoretical maximum 
of 8, so with an assumption of f=5, the lower limit of r* for P. falciparum would 
equal 1/(1+5) and thus 0.17. This theoretical expectation of r* is similar to the 
value estimated for the Papua New Guinea population sample of of 0.18 (Read 
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Country Mean r* 95% CI Number of samples Reference 
Papua New Guinea 0.18 0.15-0.22 28 Read et al. (1992) 
Senegal 0.26 0.24-0.27 284 Robert et al. (2003) 
Nigeria 0.22 0.15-0.28 ~100 Sowunmi et al. (2009) 
Cameroon 0.22 0.20-0.23 54 Robert et al. (1996) 
 
Table 5.1 Measurements of gametocyte sex ratio by microscopy within 
four P. falciparum populations. Mean r* represents the proportion of male 
gametocytes reported, as calculated through r*=Number of male 
gametocytes/(Number of male gametocytes + Number of female gametocytes). 
Whilst the Papua New Guinea population has a high proportion of single-clone 
infections (Paul et al. 1995), the other three populations within West Africa 
possess higher proportions of multiple-genotype infections (Konaté et al. 1999; 
Sowunmi et al. 2009; Ntoumi et al. 2000). 
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et al. 1992), where malaria parasites are relatively highly inbred. Any population 
level analysis would be most appropriate by having a measurement of predicted 
selfing rate (s) within the host across the genome, which has not been tested 
for. Above its lowest limit, r* will rise within P. falciparum based on the 
increasing genotypic mixedness of infection as r* = (1-F), where F is selfing 
probability. With inference of selfing probability within West African populations 
possible using the FWS index (Manske et al. 2012), the expected sex ratio of 
gametocytes in response to having a particular FWS score can be predicted. 
From r*, it is also possible to estimate FWS, with an r* = 0.17, deemed as the 
theoretical limit, equalling an FWS of 0.66 through FWS = 1-(2r*). From this, it can 
be predicted that infections with an FWS of <= 0.65 would begin to produce high 
values of r* and thus greater proportions of male gametocytes within an 
infection.  
Within the West African populations that have had their population mean FWS 
derived within this thesis (section 4.3.1), the population means ranged from 
0.77 within the endemic Northern Ghanaian population to 0.93 within the 
relatively less endemic Gambian population. Within all of these populations 
however, a significant proportion of isolates were calculated as highly clonal 
infections, where FWS >=0.95. Thus, the skewed distributions of isolate FWS 
within these populations were prohibitive to testing an association between 
inferred probability of selfing within individual isolates and the proportion of male 
gametocytes. Furthermore, whilst FWS offers an inference of the probability of 
selfing, this can only experimentally be determined by oocyst based genotyping 
from large numbers of mosquitoes (Mzilahowa et al. 2007). 
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Alternatively, this chapter examines whether local parasite populations sampled 
from contrasting areas of transmission intensity have undergone 
microevolutionary processes, leading to a local population adaptation of optimal 
sex ratio that sees parasites in local populations continuously producing overall 
optimal sex ratios, rather than adjusting to the level of diversity in a current 
infection. Genomic loci within these localities involved in gametocytogenesis 
processes have been identified as exhibiting evidence of local population 
selective processes (Mobegi et al. 2014; Duffy et al. 2015) and thus selection 
could be operating at the population level due to transmission differences 
caused by basal variation in gametocyte sex ratio commitment. 
Gametocyte prevalence within endemic regions of P. falciparum has been 
widely determined using a combination of microscopy and molecular methods 
for the detection of stage V gametocytes (Molineaux & Gramiccia 1980; 
Stepniewska et al. 2008; Bousema et al. 2006). Within this chapter, in vivo 
commitment to gametocyte production has been characterised by profiling the 
expression of genes that have been shown to quantify gametocyte sex ratios 
using sensitive molecular detection assays (Schneider et al. 2015). In addition, 
to further investigate the possibility of different basal rates of 
gametocytogenesis, the expression of genes shown to be upregulated during 
the early stages of gametocytogenesis and essential for gametocyte formation 
within 3D7A are profiled; GDV-1 and AP2-G (Eksi et al. 2012; Kafsack et al. 
2014). These investigations have been performed upon samples from two West 
African populations which have different levels of local transmission within 
Ghana and Senegal (Mobegi et al. 2012; Mobegi et al. 2014). Although the 
Senegalese population within Table 5.1 had a high proportion of multiple-
genotype infections (Konaté et al. 1999), the Senegalese samples used within 
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this chapter were collected from a region near Dakar where parasite 
transmission had substantially reduced between 2006 and 2011 due to 
increased  control efforts (Daniels et al. 2013). The Ghanaian samples used 
consisted of 12 samples from Kintampo in Central Ghana and 21 samples from 
Northern Ghana, for which  whole-genome sequence analyses had 
characterised similar levels of infection diversity to other highly endemic West 
African populations and little genetic differentiation between the two populations 
(Duffy et al. 2015). 
5.2 Materials and Methods 
Clinical isolates that were used within the gametocyte RT-PCR (section 2.2) 
had at least 100 µL of packed red blood cells thawed (section 2.3.2) and placed 
straight into TRIzol reagent (Invitrogen), before being stored at -80°C 
immediately. RNA extraction was performed using an RNeasy Micro kit 
(Qiagen) and eluted in 20 µL of elution buffer, prior to storage at -80°C.  
Subsequently, mRNA was reverse transcribed with oligo(dT) using TaqMan 
reverse transcription reagents (Life Technologies) to produce cDNA. To monitor 
any potential carryover of genomic DNA for the reverse transcription process, 
16 samples had no-RTs control set up and assessed by qPCR of the 
housekeeping transcript used. Following cDNA production, all samples were 
diluted 1 in 2 to give 40 µL of cDNA material for qPCR. 
Five different transcripts were quantified from each clinical sample; a commonly 
used housekeeping transcript serine tRNA ligase (PF3D7_0717700), the 
female-specific gametocyte transcript Pfs25 (PF3D7_1031000), the male-
specific gametocyte transcript Pfs230p (PF3D7_028900), and the early markers 
of gametocyte commitment transcripts GDV-1 (PF3D7_0935400) and AP2-G  
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 Primer 
Identity 
 
Primer Sequence (5’ to 3’) 
Target Gene Origin of primers 
 
Pfserylt-F 
 
AAGTAGCAGGTCATCGTGGTT 
 
Serine tRNA 
ligase 
 
Eksi et al. 2012 
 
Pfserylt-R 
 
GTTCGGCACATTCTTCCATAA 
 
Serine tRNA 
ligase 
 
Eksi et al. 2012 
 
Pfs25-F 
 
CCATGTGGAGATTTTTCCAAATGTA 
 
Pfs25 
Schneider et al. 
2015 
 
Pfs25-R 
 
CATTTACCGTTACCACAAGTTACATTC 
 
Pfs25 
Schneider et al. 
2015 
 
Pfs230p-F 
 
CCCAACTAATCGAAGGGATGAA 
 
Pfs230p 
Schneider et al. 
2015 
 
Pfs230p-
R 
 
AGTACGTTTAGGAGCATTTTTTGGTAA 
 
Pfs230p 
Schneider et al. 
2015 
 
GDV1-F 
 
TAGGCGTCGAAATAGTGCTAGTAGAAA 
 
GDV-1 
 
Eksi et al. 2012 
 
GDV1-R 
 
GTCCTCACAACCAGCATCATTAGTA 
 
GDV-1 
 
Eksi et al. 2012 
 
AP2G -F 
 
AACAACGTTCATTCAATAAATAAGG 
 
AP2-G 
Rovira-Graells et 
al. 2012 
 
AP2G-R 
 
ATGTTAATGTTCCCAAACAACCG 
 
AP2-G 
Rovira-Graells et 
al. 2012 
 
Table 5.2 Primers used for gametocytogenesis transcript profiling of 
clinical isolates. 
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(PF3D7_1222600), with all primers listed in table 5.2. All primers were checked 
using sequence data available at www.plasmodb.org to ensure that no SNPs 
were present within their target annealing sites. For all qPCRs, reaction and 
thermocycler conditions were the same as previously used for qPCR 
experiments for PMR quantitation (section 2.7.1). All transcripts were quantified 
in duplicate against 3D7A genomic DNA standard curves and the four 
gametocyte commitment transcripts were normalised against the seryl tRNA 
ligase housekeeping transcript using standard curve based absolute 
quantitation. 
 
5.3 Results 
5.3.1 Quantification of mRNA concentrations and quality filtering 
From the original set of 81 West African clinical isolates that underwent RNA 
extraction (48 from Senegal and 33 from Ghana), 33.3% of Senegalese isolates 
(n=16) and 84.8% of Ghanaian isolates (n=28) had a concentration of parasite 
mRNA of the housekeeping serine-tRNA ligase transcript of >1000 copies per 
µL, which was implemented as the cut off threshold for subsequent profiling of 
the four gametocytogenesis linked transcripts. From this set of 28 Ghanaian 
isolates, mRNA concentration was quantified above a threshold of 10 copies 
per µL within 27 isolates (93.8%) for AP2-G, 26 isolates (81.3%) for GDV-1, 14 
isolates (87.5%) for Pfs25 and 8 isolates (50%) for Pfs230p (Table 5.5). Within 
the set of 16 Senegalese isolates, mRNA concentration was quantified above 
the same threshold within 15 isolates (69.4%) for AP2-G, 13 isolates (63.9%) 
for GDV-1, 25 isolates (69.4%) for Pfs25 and 11 isolates (30.6%) for Pfs230p. 
The total parasite material within each of the clinical samples, as measured by 
quantification of the housekeeping transcript was significantly greater for the  
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Isolate 
ID 
Population Housekeeping 
(copies/µL)  
Pfs25 
(copies/µL) 
Pfs230p 
(copies/µL) 
AP2-G 
(copies/µL) 
GDV-1 
(copies/µL) 
INV136 Ghana 29707 366 270 410 514 
INV137 Ghana 14553 356 96 202 232 
INV138 Ghana 3578 0 0 0 0 
INV139 Ghana 7644 100 94 290 78 
INV140 Ghana 33528 248 192 420 305 
INV141 Ghana 23502 460 158 378 356 
INV155 Ghana 15811 66 52 46 33 
INV156 Ghana 1832 42 32 104 87 
INV157 Ghana 1867 24 15 44 15 
INV158 Ghana 4959 81 49 184 132 
INV159 Ghana 32729 204 262 802 114 
INV160 Ghana 6148 20 30 298 40 
N180 Ghana 277 205 0 23251 263 
N166 Ghana 7950 174 45 23 64 
N247 Ghana 1174 23 0 121 0 
N100 Ghana 6485 103 14 18 35 
N235 Ghana 2339 22 0 21 188 
N019 Ghana 18738 265 135 32 61 
N209 Ghana 218 17 0 0 0 
N224 Ghana 1932 226 0 2573 94 
N036 Ghana 12056 191 35 30 86 
N223 Ghana 1422 33 0 40 55 
N113 Ghana 57197 944 58 80 56 
N176 Ghana 4984 146 10 114 35 
N086 Ghana 16315 312 43 904 71 
N022 Ghana 1233 53 0 1414 10 
N032 Ghana 40729 15466 248 20312 831 
N175 Ghana 14681 592 132 17019 34 
N005 Ghana 748 386 0 544 0 
N292 Ghana 90467 295 48 12 86 
N098 Ghana 10299 319 50 121 183 
N237 Ghana 809 10 0 0 59 
 
Table 5.3 Mean copy number transcripts for all 5 genes profiled within the 
32 Ghanaian isolates that had a housekeeping transcript concentration of 
>100 copies per µL. All concentrations are given in copies per µL, from 
duplicate replicates against a 3D7A genomic DNA series which had a lowest 
concentration limit of 10 copies per µL, with values of 0 representing transcripts 
which were found to be at a concentration of below 10 copies per µL.
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Isolate 
ID 
Population Housekeeping 
(copies/µL) 
Pfs25 
(copies/µL) 
Pfs230p 
(copies/µL) 
AP2-G 
(copies/µL) 
GDV-1 
(copies/µL) 
PK85 Senegal 491 12 0 90 43 
PK66 Senegal 14052 12 0 80 15 
PK46 Senegal 66654 452 16 508 73 
PK61 Senegal 9777 39 20 299 105 
PK74 Senegal 3214 6421 0 134 135 
PK58 Senegal 959 0 0 0 0 
PK56 Senegal 238 24 0 0 0 
PK76 Senegal 711 297 12 63 49 
PK62 Senegal 940 0 0 0 0 
PK84 Senegal 587 14 0 0 38 
PK75 Senegal 622 776 20 3902 162 
PK83 Senegal 822 53 0 187 26 
PK68 Senegal 442 26 0 720 0 
PK45 Senegal 720 0 0 0 10 
PK64 Senegal 160 45 0 0 26 
PK39 Senegal 1249 0 0 10 0 
PK77 Senegal 2708 147 13 805 31 
PK25 Senegal 6428 344 49 82 67 
PK52 Senegal 22550 166 66 731 498 
PK44 Senegal 3405 76 0 243 0 
PK41 Senegal 352 0 0 0 0 
PK36 Senegal 2056 195 0 204 927 
PK40 Senegal 214 0 0 22 0 
PK50 Senegal 768 19 0 18 13 
PK80 Senegal 107 21 0 0 0 
PK55 Senegal 979 16 0 0 11 
PK71 Senegal 3169 109 0 374 20 
PK67 Senegal 173 0 0 13 0 
PK18 Senegal 4628 39 19 165 34 
PK07 Senegal 4182 70 16 16 1556 
PK24 Senegal 122 0 0 596 0 
PK23 Senegal 220 0 0 0 0 
PK16 Senegal 3078 0 0 0 0 
PK81 Senegal 48334 225 138 233 61 
PK65 Senegal 2816 86 0 391 50 
PK59 Senegal 885 0 12 39 15 
 
Table 5.4 Mean copy number transcripts for all 5 genes profiled within the 
36 Senegalese isolates that had a housekeeping transcript concentration 
of >100 copies per µL. All concentrations are given in copies per µL, from 
duplicate replicates against a 3D7A genomic DNA series which had a lowest 
concentration limit of 10 copies per µL, with values of 0 representing transcripts 
which were found to be at a concentration below 10 copies per µL. 
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Population Senegal Ghana 
RNA extractions performed 48 33 
Number of samples with 
housekeeping transcript 
concentration >1000 copies/µL 
16 (33.3%) 28 (84.8%) 
Number of samples with AP2-G 
transcript concentration >10 
copies/µL  
15 (93.8%) 27 (96.4%) 
Number of samples with GDV-1 
transcript >10 concentration 
copies/µL 
13 (81.3%) 26 (92.9%) 
Number of samples with Pfs25 
transcript >10 concentration 
copies/µL 
14 (87.5%) 27 (96.4%) 
Number of samples with Pfs230p 
transcript >10 concentration 
copies/µL 
8 (50%) 22 (78.6%) 
 
Table 5.5 Summary of the numbers and proportions of clinical isolates 
within each population for which each of the transcripts profiled were 
quantifiable above certain thresholds. For the housekeeping transcript, 
percentages are given above based on the total number of RNA extractions 
performed. For the four other gametocyte specific transcripts, percentages are 
given based on the number of isolates with a concentration of the housekeeping 
transcript of >1000 copies/ µL. 
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Ghanaian samples than the Senegalese population (Wilcoxon rank-sum test, p-
value < 1 x 10-5). This may explain why there were fewer Senegalese isolates 
which reached the detection threshold of >=10 copies per µL for each of the 
other gene transcripts. Individual mean copy number concentrations for each of 
the 36 Senegalese and 32 Ghanaian isolates with > 100 copies per µL of the 
housekeeping transcript are reported within Table 5.3 and Table 5.4.For each 
transcript, any isolates with a calculated concentration of <10 copies per µL, as 
determined by the lower range of the genomic DNA standard controls, were 
regarded as having a concentration of 0 copies per µL for all downstream 
analyses. Previous estimations of the proportion of isolates containing 
gametocytes has been put at about 90% using a molecular QT-NASBA 
approach which targeted the Pfs25 gene, although this was undertaken within a 
highly endemic Kenyan population (Bousema et al. 2006). This is broadly in 
agreement with the 96.4% of Ghanaian isolates and 87.5% of Senegalese 
isolates which had a Pfs25 concentration of >10 copies per µL when >1000 
copies of the housekeeping transcript were quantified.  
5.3.2 Varied isolate expression and population comparison of 
gametocytogenesis transcripts and sex ratios 
To provide quantitative information on the relative levels of each of the four 
gametocyte transcripts at the isolate level, all four gametocytogenesis 
implicated transcripts were normalised as the proportion of the housekeeping 
gene for all isolates which had a calculated housekeeping copy concentration of 
> 1000 copies per µL (Table 5.3 and Table 5.4). From this selection of 28 
Ghanaian and 16 Senegalese isolates, a subset of 22 Ghanaian and 10 
Senegalese isolate expression profiles for the four genes can be found within 
Figure 5.1, which were selected to support visual clarity of the varied distribution  
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 Figure 5.1 Normalised expression profiles for a subset of A) 22 Ghanaian 
isolates and B) 10 Senegalese isolates. Individual isolate IDs are found on 
the x-axis, whilst the representative colour scheme for each of the four 
transcripts can be found within the legend. For each of the four transcripts, the 
normalised proportion of that transcript against the prescribed housekeeping 
transcript is plotted on a log scale. These overall 32 isolates were selected on 
the basis they did not possess any outlying levels of a particular transcript, to 
aid visual clarity. Isolate INV138 in panel A) shows no evidence of expression of 
any of the four gametocytogenesis transcripts despite robust levels of 
expression of the housekeeping gene (Table 5.3). 
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of normalised expression profiles for the four gametocytogenesis transcripts. 
For instance, Senegalese isolate PK74 was not shown on the basis of showing 
markedly higher expression of the Pfs25 transcript relative to its housekeeping 
transcript expression. Within the plotted isolates, considerable variation is 
visible in the normalised expression levels recorded. For example, within the 
Senegalese samples, isolate PK25 showed higher expression of thefemale 
gametocyte specific Pfs25 gene than all other Senegalese samples, whilst for 
PK16 no expression of any of the four gametocytogenesis linked transcripts 
was detected. Meanwhile, within the Ghanaian samples, expression of the male 
gametocyte specific transcript Pfs230p is found to be highest within sample 
INV156. 
For pairwise population comparisons of expression of all four 
gametocytogenesis linked transcripts, all 28 Ghanaian and 16 Senegalese 
isolates were used, with any individual transcripts that were calculated to have a 
concentration of <10 copies per µL were regarded as being 0. From these 
comparisons, the normalised expression levels of Pfs25, AP2-G and GDV-1 
were all not significantly different (Mann Whitney U test, p-values > 0.5).The 
normalised expression level of Pfs230p within the Senegalese samples was 
lower than within the Ghanaian samples and was marginally significant when 
corrected for multiple comparison testing (Mann Whitney U test, Bonferroni 
corrected p-value = 0.048). For a comparison of sex ratios between the two 
populations, a further data filtering measure was implemented, whereby isolates 
were only included if they satisfied the criteria of having both a housekeeping 
transcript concentration of >1000 copies per µL and either an additive copy 
number of >100 copies for the two sex-specific markers Pfs25 and Pfs230p or 
the Pfs230p transcript was calculated to be at least one-tenth the concentration  
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Figure 5.2 Population male gametocyte transcript and sex ratio 
comparison of Ghanaian and Senegalese population subsets. Panel A) 
shows a slightly significant lower normalised expression of Pfs230p within 16 
Senegalese samples compared to 28 Ghanaian samples (Mann Whitney U , 
Bonferroni corrected p-value= 0.048). Panel B) is a population sex ratio 
comparison between 23 Ghanaian isolates and 11 Senegalese isolates, where 
the normalised male transcript proportion was calculated as normalised 
Pfs230p/(normalised Pfs230p + normalised Pfs25). Although the mean was 
male proportion was lower within Senegal, no significant difference was seen 
(Mann Whitney U, p-value = 0.08). 
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Figure 5.3 Pairwise correlations of normalised expression levels between 
Pfs25, AP2-G and GDV-1.  No evidence of correlation was seen between A) 
AP2-G and GDV-1 (Pearson’s r = -0.02), B) Pfs25 and AP2-G (Pearson’s r = 
0.09) or C) Pfs25 and GDV-1 (Pearson’s r = 0.07) for 44 clinical isolate samples 
pooled across the Senegalese and Ghanaian populations. 
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of the Pfs25 transcript. This led to the inclusion of 23 Ghanaian isolates and 11 
Senegalese isolates, with the removal of INV138, N247, N235, N223 and N022 
from the Ghanaian population and PK66, PK77, PK44, PK16 and PK65 from 
the Senegalese population. Whilst the Senegalese population had a lower 
mean normalised sex transcript ratio of 0.16 compared to the Ghanaian 
population of 0.268, this difference was not significant (Mann Whitney U test, p-
value = 0.08). In addition, pairwise correlations of the normalised expression 
levels of the Pfs25, AP2-G and GDV-1 genes were performed by pooling 
together the Ghanaian, but did not reveal any significant pairwise correlation 
(Figure 5.3). 
5.4 Discussion  
The analyses presented within this chapter represent the first attempt to 
quantify the expression levels of gametocyte sex specific transcripts in a 
comparison across two populations of differing transmission intensity and to 
quantify expression of the essential gametocytogenesis genes GDV-1 and AP2-
G from clinical isolates from two West African populations. In general, 
characterisation of the expression levels of specific gametocyte or early 
gametocytogenesis transcripts has not been well studied in vivo. Eksi et al. 
(2012) did quantify gametocyte expression profiles of a number of early stage 
gametocytogenesis implicated transcripts, including GDV-1, from a collection of 
twenty clinical isolates that were sampled upon the border of Thailand and 
Myanmar, finding a spectrum of isolate gametocyte expression profiles. 
However, the recently described essential early regulator of 
gametocytogenesis, AP2-G (Kafsack et al. 2014), has not had its expression 
profile characterised previously within clinical infections in vivo and no 
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molecular-based comparison of sex ratios has previously been performed for P. 
falciparum. 
Quantitative data on the distribution of profiles reported within this chapter 
provide important findings for designing further studies that may investigate sex 
ratio distributions or transcriptional variation within early or late-stage 
gametocyte markers in vivo, with great interest in these life cycles stages as 
potential transmission-blocking vaccine candidates (Kapulu et al. 2015; Nilsson 
et al. 2015). Whilst the relatively low levels of gametocytemia present within 
clinical isolates make such studies difficult, a potential approach for 
investigating stage V gametocyte-specific antigens would be to use a 
combination of monoclonal antibodies for antigens such as Pfs25 and Pfs230p 
that are available from the MR4 reagent depository (Quakyi et al. 1987; Barr et 
al. 1991) to specifically bind to and sort gametocytes for limited-cell based RT-
PCR or whole transcriptome amplification.  
Although the analysis of sex ratio within this chapter did not find a significantly 
lower proportion of male gametocytes within the Senegalese population as 
posited by evolutionary sex ratio theory, this population-level comparison was 
hampered by the relatively low expression levels of the Pfs230p transcript and 
the lower general parasite densities that were seen within the Senegalese 
population, which led to relatively small sample sizes. Alternatively, recent 
studies have characterised male and female gametocyte specific proteomes 
(Lasonder et al. 2016; Tao et al. 2014) and thus an RT-PCR assay targeting a 
more highly expressed male-specific protein may be a useful tool for such 
studies. In addition, a combination of an increased volume of sampling or the 
progression to analyses of limited cell amplification assays could overcome 
these issues. 
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In addition, the population level comparisons of the relative normalised levels of 
AP2-G, GDV-1 and Pfs25 expression reveal no significant differences, despite 
the varied levels of transmission intensity within this region. Expression of 
gametocyte specific transcripts is likely to be mediated by subtle differences in 
the seasonality of the local area, with experimental analyses of P. relictum 
having revealed that in the presence of its natural vector Culex pipens, 
infections have higher levels of parasitemia which lead to increased mosquito 
transmission levels (Cornet et al. 2014). The relationship between host-specific, 
parasite-specific, vector-specific and environmental factors that influence 
gametocytogenesis in P. falciparum remain challenging to dissect, but merits 
further investigation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
125 
 
Chapter 6. Quantifying variation in parasite multiplication rate during the 
ex vivo culture adaptation process of clinical isolates of P. falciparum. 
 
6.1 Introduction 
Due to the aforementioned success of P. falciparum whole genome sequencing 
(section 1.3) ventures such as the Pf3K project (Manske et al. 2012; Miotto et 
al. 2013; MalariaGEN 2016), over 2,500 whole-genome sequences are 
publically available for analysing clinical isolates from a range of populations 
globally (https://www.malariagen.net). However, there is comparably much less 
quantitative data available on many medically and epidemiologically relevant P. 
falciparum phenotypes derived from ex vivo clinical isolates.  
Whilst experiments on a rodent malaria model using P. chabaudi in mice have 
reported associations between parasite multiplication rate (PMR) and the 
virulence of infections (Mackinnon & Read 1999; Mackinnon & Read 2004), 
there have been conflicting reports from studies on the presence of an 
association between P. falciparum PMR within the first ex vivo cycle and the 
virulence of the infection from studies of isolates from South-East Asia 
(Chotivanich et al. 2000) and Sub-Saharan Africa (Deans et al. 2006). Whilst 
these studies provide quantitative estimations of PMR at the earliest possible 
period ex vivo, they were however only taken using a single biological replicate 
per isolate, from one replication cycle. In addition, measurements of ex vivo 
PMR and parasite invasion can be confounded by the generally low growth 
rates and any heterogeneous effects of cryopreservation and storage on 
measurements of PMR within that first cycle ex vivo (Nsobya et al. 2008; 
Bowyer et al. 2015). The most detailed analyses of in vivo growth rate across 
multiple intraerythrocytic cycles for three different ‘strains’ of P. falciparum, 
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using historical data from P. falciparum treatment of neurosyphillis cases 
reported differences in PMR across the strains and a 90% prediction interval for 
PMR across more than 200 cases of between 5.5 and 12.3 fold per 48 hour 
period (Simpson et al. 2002). Thus, this chapter focuses on quantifying PMR in 
a standardised manner from a panel of clinical isolates as they undergo culture 
adaptation ex vivo.  
Whilst parasite growth rates have been assessed within laboratory clones of P. 
falciparum previously (Reilly et al. 2007) and from cross progeny to identify 
genomic loci associated with cell cycle duration (Reilly Ayala et al. 2010), 
laboratory clones may not be representative of natural parasite populations. For 
example, it has been shown that laboratory clones have lost various 
chromosomal regions during the culture adaptation process (Cheeseman et al. 
2009).  In addition to detailing baseline information on an important phenotype 
of P. falciparum, determining the spectrum of PMR seen in clinical isolates ex 
vivo would be an important step in being able to identify other potential genomic 
or transcriptomic determinants of growth and to being able to perform controlled 
ex vivo competitive growth studies of P. falciparum to test for any evidence of 
multiple-genotype interactions. Conclusions from within-host competition 
studies of different model Plasmodium species (section 1.6.1) have given 
contrasting conclusions upon potential competitive suppression of certain 
genotypes (de Roode et al. 2005; Abkallo et al. 2015) and ideally would be 
performed within ex vivo clones or clonal isolates of P. falciparum. Within this 
chapter, I thus focus on quantifying the baseline variation ex vivo PMR and test 
the hypothesis that this is likely to increase over time during culture adaptation. 
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6.2 Materials and Methods 
Laboratory clone parasites (section 2.3.1) were thawed (section 2.3.2) and 
cultured (section 2.3.4). The limit of detection of the assay when a 3% 
haematocrit, 200µL sample was taken was assessed by using a serially diluted 
sorbitol synchronised ring stage culture of the clone 3D7A. Furthermore, the 
degradation of 3D7A-GFP genomic DNA was assessed in vitro by heating the 
volume of parasite material going into the assay at 95°C for 10 minutes, prior to 
sampling at 48 hour intervals over 6 days, alongside an unheated control set at 
0.02% parasitemia in standardised growth assay conditions (2.6.1 and 2.6.2). 
Furthermore, initial starting density of the assay was determined by setting up 
laboratory clone Dd2 in two different erythrocyte donors at four different starting 
parasitemias (0.01%, 0.0316%, 0.1% and 0.316%) to provide a measurement of 
PMR at a range of starting densities. 
For all laboratory clone assays, DNA extractions and qPCR reactions were 
carried out (2.7.1) and PMR was analysed (section 2.7.2). As a quality filtering 
step, outlying replicate time point density measurements for a laboratory clone 
were removed if they were >=0.5 log genome copies away from all other 
replicates for that clone at that timepoint and for an entire erythrocyte donor 
replication for an isolate where >=2 timepoints met the individual timepoint 
criteria. These steps only affected one Day 4 timepoint for clone Dd2 and one 
biological replicate for D10; thus PMR was estimated across 6 biological 
replications of HB3 and 3D7A-GFP, 5 biological replications for D10 and 6 
biological replications for Dd2, with the exception of a single omitted Day 4 
timepoint. In addition, giemsa stained microscopy counting of parasitemia from 
1000 red blood cells of 90 growth assay slides taken from Day 2 to Day 8 
across the four laboratory clone was performed, with a singular Dd2 Day 4 time 
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point omitted for qPCR analysis and 3 Day 2 time points for which no parasites 
were observed from a Day 2 count (2 from 3D7A-GFP, 1 from D10 and 1 from 
HB3), along with a 3D7A-GFP Day 4 count for which a poor quality smear was 
prepared and subsequently not counted. From the microscopy counts, parasite 
numbers were adjusted to account for the asynchronous presence of multi-
nucleate schizonts, with each schizont considered to have 8 genome copies. 
For ex vivo clinical isolate growth assays, isolates were thawed (section 2.3.2) 
and allowed to adapt to ex vivo conditions (section 2.3.4) for a minimum of two 
weeks, which was performed by Ms Lindsay Stewart. Day 0 of each initial 
standardised growth assay was determined by the availability of the triplicate 
biological donors, and was undertaken between Day 16 and 37 of the ex vivo 
culture adaptation process for each isolate. On Day 0 of the standardised 
growth assay, isolates were included which matched the threshold of having an 
asexual parasitemia of 0.2% based on a 1000 red blood cell count. This 
adopted cut off was used to ensure that a minimum of 90% of the erythrocytes 
that were going into each flask were from the erythrocyte donor. This led to the 
inclusion of a total of 19 clinical isolates (consisting of 6 Guinean isolates, 9 
Senegalese isolates and 4 Malian isolates) for which growth assays were set up 
accordingly (section 2.6.3) alongside the 3D7A-GFP laboratory clone control 
and qPCR was performed (section 2.7).  
Culture adaptation of these 19 isolates was continued and for those for which 
parasites were still microscopically present a minimum of 4 weeks later (n=6), 
their growth rate phenotype was requantified. A maximum of three 
measurements of ex vivo PMR were thus recorded during the culture adaptation 
process. DNA extractions and qPCR were carried out (section 2.7) and 
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subsequently underwent PMR analysis within R (2.7.2). For one of the 6 
isolates which continued to successfully adapt to culture ex vivo, PMR was 
calculated at only two timepoints during ex vivo culture adaptation, whilst the 
other 5 isolates had their PMR quantified three times. Individual outlier 
replicates were quality filtered as described for the laboratory clones, which led 
solely to the removal of a Day 4 and Day 6 timepoint for INV248 and of an 
entire biological replicate for four isolates (INV228, INV232, INV035 and 
INV243) where the laboratory clone control also did not grow within that 
erythrocyte donor. Across the initial ex vivo profiling and the repeated profiling 
for six isolates, a total of 8 sets of triplicate erythrocyte donors were used for the 
assay. Microsatellite genotyping of four loci was performed for the initial ex vivo 
estimation of PMR as described, except for isolate INV035 which was 
performed from the second ex vivo growth assay (section 2.5.2). 
 
6.3 Results 
6.3.1 Optimisation of a low starting density assay for PMR quantitation 
The limit of detection of the assay when a 200µL sample was taken from a 3% 
haematocrit culture as performed using a sorbitol synchronised ring stage 
culture of the clone 3D7A-GFP was found to be at least 0.0066% (Table 6.1). In 
addition, the test of DNA degradation over the length of the assay found that 
whilst parasite DNA was still detectable within the culture which had been 
heated at 95°C prior to inoculation on Day 6, the quantified number of genome 
copies present had decreased approximately sevenfold over this period, 
indicative of at least some DNA degradation occurring and no parasite growth 
(Table 6.2). For all initial starting densities, linear growth rates were calculated  
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 Parasitemia Calculated genome copy 
concentration per µL total culture 
6.6% 20840 
0.66% 2467 
0.066% 196 
0.0066% 20 
 
Table 6.1 Sensitivity of collecting 200 µL from a 3% haematocrit culture 
using serially diluted ring-stage 3D7A-GFP parasites. Calculated genome 
copy concentrations are shown per µL total culture, with a parasitemia of at 
least 0.0066% determined to be detectable through this sampling.  
 
Day Control genome copies per µL  
total culture 
95°C heated genome copies µL  
total culture 
0 211 225 
2 2758 79 
4 15598 34 
6 48977 33 
 
 
Table 6.2 Assessing in vitro DNA degradation of P. falciparum. qPCR 
based genome copy number quantitation of a 200µL sample from a control 
0.02% 3D7A-GFP culture which was collected 48 hourly over a 6 day period 
and to an experimental culture where 0.02% of parasites were heated at 95°C 
for 10 minutes prior to inoculation, in order to allow for assessment of in vitro 
DNA degradation. Within the 95°C heated culture by Day 6, genome copy 
number had reduced by close to sevenfold and by this point was > 1000 fold 
less than the genome copy number of the control sample. 
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across both 6 and 8 days to determine which format would provide an optimal 
assay length for PMR quantitation (Figure 6.1). The 6 day assay estimate 
consistently gave a slightly higher estimate of PMR across all parasite starting 
densities and was thus selected for use in later experiments (Table 6.3). 
Although not a primary aim of this investigation, it should be noted how the 
rates of growth were lower for assays at higher starting parasitemia, as these 
reached density limiting conditions by the end of the assay. This suggests that 
in vitro PMR could be highly sensitive to parasite density, with the low starting 
parasitemia adopted here designed to minimise any such effect. To offer a 
compromise between the least density affected rate of growth over 6 days, 
minimising any potential effect of variation from initiating low parasite density 
cultures and keeping the vast majority of erythrocytes at Day 0 as fresh as 
possible, the starting parasitemia was set at 0.02% for the subsequent 
experiments.  
6.3.2 Quantifying growth rates of laboratory clones 
Six biological replications, with an individual erythrocyte donor being placed into 
each flask, were set up for quantifying PMR for each of the four laboratory 
clones used within the study; 3D7A-GFP, Dd2, D10 and HB3 and were 
monitored over an 8 day period to test whether the slightly lower PMR 
estimated for the 8 day assay in comparison to the 6 day assay for Dd2 was 
also observed for the three other laboratory clones. As expected, a lower 
estimate of PMR was seen for the 8 day assays for all four clones (Figure 6.2), 
so the 6 day assay was confirmed as appropriate. Although mean PMR as 
determined through general linear modelling of the four laboratory clones 
ranged from 7.59 in HB3 to 10.53 in Dd2 per 48 hour period over the 6 day 
assay (Table 6.4), the calculated confidence intervals for all four laboratory  
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Figure 6.1 Effect of starting density on quantified PMR estimated over 
either 6 or 8 days in vitro from two biological replicates using laboratory 
clone Dd2. General linear models were fitted across the biological duplication 
for 6 days (as represented by the red line and dashed red x-axis cut-off) and 8 
days (as represented by the black line and dashed x-axis cut-off). At all starting 
densities, PMR is estimated to be slightly higher when measured over 6 days 
rather than 8 days (Table 6.3). 
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Initial Density Days PMR Upper 95% CI Lower 95% CI 
0.01 % 6 9.02 11.81 6.90 
0.01 % 8 7.08 9.10 5.51 
0.0316 % 6 6.26 8.22 4.77 
0.0316 % 8 4.70 6.27 3.52 
0.1 % 6 4.25 6.44 2.80 
0.1 % 8 3.03 4.38 2.10 
0.316 % 6 2.39 4.56 1.97 
0.316 % 8 2.39 3.25 1.76 
 
Table 6.3 Parasite multiplication rates (PMR) per 48 hours estimated for 
the Dd2 clone performed in biological duplicate, with upper and lower 95% 
confidence intervals for assays measured over 6 and 8 days for four 
different starting parasite densities. 
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Figure 6.2 Quantifying parasite multiplication rates for four laboratory 
clones of P. falciparum. Whilst 8 day assays were performed, as also seen 
within Figure 6.1, the Day 8 measurement of genome copy density appeared to 
be affected by a possible density-dependent reduction in PMR in this period. 
Thus PMR was calculated over 6 days as indicated through fitting of a general 
linear model across the biological replications, as represented by the red line 
and dashed red x-axis cut off. 
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Clone PMR Upper 95% CI Lower 95% CI Coefficient of 
determination (R2) 
3D7A-GFP 8.09 9.64 6.79 0.97 
Dd2 10.53 13.07 8.48 0.96 
D10 7.83 9.41 6.52 0.97 
HB3 7.59 9.00 6.40 0.97 
 
Table 6.4 Parasite multiplication rates (PMR) per 48 hours for the four 
laboratory clones (with upper and lower 95% confidence intervals) 
quantified over the duration of a 6 day assay. 
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clones overlapped (3D7A-GFP 95% CI [6.79 – 9.64], Dd2 95% CI [8.48 – 
13.07], D10 95% CI [6.52-9.41], HB3 95% CI [6.40 – 9.00]). 
In addition, correlation of the microscopy count data and qPCR estimation was 
highly significant (Pearson’s r = 0.93, p-value < 1 x 10-10), whilst the mean 
difference and 95% confidence limits of agreement between the two methods, 
when the microscopy measurement was subtracted from the qPCR based 
measurement, was 0.216 log units (-0.454 log units to 0.885 log units) (Figure 
6.3), which was similar to previously published comparisons of microscopy and 
qPCR (Nwakanma et al. 2009). The slightly higher measurement seen could 
potentially be explained by the sensitivity of the qPCR assay, which could 
include the quantitation of genome copies which have been generated during 
asexual replication, but have not successfully invaded or developed within a red 
blood cell and have subsequently not yet been degraded within the culture, or 
alternatively the presence of mature trophozoites which have begun to undergo 
mitosis, but not yet progressed to the schizont stage. 
6.3.3 Quantifying growth rates of ex vivo clinical isolates 
Of the 19 clinical isolates that were put into the 6 day estimation of PMR 
following at least two weeks of ex vivo culture adaptation (Table 6.5), two 
isolates were characterised as having not grown successfully over the course of 
the assay, as determined by possessing a PMR of <1 (INV221 and INV243). 
Coefficient of determination values for mean PMR across the remaining 17 
isolates were generally high, with R2 values for fourteen isolates > 0.75. This 
was implemented as a threshold above which the general linear model fit was 
considered as acceptable, which three other isolates (INV228, INV248 and 
INV264) did not meet. This threshold was well within the R2 range of previous 
logistic in vivo (Bejon et al. 2005) and linear in vitro (Petersen et al. 2015) model  
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Figure 6.3 Concordance between parasite numbers as determined by 
giemsa-based microscopy and qPCR based quantitation. A) Correlation plot 
of the two measures is highly significant from comparison of 90 measurements 
for four laboratory clones across the 8 day assay format (Pearson’s r = 0.93, p-
value < 1 x 10-10). B) Bland-Altman plot where dashed lines represent 95% 
confidence limits of agreement between the two methods (using a mean ± 1.96 
x standard deviation approach), where the solid line represents the mean 
difference of the microscopy approach from the qPCR approach.  
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Table 6.5 Parasite multiplication rates (PMR) per 48 hours for nineteen 
clinical isolates (with upper and lower 95% confidence intervals) 
quantified over the duration of a 6 day assay. Isolates were put into the 
assay between 15 and 37 days during ex vivo adaptation, depending on 
erythrocyte donor availability. 
Isolate ID Days ex 
vivo 
PMR 95% 
Upper CI 
 
95% 
Lower CI 
R2 value 
3D7A NA 8.79 9.80 7.88 0.95 
INV216 32 1.97 2.56 1.51 0.78 
INV218 32 3.15 4.22 2.35 0.88 
INV220 32 2.45 3.03 1.79 0.90 
INV221 32 0.65 0.85 0.50 0.56 
INV226 25 2.12 2.59 1.73 0.87 
INV231 18 3.79 5.38 2.67 0.87 
INV228 25 1.12 1.30 0.98 0.41 
INV232 25 2.52 3.16 2.01 0.94 
INV243 18 0.72 0.98 0.53 0.53 
INV246 16 4.09 5.55 3.01 0.92 
INV247 16 2.48 2.96 2.08 0.93 
INV249 16 3.68 4.94 2.74 0.91 
INV250 16 3.87 4.24 3.53 0.99 
INV251 16 2.23 2.60 1.91 0.93 
INV248 31 2.01 5.08 0.79 0.36 
INV264 15 1.26 1.42 1.11 0.67 
INV211 35 2.21 2.75 1.78 0.88 
INV215 37 3.56 4.95 2.57 0.89 
INV035 15 2.47 3.36 1.82 0.90 
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Figure 6.4 Quantifying parasite multiplication rates for a selection of four 
clinical isolates. PMR was quantified across the 6 day assay format previously 
described, to provide a measurement through multiple asexual replication 
cycles. 
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Figure 6.5 Parasite multiplication rates (PMR) per 48 hours for 14 West 
African clinical isolates quantified over 6 days using a general linear 
model approach. All isolate PMRs were quantified within biological triplicate, 
except for INV232 and INV035, which were performed in biological duplicate. 
The 14 isolates shown within this figure were those from table 6.6 with a PMR 
calculated to be >=1 fold per cycle, with dashed horizontal lines representing a 
PMR of 1 and 3. Mean PMR as calculated across the 14 clinical isolates was 
2.90.  
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agreements for calculation of PMR for P. falciparum infections. The replication 
rates amongst these 14 remaining isolates ranged from 1.97 for isolate 
INV216to 4.10 for isolate INV246, with a mean PMR of 2.90 (Figures 6.4 and 
6.5). In addition, four locus microsatellite genotype profiles that were generated 
for these 14 clinical isolates defined to have grown during the assay from the 
extracted DNA material used for qPCR analysis confirmed that all 14 isolates 
were genotypically distinct and had not been cross contaminated during culture 
adaptation (Table 6.6). 
6.3.4 Repeated profiling of PMR over the ex vivo culture adaptation 
process  
For 6 of the initial 19 isolates that were put into the growth assay, parasites 
which were still visible by giemsa stained slide microscopy a minimum of four 
weeks after they had originally had their PMR profiled were put into another 
assay and PMR was determined across 6 days as previously seen (INV035, 
INV221, INV231, INV246, INV249 and INV250), with INV035 being profiled at 
two timepoint and all others isolates being profiled at three timepoints. These 
assays were subjected to the previously described filtering procedures, which 
led to the removal of one biological replicate within the final temporal PMR 
profile generated for each of the six isolates, due to this replicate not appearing 
to support growth within the 3D7A-GFP laboratory clone.  
Visualisation of these longitudinal PMR estimations during ex vivo adaptation, 
revealed that INV221 and INV035 had increase in growth rate during this period 
(Figure 6.6), however the other four isolates had maintained a relatively stable 
PMR throughout the adaptation process, although confidence intervals 
generated for the final temporal point were large due to having only been 
calculated across a biological duplicate.  This analysis methodology however  
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Sample ID TA1 PolyA PfPK2 TAA109 
INV216 169 156 163 NA 
INV218 166 159 172 172 
INV220 160 153 160 160 
INV226 166 156 160 160 
INV231 166 156 169 160 
INV232 160 156 172 160 
INV246 166 168, 162 166, 169 175 
INV247 166 117 160 160 
INV249 163 159 166 160 
INV250 196, 178 159 163, 156 175 
INV251 160, 166 153, 156 169, 160 160 
INV211 166 156 172 160, 196 
INV215 160 156 172 160 
INV035 163 168 169 172 
 
Table 6.6 Microsatellite genotype profiles for four loci for 14 clinical 
isolates that had their PMR quantified. The numbers under the four loci refer 
to the allelic trinucleotide bin size that was recorded using Genescan. Where 
two separate numbers are present for the same isolate at the same loci, 
multiple alleles were scored, with the major allele present in bold typing. For 
isolate INV216, the TAA109 locus failed to produce an allele call, but its three 
locus profile confirmed it as distinct from the other isolates. 
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did not account for any potential batch heterogeneity of culture media or 
erythrocyte donor on influencing isolate PMR. Due to this, a normalised PMR 
estimate for each isolate was determined using the PMR data obtained from the 
laboratory clone control that was run alongside every biological triplicate 
performed. For this, all independent rates of 3D7A-GFP growth as calculated 
were averaged (Table 6.6). The difference between the growth rate of the 
clinical isolate and its particular 3D7A-GFP control estimation was calculated 
and used to subsequently normalise against the averaged rate of 3D7A-GFP 
growth across all relevant estimations of 3D7A-GFP growth. Hence for isolate 
INV231, this was done using 3D7CG1, 3D7AG5 and 3D7CG7 (Table 6.6), 
whilst for isolates INV246, this was done using 3D7CG4, 3D7CG6 and 
3D7CG7. Following this normalisation process (Figure 6.7), across all repeated 
isolates there was a significant increase in normalised PMR after a minimum of 
4 or 8 additional weeks undergoing ex vivo culture adaptation (Wilcoxon rank 
sum test; Timepoint 1 vs Timepoint 2 p- value <0.005, Timepoint 1 vs Timepoint 
3 p-value <0.003), although no difference was seen between the second and 
third timepoints recorded (Wilcoxon rank sum test p-value =0.79). The mean 
PMR values across all repeated isolates for the three normalised timepoint data 
sets were respectively 2.72, 4.57 and 4.86. 
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 Assay ID Isolate ID Days 
ex vivo 
Ex vivo 
repeat 
PMR Upper 95% 
CI 
Lower 95% 
CI 
CG1 3D7A-GFP   8.83 11.43 6.83 
 INV221 32 1 0.65 0.85 0.50 
 INV231 18 1 3.79 5.38 2.67 
CG4 3D7A-GFP   10.86 14.70 8.01 
 INV246 16 1 4.09 5.55 3.01 
 INV249 16 1 2.48 4.94 2.74 
 INV250 16 1 3.87 4.24 3.53 
CG5 3D7A-GFP   8.25 10.67 6.38 
 INV221 81 2 4.00 4.97 3.21 
 INV231 67 2 5.47 6.64 4.51 
CG6 3D7A-GFP   8.00 9.53 6.72 
 INV246 45 2 4.04 4.54 3.60 
 INV249 45 2 3.22 3.77 2.76 
 INV250 45 2 4.96 6.06 4.06 
CG7 3D7A-GFP   7.53 9.57 5.93 
 INV035 15 1 2.47 3.36 1.82 
 INV221 114 3 4.49 5.54 3.64 
 INV231 100 3 4.56 6.82 3.06 
 INV246 76 3 3.04 8.08 1.14 
 INV249 76 3 3.49 5.26 2.32 
 INV250 76 3 3.90 5.32 2.87 
CG8 3D7A-GFP   9.16 11.88 7.06 
 INV035 114 2 7.80 10.09 6.03 
 
Table 6.7 Repeated profiling of ex vivo PMR for six clinical isolates 
through the culture adaptation process. The Isolate ID shows the isolate and 
the Assay ID the biological triplicate (e.g. CG7) in which their profile was taken. 
For all rows shown, biological triplicates were used for calculation of PMR, 
except for all CG7 isolates for which biological duplicate was used. 
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Figure 6.6 Profiles of 6 ex vivo clinical isolate which had their PMR 
quantified more than once during the culture adaptation process. Growth 
rates were requantified for 5 clinical isolates three times and twice for one 
isolate, with a minimum of 4 weeks between the sequential time points taken. 
The x-axis refers to how long each isolate had been in culture on the day each 
growth assay was initiated. 
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Figure 6.7 Normalised repeated profiling of clinical isolates during the ex 
vivo culture adaptation process. Normalised PMR for the six clinical isolates 
within Figure 6.6 against the 3D7A laboratory clone control present within set of 
biological replicates.  The minimum period between time points was 4 weeks, 
with highly significant differences seen between timepoint 1 and timepoints 2 
and 3. Each colour across the three different timepoint represents the same 
isolate.  
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6.4 Discussion 
This chapter focuses on quantifying the variation of an important phenotype of 
clinical isolates of P. falciparum that has been previously relatively neglected; 
ex vivo PMR during the culture adaptation process. Ex vivo culture adaptation 
of clinical isolates of P. falciparum remains challenging even over short time 
periods (Nsobya et al. 2008) as underlined by the initially low PMR reported 
amongst clinical isolates within this study. Only 31.1% (n=19 out of 61) of 
thawed clinical isolates reached the first timepoint for ex vivo growth 
phenotyping, which was taken between 16 and 37 days in ex vivo culture based 
on the availability of triplicate blood donors at the same point. Of these nineteen 
isolates, 31.5% of isolates (n=6) successfully continued to adapt to ex vivo 
culture and had at least one additional point at which their ex vivo growth rate 
was quantified, with 5 of them having two additional timepoints profiled. These 
proportions of successful ex vivo culture adaptation are in agreement with a 
previous study which measured copy number evolution during ex vivo culture 
adaptation (Dr Ian Cheeseman, LSHTM PhD thesis 2010). Whilst extrinsic 
factors such as isolate storage conditions can affect the cultivability of clinical 
isolates of P. falciparum, the potential contribution of other possible intrinsic 
phenotypic, genomic or transcriptional properties of parasites collected from 
natural populations has not been investigated widely, although a recent study of 
clinical Indian isolates suggests that ex vivo ‘cultivability’ of specific isolates is 
consistent from different cryopreservation aliquots within separate erythrocyte 
batches (White Jr et al. 2016). 
Within this chapter, standardised quantitation of ex vivo PMR with biological 
replication over multiple intraerythrocytic cycles was performed for a set of 19 
West African isolates. Previous reports of the multiplication rates of P. 
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falciparum clinical isolates have been recorded at the first ex vivo cycle from 
South East Asian and African populations (Chotivanich et al. 2000; Deans et al. 
2006), reporting vastly different mean PMRs of 8.3 and 2.3 respectively. The 
PMR seen within this chapter is thus much closer to the low multiplication rates 
previously reported for the Malian and Kenyan populations performed by Deans 
et al. (2006). These previous studies were however performed without biological 
replication of erythrocyte donors, although they do provide an ex vivo measure 
of PMR after the shortest possible period of ex vivo adaptation. Whilst in vivo 
PMR of P. falciparum has previously been calculated from blood smear 
microscopy (Simpson et al. 2002) to show approximately 8-fold rates of growth, 
similar to those exhibited by the four laboratory clones profiled here, the 
calculated mean PMR of the ex vivo isolates was much lower than this at 2.90 
fold.  
Moreover, for the isolates that continued to successfully adapt to ex vivo 
culture, PMR significantly increased when normalised against the PMR of the 
3D7A-GFP control profiled. Transcript expression changes of the erythrocyte 
membrane protein 1 (PfEMP1) during ex vivo culture adaptation have been 
previously reported (Peters et al. 2007; Zhang et al. 2011), as the parasite 
grows in a vastly different nutritional and physiological environment (Le Roux et 
al. 2009). Epigenetic mediated regulation of clonally variable transcriptional 
variation has been reported within a range of laboratory adapted parasite clones 
(Rovira-Graells et al. 2012), but has yet to be examined within ex vivo clinical 
isolate culture adaptation. Such a study would be complicated however by the 
difficulties of lower parasite multiplication rates and the need for tight 
synchronisation of parasites, in addition to discerning the potential contributions 
of separate genotypes within the same infection.  
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The phenotyping performed within this chapter broadly quantifies parasite 
growth rate over a set 48-hour period to enable comparison between different 
isolates. There are several other cellular parasite features that could influence 
parasite growth rate such as merozoite numbers per schizont, intraerythrocytic 
duration and red blood cell invasion efficiency. For instance, the laboratory 
clone Dd2 has a mean intraerythrocytic cycle length of 44 hours and mean 
merozoite number per schizont of 18, whereas HB3 takes 50 hours per 
intraerythrocytic cycle and possesses a mean of 16 merozoites per schizont 
respectively, whilst invasion efficiency of Dd2 is approximately 35% of 
merozoites compared to 25% for HB3 (Reilly et al. 2007). Any potential 
spectrum of these intrinsic, cellular parasite features has not been characterised 
for ex vivo isolates and thus not previously correlated with ex vivo PMR. 
Although more challenging with ex vivo isolates due to the lower rates of PMR 
seen, a potential method to examine at least the variation of merozoite number 
and cell cycle duration would be to use a combination of early ring-stage 
sorbitol synchronisation, careful monitoring of parasite development for each 
isolate through the intraerythrocytic cycle and use of the E64 protease inhibitor 
(Hill et al. 2014) to block merozoite egress from the schizont and provide a 
simultaneous count of merozoite numbers from a proportionally enriched 
schizont-stage culture and through regular giemsa-stained smearing of the 
development cycle for each isolate, determine a distribution of cell cycle 
duration for each isolate, where the read out of the experiment would be the 
proportion of parasites that possess multi-nucleate schizonts at that timepoint 
post-invasion. 
Quantitative information on the variation seen within natural populations P. 
falciparum is important baseline parasitological information and is the first 
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necessary step of any clinical isolate forward genetic based screens (Anderson 
et al. 2010; Cheeseman et al. 2012) to identify potential genomic or 
transcriptional markers that underlie phenotypic variation within traits of P. 
falciparum from natural populations such as ex vivo PMR or gametocyte 
commitment (section 1.7, section 5 and section 8.4).  
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7. Development of tools and assays to investigate potential competitive 
interactions between P. falciparum genotypes in culture 
7.1 Introduction 
Multiple-genotype infections of P. falciparum are widespread, particularly within 
regions of high infection endemicity such as West Africa (Mobegi et al. 2012; 
Manske et al. 2012). Furthermore, these multiple-genotype infections are further 
complicated by the presence of a spectrum of relatedness between different 
genotypes (section 1.5.1). Several studies within rodent and lizard Plasmodium 
species have (section 1.6.1 and 1.6.2) investigated potential genotype 
interactions. A paucity of studies have however extended this research to an in 
vitro system of P. falciparum. Two studies have examined the potential effect of 
competition on in vitro growth rates for two clones each using qPCR based 
approaches, but came to different conclusions. One study reported a genotype 
specific competitive suppression effect, which was determined by comparing 
differences in the end point densities of competition assays between Dd2 and 
HB3 with monoculture control cultures (Wacker et al. 2012). The other 
published study however emphasises an issue in assessing such potential 
interactions, as it is difficult to separate the direct response of a parasite due to 
the presence of a competitor with potential indirect responses caused by 
possible density dependence and reported that alterations to the growth rate of 
two laboratory clones, Dd2 and K1, was due to the additive density of all clones 
present within the culture, rather than genotype specific suppression (Zervos et 
al. 2012).  
If, as suggested for P. chabaudi and P. mexicanum, the parasite is able to 
induce a phenotypic response due to the genotypic composition of the infection 
(Reece et al. 2008; Neal & Schall 2014), it raises the prospect of a variety of 
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other transcriptional responses due to the presence of different genotypes that 
have not been investigated previously in P. falciparum due to the difficulty of 
physical clone separation. Whilst potential changes in gametocyte commitment 
could be investigated, such a genotype specific fluorescence system would 
allow for the investigation of any transcriptional changes associated with 
genotype competition, potentially across the parasite life cycle. Mechanisms 
that are required for any non-self recognition system mediating transcriptional 
responses would require the strong balancing selective forces seen operating 
on P. falciparum populations to maintain the diversity required for genotype 
distinction (Rousset & Roze 2007). Synchronisation of phenotypic responses 
amongst clone mates would also likely require efficient intercellular 
communication pathways, which could possibly exist in microvesicle trafficking 
systems between infected red blood cells that have been found to promote 
sexual commitment (Dyer & Day 2003; Mantel et al. 2013; Regev-Rudzki et al. 
2013). To aid such studies, the most versatile fluorescent parasite tools for in 
vitro competition would have constitutive expression of a fluorescent protein 
across the entire parasite life cycle, as previously reported for a transfected 
clone of 3D7A (Talman et al. 2010). In addition, an integrated copy of the 
plasmid within the parasite genome would be desired due to cultures containing 
episomally fluorescent transfected parasites potentially consisting of a 
significant proportion of non-fluorescent parasites (Babbitt et al. 2012). 
Within this chapter, I use allele-specific qPCR assays designed to assess 
competition in an alternative manner to other Plasmodium studies, by focusing 
on growth rate of each individual genotype within a mixed in vitro culture. If 
competitive suppression is a genotype-specific effect and not due to potential 
density-dependent effects, it can be hypothesised that any potential 
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suppressive effect would be visible by observing a reduced PMR of parasites 
under controlled in vitro competition assays across multiple cycles.  
I also hypothesise that the production of different laboratory clones expressing 
differentially coloured fluorescent proteins (Gibson et al. 2008; Regev-Rudzki et 
al. 2013;) would be a novel tool to further investigate potential genotype 
interactions of P. falciparum in an in vitro setting. Such an approach would allow 
for study of direct parasite-parasite interactions from potentially confounding 
factors that are present within mouse malaria models such as immune-
mediated competition (Raberg et al. 2006; Santhanam et al. 2014; Abkallo et al. 
2015). Thus, I developed a small panel of fluorescent parasite genotypes 
expressing different fluorescent proteins, with the aim of integration at the Pf47 
locus (Talman et al. 2010), for potential in vitro investigation of genotype 
competition in P. falciparum. 
 
7.2 Materials and Methods: 
For in vitro P. falciparum competitive growth experiments, laboratory clones 
3D7A-GFP, Dd2, D10 and HB3 (section 2.3.1) were thawed (section 2.3.2) and 
cultured (section 2.3.4). The pan-genotype and allele-specific and qPCR assays 
that were used were either found following a literature review or designed with 
the aid of Primer 3 (section 2.5.3). Due to the use of SYBR green for all qPCR 
assays, all qPCR assays run underwent melt-curve analysis using Rotor-Gene 
6 software to ensure specificity of the generated amplicons (Table 7.1). For the 
melt-curve, post-amplification products were subjected to an additional ramping 
melt step up to 99 degrees centigrade. Only single peaks were generated by 
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Primer 
Identity 
Primer Sequence (5’ to 3’) Amplicon 
Size (bp) 
Target 
Gene 
Primer 
usage 
(target 
clone in 
bold) 
Origin of 
primers 
Pfs25-F CCATGTGGAGATTTTTCCAAATGTA 143 Pfs25 Pan-
genotype 
Schneider 
et al. 2015 
Pfs25-R CATTTACCGTTACCACAAGTTACATTC     
      
HB3 
MSP1-F 
GAAATTGCCAAAACTATTAAATTTAATATTGATAG 133 MSP-1 HB3 + 
Dd2, HB3 
+ 3D7, 
HB3 + 
D10 
Wacker et 
al. 2012 
HB3 
MSP1-R 
GGTTCAGTTGATTCCTTTGTTTCAAC     
      
Dd2 
MSP1-F 
AATTGCCAAAACTATTAAATTTAACATTGATAG 131 MSP-1 HB3 + 
Dd2, HB3 
+ 3D7, 
HB3 + 
D10 
 
Wacker et 
al. 2012 
Dd2 
MSP1-R 
TGAACAGATTTCGTAGGATCTTGTGA  MSP-1  Wacker et 
al. 2012 
      
K1 
MSP1-F 
AAATGAAGAAGAAATTACTACAAAAGGTGC 235 MSP-1 3D7 + 
Dd2, 3D7 
+ D10 
Chen et al. 
2014 
K1 
MSP1-R 
GCTTGCATCAGCTGGAGGGCTTGCACCAGA  MSP-1  Chen et all 
2014 
      
MAD20 
MSP1-F 
AAATGAAGGAACAAGTGGAACAGCTGTTAC Dd2=205,D10= 
168 
MSP-1 3D7 + 
Dd2, 3D7 
+ D10 
Chen et ai. 
2014 
MAD20  
MSP1-R 
ATCTGAAGGATTTGTACGTCTTGAATTACC  MSP-1  Chen et al. 
2014 
      
Dd2 
MSP6-F 
AAGAGCCAACATCGGAGGAATATC 116 MSP-6 Dd2 + 
D10 
Newly 
designed 
Dd2 
MSP6-R 
CGGTTTTGAGTATTTGGTCTGGT  MSP-6  Newly 
designed 
      
D10 
MSP6-F 
ATCAATATACTGGTACATCTATATCAGGTAT 148 MSP-6 Dd2 + 
D10 
Newly 
designed 
D10 
MSP6-R 
CAGAGAAGTTGTAGTACTATTACTATGAGA  MSP-6  Newly 
designed 
 
Table 7.1. Allele-specific qPCR assay primer information for assessment 
of in vitro competitive growth. 
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melt-curve analysis across all assays, indicative of specific, single product 
generation as previously performed for Plasmodium allele-specific assays 
(Cheesman et al. 2003). Moreover, all assays were found not to amplify the 
non-target P. falciparum clone alleles needed to perform allele-specific absolute 
quantitation in the presence of such non-target alleles. To ensure allele-specific 
quantitation accuracy, copy number mixtures of extracted non-target and target 
allele clone DNA were set up in triplicate for all primers but the pan-genotype 
Pfs25 assay in the ratios 99:1, 90:10, 50:50, 10:90, 1:99. Competitive growth 
assays were set up using a modification of the standardised growth assay 
(section 2.6.4) for the six possible combinations in triplicate erythrocyte donors 
alongside monoculture controls. DNA extractions were subsequently performed 
(section 2.7.1) and PMR of each clone in competition was determined (section 
2.7.3). 
For transfection experiments, laboratory clones 3D7A, Dd2 and D10 were used 
and the pEFGFP plasmid was modified to contain either a mCherry or mKate2 
encoding sequence (section 2.8.3). Subsequently, the laboratory clones were 
transfected (section 2.8.7), live parasite images were taken to confirm parasite 
fluorescence of the appropriate fluorophores (section 2.8.9) and when 
integration at the Pf47 locus was detectable by PCR (section 2.8.6) following 
successive rounds of on/off drug selection, limiting dilution cloning was 
performed (section 2.8.8). Concordance between allele-specific qPCR and 
fluorescent microscopy counting was subsequently assessed (section 2.8.10). 
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7.3 Results 
7.3.1 Validation of allele-specific qPCR assays for in vitro competition: 
From the melt-curve analysis, only single peaks were seen across all assays 
indicative of specific, single product generation, whilst all assays were also 
confirmed to not amplify the non-target P. falciparum clone alleles needed to 
perform allele-specific quantitation of pairwise competition (de Roode et al. 
2003) (Figure 7.1). In addition, these assays were further validated by 
quantifying known in vitro mixtures of target and non-target alleles for each 
allele-specific qPCR assay over a proportional ratio range of 99:1, 90:10, 50:50, 
10:90 and 1:99 (Figure 7.2), which found an extremely high degree of 
concordance between the observed and expected proportions of quantified 
DNA (R2 values for all 6 allele-specific qPCR assays > 0.99). Standard curves 
produced during the qPCR run for each assay showed efficient levels of 
amplification across a 1 x 106 genome copies to 10 genome copies per µL 
genomic DNA dilution series (R2 values were consistently above 0.99 and 
amplification efficiency above 0.90), whilst negative template controls did not 
pass the amplification threshold. In addition, for each assay a limit of detection 
of at least 10 genome copies per µL was recorded. 
7.3.2 Quantifying in vitro competitive growth rates of P. falciparum: 
Using the allele-specific qPCR assays, PMR of the four laboratory clones in 
monoculture and pairwise competition with the three other clones was 
performed. Importantly, to ensure that parasites within control and experimental 
flasks experienced the same overall parasite density conditions, initial starting 
parasitemia of each competition flask was half that of the monoculture control, 
with the other 50% coming from the presence of the additional competing 
laboratory clone. Across the three intraerythrocytic cycles from which PMR was 
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Figure 7.1 Fluorescent melt curve analysis confirms allele-specificity of 
qPCR assays used for in vitro competition studies.  Melt curve peaks are 
shown for each of the amplicons produced by the 6 allele-specific qPCR assays 
used. Primer sets are labelled as A) HB3 MSP1, B) Dd2 MSP1, C) D10 MSP6, 
D) Dd2 MSP6, E) K1 MSP1 and F) MAD20 MSP1. Panel E and F does show 
increased levels of background fluorescence, but this did not affect allele-
specific quantitation (Figure 7.2). Within each panel, the target clone was run in 
duplicate alongside a duplicate of the non-target clone to be distinguished from.  
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 Figure 7.2 Allele-specific quantitation of controlled mixtures of genomic 
DNA of four laboratory clones. For each allele-specific primer used, control 
mixtures containing ratios of the two clones to be distinguished between were 
made up of 99:1, 90:10, 1:1, 10:90 and 1:99. Points represent the mean of three 
technical replicates, whilst diagonal lines represent where the observed 
percentage would equal the expected percentage quantified for each clone. 
Primer sets are labelled as A) and B) quantitation of mixtures of HB3 and Dd2 
by HB3 MSP1 and Dd2 MSP1 primers, C) and D) quantitation of mixtures of 
3D7A and MAD20-like D10 by K1 MSP1 and MAD20 MSP1 primers and for E) 
and F) quantitation of mixtures of D10 and Dd2 by D10 MSP6 and Dd2 MSP6 
primers, with all R2 values >0.99. 
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calculated, no difference was detected between monoculture PMR and PMR of 
any clone when in competition with any of the three other laboratory clones 
(Figure 7.3, Table 7.2). Thus, there was no evidence of a significant phenotypic 
growth response of a clone when placed into in vitro growth with another clone 
at the range of densities experienced over the course of the assay. The 
absence of this process, termed competitive suppression, within the dataset is 
in disagreement with a previous report of HB3 being suppressed by Dd2 
(Wacker et al. 2012), which was determined using comparisons of endpoint 
genome copy density after 11 days of competition.  
7.3.3 Generation of differentially fluorescent P. falciparum parasites 
From transfection of the three different fluorescent proteins GFP, mCherry and 
mKate2, fluorescence was monitored by live parasite microscopy. Using an 
initial drug selection regime of 2.5 µM for pEFGFPLM1 and pEFmCherryLM2, 
only the 3D7A-mCherry parasite line was found to show evidence of integration 
at the Pf47 locus. The second round of transfections, used pEFGFP and 
pEFmKate2LM, since mKate2 was purportedly a brighter fluorescent protein 
within the red spectral overlap and were subject to a 5 nM WR99210 
concentration. Subsequently, 6 parasite lines were confirmed to express the 
appropriate fluorescent protein (Figure 7.4) and also to show evidence of the 
Pf47 locus by PCR (Figure 7.5). Two of these lines were successfully cloned to 
produce 3D7A-mCherry-CL3 and D10-mKate2-CL4. Whilst 3D7A-mKate2-CF11 
also did not show PCR evidence of the wild-type Pf47 locus, but would need 
repeating with a higher parasitemia culture due to the faint integration PCR 
band recorded (Figure 7.5B, Lane 7). Although the other three lines also 
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Figure 7.3.  Quantitation of PMR for four laboratory clones across three 
intraerythrocytic cycles for all six possible pairwise in vitro competitive 
scenarios. Error bars are 95% confidence intervals around mean PMR values 
derived by general linear modelling for A) 3D7A in monoculture and pairwise 
competition, B) Dd2 in monoculture and pairwise competition, C) D10 in 
monoculture and pairwise competition and D) HB3 in monoculture and pairwise 
competition.  
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Culture scenario PMR Upper 95% CI Lower 95% CI 
3D7A-GFP 
Monoculture 
7.13 8.96 5.67 
3D7A-GFP vs Dd2 7.11 9.29 5.44 
3D7A-GFP vs D10 7.70 9.62 6.16 
3D7A-GFP vs HB3 7.68 10.04 5.64 
Dd2 Monoculture 9.13 11.87 7.03 
Dd2 vs 3D7A-GFP 12.16 15.60 9.48 
Dd2 vs D10 12.39 15.37 9.98 
Dd2 vs HB3 9.92 13.18 7.46 
D10 Monoculture 6.91 8.58 5.56 
D10 vs 3D7A-GFP 6.76 8.61 5.31 
D10 vs Dd2 7.69 10.20 5.79 
D10 vs HB3 7.29 10.50 5.06 
HB3 Monoculture 6.74 7.96 5.71 
HB3 vs 3D7A-GFP 6.70 8.52 5.27 
HB3 vs Dd2 6.28 7.88 5.00 
HB3 vs D10 6.59 8.51 5.10 
 
Table 7.2. Parasite multiplications rates (PMR) calculated for the four 
laboratory clones in pairwise competitive growth experiments with upper 
and lower confidence intervals taken from growth across three 
consecutive 48 hour periods. All rates are given per 48 hour period for each 
monoculture and PMR scenario, with bold letter typing indicating which of the 
clones within competition the rates of growth and confidence intervals 
correspond to. 
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Figure 7.4 Confirmation of fluorescent protein expression in P. falciparum. 
Imaged under a 40x lens of an EVOS FL Cell Imaging System, fluorescent 
images are shown for A) 3D7A-mCherry, B) 3D7A-mKate2, C) D10-mKate2, D) 
Dd2-mKate2, E) Dd2-GFP and F) D10-GFP. 
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Figure 7.5 PCR-based integration genotyping for the fluorescent parasites 
at the Pf47 locus. In both gels A and B the top half of the gel shows genotyping 
for the wild type (WT) Pf47 locus using primers AT1 and AT2, whereas the 
bottom half shows genotyping for the integrated Pf47 locus, using primers AT1 
and ST509. On gel A, L= 1 kb ladder, 1= 3D7A WT, 2= D10 WT, 3= Dd2 WT, 
4=3D7A-GFP integration control, 5= 3D7A-mCherry-CL3, 6= D10-mKate2-CL4 
and 7= Dd2-GFP. On gel B, L=1 kb ladder, 1= 3D7A WT, 2= Dd2 WT, 3=D10 
WT, 4= 3D7A-GFP integration control, 5= D10-GFP, 6= Dd2-mKate2, 7= 3D7-
mKate2 CF11. Both the WT and integration bands are similarly sized amplicons 
at approximately 1 kb. 
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 underwent cloning after they showed evidence of integration cloning, clones 
were not successfully obtained and this would need to be repeated to generate 
clonal lines lacking wild-type parasites possessing episomal plasmid copies. 
Moreover, clonal identity after several months of drug selection was confirmed 
by the appropriate allele-specific qPCR assay. In order to confirm that the use 
of fluorescent protein expressing parasites could potentially be a useful tool for 
analyses of competition in vitro for P. falciparum, live parasite counts of 
controlled mixtures of fluorescent parasites were compared against proportions 
of genotypes within the mixture using allele-specific qPCR assays. This was 
performed using combinations of 3D7A-GFP, D10-mKate2-CL4, Dd2-GFP and 
3D7A-mCherry-CL3, which allowed for the 3 possible in vitro competition 
scenarios between these genotypes; 3D7A-mCherry with Dd2-GFP, 3D7A-GFP 
with D10-mKate2-CL4 and Dd2-GFP with D10-mKate2-CL4. Through 
comparison of mixtures of sorbitol synchronised early trophozoite stage 
parasites for the three clones across a range of ratios from 20:1 to 1:20 using 
live imaging microscopy (Figure 7.6) and allele-specific qPCR provided good 
concordance between the two methods  (Figure 7.7, Dd2-GFP and D10-
mKate2-CL4 R2 = 0.984; 3D7A-GFP and D10-mKate2-CL4 R2 = 0.994; 3D7A-
mCherry-CL3 and Dd2-GFP R2 = 0.998). 
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Figure 7.6 Examples of fluorescent overlay live parasite images for 
correlation with genome copy numbers by allele-specific qPCR.  Panel A) 
shows an approximate 20:1 ratio mixture of Dd2-GFP and D10-mKate2, whilst 
Panel B) shows an approximate 10:1 ratio mixture of 3D7A-GFP and D10-
mKate2. 
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Figure 7.7 Concordance of measurement of controlled mixtures of 
parasites expressing different fluorescent proteins through live imaging 
microscopy and allele-specific qPCR. Microscopic proportions of mixes of 
fluorescent parasites were calculated from counts of a minimum of 200 
parasites, with allele-specific qPCR assays for A) 3D7A-GFP with D10-mKate2-
CL4, B) 3D7A-mCherry-CL3 with Dd2-GFP and C) Dd2-GFP with D10-mKate2-
CL4. Proportions shown with each panel are for the first named parasite line 
within each mixture, all R2 values >=0.98.  
 
 
 
167 
 
7.4 Discussion: 
Within this chapter, an allele-specific qPCR based approach has been used to 
assess the growth rates of four laboratory clones in the presence of a 
competitor, which showed no significant differences in PMR recorded within 
monoculture conditions and pairwise competition assays from low starting 
parasitemias. Previous studies that have quantified in vitro competitive growth 
of different P. falciparum genotypes using either allele-specific qPCR or 
pyrosequencing approaches under different conditions, have reached different 
conclusions. One study reported a significant effect of asymmetrical competitive 
suppression of Dd2 over HB3 based on an endpoint measurement of density 
(Wacker et al. 2012). Whilst data within this study would support that finding if 
endpoint densities at Day 6 were compared for these two clones, another study 
which measured PMR of Dd2 and HB3 using deep sequencing of SNPS located 
within the PfCRT gene over a 2 month period found Dd2 to have only a 2.2% 
increased PMR over HB3 in co-culture per cycle (Petersen et al. 2015), thus 
suggesting that there was no evidence of the strong suppressive effect reported 
by Wacker et al. (2012). 
The assay format used within this chapter was adopted to provide a quantitative 
measurement of genotype-specific PMR across multiple intraerythrocytic cycles 
from a low starting parasitemia to minimise any potential density-dependent 
effect on parasite growth rate. It should be noted however that, any genotype-
specific competitive effect is likely also to be density-dependent and another 
study of in vitro competition between parasites genotypes reported that the total 
density of parasite genotypes was the key factor that influenced genotype-
specific PMR (Zervos et al. 2012). Thus, further assays across a range of 
starting densities and ratio concentrations of different genotypes could be 
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utilised to ascertain whether genotype-specific competitive effects on PMR are 
present within P. falciparum. Furthermore, laboratory clones that have been 
adapted to culture and grown for long periods of time in genotypic isolation may 
have lost any potential phenotypic response to competition, whilst the laboratory 
clones used within this thesis appear to have similar rates of growth within the 
adopted assay format. Data on the ex vivo PMR exhibited by clinical isolates, as 
provided by this thesis (section 6), will aid the design of assays to test for 
competitive growth interactions between clinical isolates that exhibit different 
PMR. It would be expected that if two clinical isolates genotypes were co-
cultured, that if there was no parasite interactive effect on PMR, that the 
genotype with the higher rate of growth would increase its proportion within the 
culture at a rate that could be predicted from the monoculture PMR seen by 
each isolate. Subsequently, a departure from this model could then be tested 
for to look for evidence of any potential interaction. 
Using the parasite lines produced within this chapter, competitive interaction 
studies would be able to be performed through microscopy over longer-time 
periods than 6 days and be also tested for simultaneously tested for using the 
allele-specific qPCR assays. In addition, an in vitro genotype specific differential 
fluorescence system would also uniquely allow for physical separation of P. 
falciparum genotypes through cell sorting approaches (Miao et al. 2010; Miao & 
Cui 2011), that could offer a system to investigate potential plastic phenotypic 
responses to genotype competition such as gametocytogenesis (Reece et al. 
2008; Neal & Schall 2014). 
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8. Discussion 
The analyses within this thesis investigate the genomic diversity of clinical 
infections at the within-host level within West Africa, apply in vitro methods for 
the dissection of competition between multiple genotypes and focus on 
characterising baseline parasitological information of two clinically and 
epidemiologically relevant traits which have previously been reported as 
showing evidence of plastic responses to the presence of co-infecting 
genotypes within Plasmodium (Pollitt et al. 2014; Reece et al. 2008). 
 
8.1 Whole genome sequence based investigation of within-host diversity 
Initially within this thesis, measures of the within-host diversity of an endemic 
West African population from a whole genome sequence methodology (Manske 
et al. 2012; Auburn et al. 2012) were compared against those from a traditional 
microsatellite based assessment (Anderson et al. 2000; Mobegi et al. 2012). 
These analyses provide correlative and complementary information on the 
within-host genotypic structure of P. falciparum infections within this population. 
Whilst almost the microsatellite typing provided sensitive detection of distinct 
clones within almost all infections profiled, the quantitative whole-genome 
approach highlighted that the >50% of infections were consisted predominantly 
of genotypically similar parasites, in agreement with other studies (Druihle et al. 
1998; Nkhoma et al. 2012). In addition, there appears to be no general 
consensus within P. falciparum population genetics as to what the definition of a 
single clone infection is, but within this thesis I generally have applied the 
terminology of having predominantly single-genotype infections.  
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Unlike the sensitive PCR based approaches, FWS relies on the use of read 
count data to determine levels of within-host and within-population 
heterozygosity at biallelic SNPs. Within the filtering pipeline for calculation of 
FWS, a minimum total coverage of 20 reads for an isolate and a minimum 
coverage of 5 reads for the minor population allele within an isolate were 
implemented. Thus, within isolates with coverage of 20 reads at a particular 
SNP, the minor allelic variant would need to have a frequency of 25% at that 
position to be considered within the analysis. Minor alleles are thus more likely 
to be detected at SNPs with greater sequencing coverage.  Moreover, sampling 
of genome sequencing read count data would have some technical noise, or 
randomness, in counting alleles, with minor alleles where reads were counted 
closer to the 5 read limit, likely to be more greatly affected. In addition to this, 
any single timepoint measure of within-host diversity, will not overcome the 
issue of proportions of clones in peripheral blood of infected humans with 
asymptomatic cases vary over time, and can show marked differences between 
successive days (Farnert et al. 1997).  
Thus, it is plausible that the within-host minor allele frequency within particular 
isolates at certain SNP loci be underestimated and contribute to a reduced 
measure of within-host heterozygosity and thus an elevated isolate or loci-
specific FWS score. To date there has yet to be a direct comparison of the 
sensitivity of detecting minor alleles through PCR and Illumina-based short read 
sequencing (Auburn et al. 2012). A potential approach to do this would be to 
make controlled mixtures of laboratory clones at a range of starting 
concentrations and perform both whole-genome sequencing and allele-specific 
PCR typing to compare their sensitivity.   
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Within the Guinean population analysis presented in this thesis however, no 
correlation was seen between isolate FWS score and mean sequence coverage 
depth, whilst average genome-wide coverage for all 95 isolates was greater 
than 80 reads per SNP (Figure 3.3C). In addition, within the genome-wide 
scans of the FWS index, the approach focused on identifying loci with 
consistently high levels of within-host homozygosity, such as within a scenario 
where a SNP has a high population minor allele frequency, but both biallelic 
variants are never found together within the same isolate in the population and 
the two alleles are effectively being 'segregated' within different hosts. Thus, the 
sensitivity of counting the minor allele within-host would have no effect on being 
able to identify SNPs where the two alleles are consistently being segregated 
amongst different hosts within the population. 
An additional confounding factor in interpreting FWS is the presence of multiple 
clones at different frequencies (section 3.1) and the spectrum of relatedness 
seen between these clones present within an infection (Figure 1.5). FWS does 
not distinguish between separate clones that are present within a host, instead 
providing a measure of relatedness and relative proportions on a scale between 
0 and 1. In order to precisely characterise the relative contributions of multiple 
clones within an infection in producing an FWS score, there are two potential 
options. Firstly, quantitative allele-specific genotyping, as previously applied to 
in vitro protist experiments (Minter et al. 2015) could be designed to sensitively 
characterise and quantify contributions of different clones at any desired loci. 
Alternatively, to fully elucidate the relative frequencies of multiple clones across 
several SNP positions, potentially to the length of individual chromosomes, 
would require haplotype reconstruction or phasing. At present, it is difficult to 
reconstruct such haplotypes, as for example, across five biallelic SNPs for 
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which reads are counted for both alleles, the number of potential clones or 
haplotypes present across that loci could theoretically be up to 25, or 32 distinct 
clones (Nkhoma et al. 2012). Deep sequencing approaches do offer the 
potential to link together separate reads to enable haplotype reconstruction, but 
this is aided by the availability of long-read sequencing fragments, potentially 
greater than 10kb in length, that ensure haplotypes are generated for the 
majority of genes within a Plasmodium genome and offer greater overlap 
between adjacent sequence reads for computational reconstruction of individual 
haplotypes from the same infection (Kuleshov et al. 2014; Vembar et al. 2016). 
Furthermore, only repeated longitudinal sequencing or genotyping of an 
infection would be able to detect any clones within an infection that may be 
undetectable from a single time point estimate, due to sequestration. 
8.2 Identification of molecular targets of within-host selection 
Furthermore, implementation of an allele-frequency based scan of within-host 
heterozygosity across the genome within this thesis did not identify loci that are 
consistently homozygous at the within-host level within multiple populations in 
West Africa. Potential loci under strong within-host selective forces could offer 
in vivo growth advantages to particular alleles, or potentially lead to strain-
specific immune suppression or clearance, as has previously been reported 
within the genetic cross progeny within Plasmodium parasites. There are 
however alternatives to further examine potential evidence of within-host 
selection of P. falciparum from clinical isolates using sequencing based 
analyses (section 4.4), through application of long-read sequencing 
technologies, haplotype based phasing or transcriptomic analyses.  
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Within other pathogen species, within-host selection of genomic loci and 
phenotypes such as virulence is classically interrogated using an experimental 
evolution approach (Wright et al. 2011; Didelot et al. 2016). Within the genus 
Plasmodium, a combination of in vitro adaptation and whole genome 
sequencing has monitored genomic changes over long periods of time to profile 
baseline rates of mitotic evolution in P. falciparum (Bopp et al. 2013; Claessens 
et al. 2014), however this would only ethically be possible to replicate within 
clinical isolates within asymptomatic cases that would allow for repeated 
sampling (Farnert et al. 1997), which would need to be combined with 
sequencing pipelines using only limited quantities of genomic DNA (Oyola et al. 
2014; Nair et al. 2014). In addition, a comparative genomics and in vitro 
adaptation approach has also been utilised to identify a normocyte binding 
protein that is significantly advantageous for the invasion of human erythrocytes 
by the zoonotic parasite P. knowlesi (Moon et al. 2016). An experimental study 
assessing within-host genomic evolution would however be possible using a 
rodent malaria parasite system, which have so far only been used to assess 
phenotypic responses to pressures such as drug treatment, selection for 
virulence, immunisation and competition from other genotypes (Nuralithia et al. 
2015; Abkallo et al. 2015; Huijben et al. 2013; Barclay et al. 2008; Mackinnon & 
Read 1999; Bell et al. 2006; de Roode et al. 2005).  
None of these studies have however sought to uncover the molecular targets of 
selection, but a potential avenue of research would be to subject a genetically 
modified P. berghei parasite line which has been generated as a ‘super mutator’ 
through destruction of the DNA proofreading activity domain of DNA 
polymerase į WR YDULRXV VHOHFWLRQ SUHVVXUHV DQG PRQLWRU JHQRPLF VHOHFWLRQ
This line has been determined to have an approximately 90-fold higher mutation 
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rate than that of the parental P. berghei parasite (Honma et al. 2014), which 
would significantly facilitate temporal within-host evolution experiments. 
Alternatively, it could also be possible to adopt the same transfection approach 
targeting the orthologous gene within other rodent malaria models such as P. 
yoelli or P. chabaudi, or adapted to P. falciparum for in vitro experimental 
evolution studies. 
Within this thesis, I also apply and develop methodologies that allow for further 
investigation of a putative mediator of selection within the host, which is the 
genetic composition of an infection. If kin discrimination mechanisms (Reece et 
al. 2008) are present within P. falciparum, then this could influence other 
parasite phenotypes to gametocyte production strategies. An in vitro system 
allows for dissection of such potential parasite-parasite interactions (Mantel et 
al. 2013; Regev-Rudzki et al. 2013) without the confounding presence of 
immune-mediated responses. Even with potential physical separation of clones 
from in vitro mixed infections using fluorescent methods, it is possible that long-
term laboratory adapted parasites have lost such phenotypes and thus co-
culture studies using recently adapted clinical isolates would be ideal, which will 
require sensitive versatile assays to monitor PMR of parasites within 
competitive scenarios. Furthermore, if transcriptional responses to co-culture 
were pursued, these could potentially avoid the need for physical separation by 
calling SNPs from a deep RNA-Seq profile of the co-culture (Yamagishi et al. 
2014), but this would also need to overcome difficulties in distinguishing 
genuine differential expression from differences in intraerythrocytic cycle stage 
(Lemieux et al. 2009). 
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8.3 Disparity between the availability of genomic and phenotypic 
information 
This thesis underlines what I believe to be one of the clearest dichotomies 
within malariology research at present; the discrepancy between having 
genomic sequence data available for thousands of clinical isolates taken from a 
global range of populations and the limited quantitative phenotypic information 
available on some key parasitological phenotypes such as clinical isolate 
growth rate ex vivo and transcriptional expression levels of gametocytogenesis 
markers in vivo. Profiling of the ex vivo PMR of nineteen clinical isolates within 
this study remarkably represents the largest biologically replicated survey 
undertaken. Whilst laboratory adapted isogenic lines offer tractable, flexible 
systems for reverse genetic based approaches to probe gene function, 
phenotypic characterisation of ex vivo isolates is more representative of natural 
parasite population than long term laboratory adapted clones, due to genomic 
and phenotypic adaptations occurring during the culture adaptation process. 
These include the reported deletion of chromosome regions that are essential 
for the production of gametocytes (Alano et al. 1995) and the identification of 
gene copy number amplification and deletion events throughout the genome of 
laboratory adapted clones (Cheeseman et al. 2009).  
To complement further phenotyping of ex vivo clinical isolates further, two key 
developments are required. Firstly, high throughput protocols, potentially 
through adaptation of the approaches designed within this thesis, would 
significantly increase the production of isolate phenotyping data and ideally 
would be performed within a plate based format. Although gametocyte 
production methodologies are well established for laboratory clones (Fivelman 
et al. 2007; Brancucci et al. 2015; Delves et al. 2016), monitoring of ex vivo 
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gametocyte production has rarely been reported. Ex vivo attempts of 
gametocytogenesis of clinical isolates have described differences in ex vivo 
gametocyte production and sex ratio phenotypes of clones that had been 
propagated both within and between parental isolates (Ponnudurai et al. 1982; 
Graves et al. 1984). In addition, another study has reported that 100% of 44 
clinical isolates which underwent ex vivo culture adaptation continued to 
produce gametocytes after a period of between 4 and 11 weeks (Nakazawa et 
al. 2011). Despite the observations of phenotypic differences in 
gametocytogenesis, no study has characterised any genomic or transcriptional 
differences in parasites that show evidence of different gametocyte commitment 
strategies. 
Moreover, the culture adaptation process remains a limiting factor on the 
successful phenotyping of clinical isolates ex vivo, with significant nutritional 
and physiological differences between the in vitro and in vivo environments (Le 
Roux et al. 2009), in addition to the challenges associated with cryopreserving 
clinical isolates. Furthermore, the lower reported initial ex vivo PMR seen within 
African isolates (Deans et al. 2006) is likely to make adaptation of parasites 
from these populations more challenging than South-East Asian parasite 
populations (Chotivanich et al. 2000). Presently, it is still uncertain how ex vivo 
phenotypes of isolates correlate with in vivo phenotypes, particularly due to the 
phenotypic and transcriptional plasticity that has been widely reported within P. 
falciparum of both laboratory clones and clinical isolates. Establishment of 
clinical grade cell banks of ex vivo clinical isolates is a possibility for controlled 
human malaria infection studies (Stanisic et al. 2015), which would allow for 
such correlative studies of baseline phenotypes in vivo and ex vivo. 
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8.4 Identifying genomic determinants of phenotypic and transcriptional 
variation from recently adapted P. falciparum clinical isolates 
The principles of identifying loci that are highly significantly associated with a 
particular trait of P. falciparum recorded within natural populations has been 
pioneered through using a combination of parasite phenotyping and genetic 
differentiation and haplotype-based genome scans to identify regions that were 
associated with a slow artemisinin clearance phenotype exhibited by isolates 
within certain populations (Anderson et al. 2010; Cheeseman et al. 2012). Such 
an approach has been further advanced by the developments of pooled 
sequencing methods to scan for genomic determinants of a phenotype 
(Cheeseman et al. 2015). Within yeast genetics, due to the availability of high 
throughput methods for phenotyping and robust ex vivo adaptation possible, it 
has been possible to quantify heterogeneity of over 200 phenotypes and identify 
significantly associated genomic variants for 89 of them within Saccharmoyces 
pombe (Jeffares et al. 2015). These studies have all relied on using large 
sample size numbers of to associate genomic loci with a particular phenotype, 
whilst the broad range phenotyping applied to S. pombe is not presently 
feasible for application to P. falciparum.  
Within this thesis, two important phenotypes of clinical isolates are investigated; 
ex vivo PMR and gametocyte transcript expression. An alternative forward 
genetics based approach that would require only small numbers of isolates, 
limited whole-genome sequencing and enable rapid discovery of genes 
associated with particular phenotypes of P. falciparum would be a linkage group 
selection approach (Culleton et al. 2005). This would require the use of a 
humanized mouse within which harvest of recombinant progeny is possible 
(Vaughan et al. 2015) and ex vivo gametocytogenesis of clinical isolates 
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(Graves et al. 1984; Nakazawa et al. 2011). Other than the previous necessity 
to use a chimpanzee within a cross that is now avoided by the use of the 
humanized mouse, another current limit on a linkage group selection approach 
for P. falciparum is the development of phenotype-specific selection assays that 
are applied to pooled recombinant progeny.  For investigation of potential loci 
associated with PMR (section 6), two ex vivo isolates could be selected for 
crossing by exhibiting very different replication rate measures and subject to 
growth selection (Pattaradilokrat et al. 2009), followed by genome-wide 
sequencing of the selected progeny pool to identify loci that show evidence of 
increased homozygosity compared to the unselected progeny pool. 
This assay design, which would potentially be applicable to any phenotype 
which is selectable in vitro, consists of three stages; firstly selecting isolates 
showing marked variation in a particular phenotype, secondly gametocyte 
production of these clonal parasite lines and subsequent crossing within the 
humanized mouse model and thirdly a phenotype-specific selection assay on 
the recombinant progeny produced. So far only loci associated with growth 
rates, drug resistance and strain-specific immunity have been identified using a 
linkage group selection approach (section 1.8). A number of other phenotype-
selection assays are possible in vitro, but would be likely to result in the 
production of relatively low parasite densities, thus requiring the application of 
limited-cell sequencing approaches (Oyola et al. 2014). Another example of a 
phenotype-specific selection assay to identify associated genomic loci would be 
to induce gametocytogenesis in vitro for the pooled cross progeny, using a pan-
gametocyte or sex-specific selection assay, through the use of antibodies (Barr 
et al. 1991; Quakyi et al. 1987 and cell-sorting or magnetic separation (Ribaut et 
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al. 2008) to ensure a high purity population of gametocytes are selected and 
subsequently sequenced. 
 In addition, the high levels of transcriptional variation that are seen within P. 
falciparum could also be subject to a similar pooled progeny approach to 
identify genome regions polymorphisms that influence expression of a specific 
transcript, as performed using genome-wide  expression quantitative trait loci 
(eQTL) mapping of a genetic cross between HB3 and Dd2, which required 
culturing and microarray transcript profiling for 36 different clones at 18 hours 
post invasion (Gonzales et al. 2008). Clinical isolates display a spectrum of 
variation in transcript expression, most notably for transcripts expressed at the 
schizont stage (section 1.7). Antibody-based selection of differentially 
expressed transcripts (Nery et al. 2006) in a recombinant progeny pool and cell-
sorting could reveal genomic variants that regulate the expression of invasion 
genes (Josling et al. 2015), of which several are vaccine candidates for P. 
falciparum (Conway 2015). 
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